{ "source": "US FDA: original approvals since 2021 (Drugs@FDA)", "attribution": "Source: U.S. Food and Drug Administration, Drugs@FDA via openFDA. Not endorsed by the FDA.", "licence": "Public domain (U.S. government work); see openFDA terms", "retrieved": "2026-10-13T06:04:13+00:00", "count": 4765, "records": [ { "application_number": "ANDA215701", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090363", "application_type": "ANDA", "sponsor_name": "PIRAMAL CRITICAL", "brand_names": [ "DESFLURANE" ], "active_ingredients": [ "DESFLURANE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "INHALATION" ], "approval_date": "2026-10-05", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA220492", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219617", "application_type": "NDA", "sponsor_name": "EVER VALINJECT", "brand_names": [], "active_ingredients": [], "dosage_forms": [], "routes": [], "approval_date": "2026-10-01", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220722", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220181", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LEVOCARNITINE" ], "active_ingredients": [ "LEVOCARNITINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219175", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218361", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "MUPIROCIN CALCIUM" ], "active_ingredients": [ "MUPIROCIN CALCIUM" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220963", "application_type": "NDA", "sponsor_name": "RARE THYROID THERAPEUTICS INTERNATIONAL AB", "brand_names": [ "EMCITATE" ], "active_ingredients": [ "TIRATRICOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216254", "application_type": "ANDA", "sponsor_name": "NEPHRON", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212778", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "PREDNISOLONE ACETATE" ], "active_ingredients": [ "PREDNISOLONE ACETATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221198", "application_type": "NDA", "sponsor_name": "INCYTE CORP", "brand_names": [ "ATEBRIOZ" ], "active_ingredients": [ "ZILURGISERTIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA221109", "application_type": "NDA", "sponsor_name": "AZURITY PHARMACEUTICALS INC", "brand_names": [], "active_ingredients": [], "dosage_forms": [], "routes": [], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "NDA220415", "application_type": "NDA", "sponsor_name": "ABBVIE INC", "brand_names": [ "JUVMO" ], "active_ingredients": [ "TAVAPADON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA218379", "application_type": "NDA", "sponsor_name": "ADVENTAPHARMA DWC LLC", "brand_names": [ "ZUEINO" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761481", "application_type": "BLA", "sponsor_name": "TEVA PHARMACEUTICALS, INC.", "brand_names": [ "DEGEVMA" ], "active_ingredients": [ "DENOSUMAB-ADET" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA221041", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220590", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218687", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218485", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213131", "application_type": "ANDA", "sponsor_name": "HONG KONG", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203830", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "NAFCILLIN SODIUM" ], "active_ingredients": [ "NAFCILLIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216242", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CRISABOROLE" ], "active_ingredients": [ "CRISABOROLE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2026-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215268", "application_type": "ANDA", "sponsor_name": "NEPHRON", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211255", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "LINACLOTIDE" ], "active_ingredients": [ "LINACLOTIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220425", "application_type": "NDA", "sponsor_name": "ELEVAR THERAPEUTICS INC", "brand_names": [ "LYRFIGTU" ], "active_ingredients": [ "LIRAFUGRATINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761408", "application_type": "BLA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "ONSWIK" ], "active_ingredients": [ "INSULIN EFSITORA ALFA-GOBE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-09-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220876", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "NORGESTIMATE AND ETHINYL ESTRADIOL" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORGESTIMATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2026-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218355", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214598", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA222000", "application_type": "NDA", "sponsor_name": "AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE, USP" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2026-09-22", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA220509", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE" ], "active_ingredients": [ "HOMATROPINE METHYLBROMIDE", "HYDROCODONE BITARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212330", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "EMPAGLIFLOZIN" ], "active_ingredients": [ "EMPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210489", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "AMLODIPINE BESYLATE" ], "active_ingredients": [ "AMLODIPINE BESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220597", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217060", "application_type": "ANDA", "sponsor_name": "LANTHEUS MEDICAL", "brand_names": [ "BRAVNETSA" ], "active_ingredients": [ "LUTETIUM LU-177 DOTATATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220524", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219260", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218217", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LANREOTIDE ACETATE" ], "active_ingredients": [ "LANREOTIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219652", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217891", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "CALCIUM GLUCONATE IN SODIUM CHLORIDE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220657", "application_type": "ANDA", "sponsor_name": "DIFGEN PHARMS", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218560", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210944", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "MILNACIPRAN HYDROCHLORIDE" ], "active_ingredients": [ "MILNACIPRAN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207399", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "MILNACIPRAN HYDROCHLORIDE" ], "active_ingredients": [ "MILNACIPRAN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218525", "application_type": "NDA", "sponsor_name": "CURIUM", "brand_names": [ "BEXLUTRY" ], "active_ingredients": [ "LUTETIUM LU-177 DOTATATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220438", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "LETROZOLE" ], "active_ingredients": [ "LETROZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219832", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218210", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214418", "application_type": "ANDA", "sponsor_name": "AUROLIFE PHARMA LLC", "brand_names": [ "BECLOMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BECLOMETHASONE DIPROPIONATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218592", "application_type": "NDA", "sponsor_name": "TELIX", "brand_names": [ "PIXCLARA" ], "active_ingredients": [ "FLORETYROSINE F-18" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-09-11", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761463", "application_type": "BLA", "sponsor_name": "SCHOLAR ROCK INC", "brand_names": [ "ISEMBYLD" ], "active_ingredients": [ "APITEGROMAB-MSTN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-11", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219579", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217072", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "METOCLOPRAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "METOCLOPRAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220884", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "SPIRONOLACTONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220336", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220136", "application_type": "ANDA", "sponsor_name": "ZHEJIANG JUTAI PHARM", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211182", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "IBRUTINIB" ], "active_ingredients": [ "IBRUTINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220359", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "ETCAMAH" ], "active_ingredients": [ "CAMIZESTRANT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-04", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219183", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220613", "application_type": "NDA", "sponsor_name": "HANDA ONCOL", "brand_names": [ "OMCAZIO" ], "active_ingredients": [ "CABOZANTINIB LAURYLSULFATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA220210", "application_type": "NDA", "sponsor_name": "IONIS PHARMS INC", "brand_names": [ "ZANVASTRO" ], "active_ingredients": [ "ZILGANERSEN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRATHECAL" ], "approval_date": "2026-09-03", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220865", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TAPENTADOL HYDROCHLORIDE" ], "active_ingredients": [ "TAPENTADOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219478", "application_type": "ANDA", "sponsor_name": "BPI LABS", "brand_names": [ "TESTOSTERONE CYPIONATE" ], "active_ingredients": [ "TESTOSTERONE CYPIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208343", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "MODAFINIL" ], "active_ingredients": [ "MODAFINIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214523", "application_type": "ANDA", "sponsor_name": "PRECISION DOSE INC", "brand_names": [ "ALENDRONATE SODIUM" ], "active_ingredients": [ "ALENDRONATE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213631", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210245", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220919", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "DIFELIKEFALIN ACETATE" ], "active_ingredients": [ "DIFELIKEFALIN ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220741", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219718", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219429", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS LTD", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213234", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210232", "application_type": "ANDA", "sponsor_name": "SPIL", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220605", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS AM", "brand_names": [ "MIMRYLO" ], "active_ingredients": [ "RUSFERTIDE ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-08-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219037", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "CALCIUM GLUCONATE IN SODIUM CHLORIDE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221443", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "BIXLENVO SUNLENCA STARTER PACK (COPACKAGED)" ], "active_ingredients": [ "BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM", "LENACAPAVIR SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-27", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA221104", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "BIXLENVO" ], "active_ingredients": [ "BICTEGRAVIR SODIUM", "LENACAPAVIR SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-27", "review_priority": "PRIORITY", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA220106", "application_type": "NDA", "sponsor_name": "PRIOVANT THERAP", "brand_names": [ "LISRAYA" ], "active_ingredients": [ "BREPOCITINIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220938", "application_type": "ANDA", "sponsor_name": "ORBICULAR PHARM TECH", "brand_names": [ "NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2026-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220910", "application_type": "NDA", "sponsor_name": "REVOLUTION MEDICINES", "brand_names": [ "RASONQUE" ], "active_ingredients": [ "DARAXONRASIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA213225", "application_type": "NDA", "sponsor_name": "SUN PHARM", "brand_names": [ "VOBRIG" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-08-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214173", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219519", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "RIFABUTIN" ], "active_ingredients": [ "RIFABUTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204681", "application_type": "ANDA", "sponsor_name": "SOCORRO N1", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2026-08-21", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA220873", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ASCORBIC ACID" ], "active_ingredients": [ "ASCORBIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218869", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218419", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "LISINOPRIL" ], "active_ingredients": [ "LISINOPRIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761508", "application_type": "BLA", "sponsor_name": "REGENERON PHARMACEUTICALS, INC", "brand_names": [ "PASATRU" ], "active_ingredients": [ "GARETOSMAB-GRTS" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220118", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216255", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219942", "application_type": "ANDA", "sponsor_name": "STERINOVA INC", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219232", "application_type": "ANDA", "sponsor_name": "GLENMARK SPECLT", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2026-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210592", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209813", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218524", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219460", "application_type": "ANDA", "sponsor_name": "CREEKWOOD PHARMS", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218873", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PITOLISANT HYDROCHLORIDE" ], "active_ingredients": [ "PITOLISANT HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218846", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PITOLISANT HYDROCHLORIDE" ], "active_ingredients": [ "PITOLISANT HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213878", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CABOZANTINIB S-MALATE" ], "active_ingredients": [ "CABOZANTINIB S-MALATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221075", "application_type": "NDA", "sponsor_name": "BRISTOL MYERS SQUIBB", "brand_names": [ "ZENBEXUS" ], "active_ingredients": [ "IBERDOMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA220496", "application_type": "NDA", "sponsor_name": "CERVEAU LANTHEUS", "brand_names": [ "TAUKLARIFY" ], "active_ingredients": [ "FLORQUINITAU F-18" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220465", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "FIDAXOMICIN" ], "active_ingredients": [ "FIDAXOMICIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210426", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220110", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2026-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205357", "application_type": "ANDA", "sponsor_name": "BOSTAL DRUG", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220288", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219286", "application_type": "ANDA", "sponsor_name": "VIWIT PHARM", "brand_names": [ "GADOTERATE MEGLUMINE" ], "active_ingredients": [ "GADOTERATE MEGLUMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221892", "application_type": "NDA", "sponsor_name": "LINDE GAS EQUIP", "brand_names": [ "NITROUS OXIDE, USP" ], "active_ingredients": [ "NITROUS OXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2026-08-09", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA218130", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217549", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SODIUM ZIRCONIUM CYCLOSILICATE" ], "active_ingredients": [ "SODIUM ZIRCONIUM CYCLOSILICATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208757", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS UT INC", "brand_names": [ "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "BENZOYL PEROXIDE", "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220448", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LORATADINE AND PSEUDOEPHEDRINE SULFATE" ], "active_ingredients": [ "LORATADINE", "PSEUDOEPHEDRINE SULFATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208458", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220860", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "ORZEYFUL" ], "active_ingredients": [ "OVEPOREXTON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-05", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216481", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214551", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219946", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219334", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219926", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219139", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "INDOCYANINE GREEN" ], "active_ingredients": [ "INDOCYANINE GREEN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761376", "application_type": "BLA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "ZIMRIXBY" ], "active_ingredients": [ "RITUXIMAB-CDXX" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2026-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220513", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220017", "application_type": "ANDA", "sponsor_name": "KLM LABS PVT", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219996", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217426", "application_type": "ANDA", "sponsor_name": "DEVA HLDING", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220413", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220172", "application_type": "ANDA", "sponsor_name": "STIRA", "brand_names": [ "ASCORBIC ACID" ], "active_ingredients": [ "ASCORBIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221094", "application_type": "NDA", "sponsor_name": "CMP DEV LLC", "brand_names": [ "QLONILIK" ], "active_ingredients": [ "CLONIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-07-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA220381", "application_type": "NDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "GLYCOPHOS" ], "active_ingredients": [ "SODIUM GLYCEROPHOSPHATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-29", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217505", "application_type": "ANDA", "sponsor_name": "LNK INTL INC", "brand_names": [ "POLYETHYLENE GLYCOL 3350" ], "active_ingredients": [ "POLYETHYLENE GLYCOL 3350" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212496", "application_type": "ANDA", "sponsor_name": "ANDAS 5 HOLDING", "brand_names": [ "DOFETILIDE" ], "active_ingredients": [ "DOFETILIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219990", "application_type": "NDA", "sponsor_name": "VIATRIS SPECIALTY", "brand_names": [ "GWYN LO" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORELGESTROMIN" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220579", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219882", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219448", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218814", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218728", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218727", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215575", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215260", "application_type": "ANDA", "sponsor_name": "TAMARANG", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214368", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214364", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214338", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214319", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214311", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214306", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214236", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214230", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214126", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213915", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220365", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219234", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213087", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2026-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219962", "application_type": "NDA", "sponsor_name": "KENVUE BRANDS", "brand_names": [ "TYLENOL WITH NAPROXEN" ], "active_ingredients": [ "ACETAMINOPHEN", "NAPROXEN SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-24", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA218145", "application_type": "NDA", "sponsor_name": "OTSUKA PHARMACEUTICAL CO LTD", "brand_names": [ "SIMTRIYO" ], "active_ingredients": [ "CENTANAFADINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [], "approval_date": "2026-07-24", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761497", "application_type": "BLA", "sponsor_name": "EMERGE BIOSCIENCE PTE. LTD.", "brand_names": [ "GARZULYS" ], "active_ingredients": [ "INSULIN ASPART-FSAN" ], "dosage_forms": [ "VIAL", "PEN" ], "routes": [ "MULTIDOSE", "PREFILLED" ], "approval_date": "2026-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761320", "application_type": "BLA", "sponsor_name": "OUTLOOK THERAPEUTICS, INC.", "brand_names": [ "LYTENAVA" ], "active_ingredients": [ "BEVACIZUMAB-VIKG" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-DOSE" ], "approval_date": "2026-07-24", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA220196", "application_type": "ANDA", "sponsor_name": "HISUN PHARM HANGZHOU", "brand_names": [ "FLUDARABINE PHOSPHATE" ], "active_ingredients": [ "FLUDARABINE PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220185", "application_type": "NDA", "sponsor_name": "NUVALENT", "brand_names": [ "JIDEYTRO" ], "active_ingredients": [ "ZIDESAMTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220943", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220076", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218349", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217384", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ADAPALENE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220447", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218495", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PITOLISANT HYDROCHLORIDE" ], "active_ingredients": [ "PITOLISANT HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216933", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216051", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209526", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CARFILZOMIB" ], "active_ingredients": [ "CARFILZOMIB" ], "dosage_forms": [ "INJECTABLE", "POWDER" ], "routes": [ "INJECTION", "INTRAVENOUS" ], "approval_date": "2026-07-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221805", "application_type": "NDA", "sponsor_name": "NOBLE GAS SOLUTIONS INC.", "brand_names": [ "AIR" ], "active_ingredients": [ "AIR" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2026-07-19", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA216515", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218298", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2026-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220848", "application_type": "NDA", "sponsor_name": "MSD", "brand_names": [ "LIPFENDRA" ], "active_ingredients": [ "ENLICITIDE DECANOATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214872", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ETODOLAC" ], "active_ingredients": [ "ETODOLAC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219908", "application_type": "NDA", "sponsor_name": "CELCUITY", "brand_names": [ "REVTORPYK" ], "active_ingredients": [ "GEDATOLISIB" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220857", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "PROPOFOL" ], "active_ingredients": [ "PROPOFOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210750", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "AFATINIB DIMALEATE" ], "active_ingredients": [ "AFATINIB DIMALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210725", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "AFATINIB DIMALEATE" ], "active_ingredients": [ "AFATINIB DIMALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219766", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213204", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "ALPRAZOLAM" ], "active_ingredients": [ "ALPRAZOLAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209938", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218579", "application_type": "NDA", "sponsor_name": "PROVEPHARM SAS", "brand_names": [ "ZYOGREEN" ], "active_ingredients": [ "INDOCYANINE GREEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, INTERSTITIAL" ], "approval_date": "2026-07-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219788", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "RILPIVIRINE HYDROCHLORIDE" ], "active_ingredients": [ "RILPIVIRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214997", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "ILOPROST" ], "active_ingredients": [ "ILOPROST" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2026-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220790", "application_type": "NDA", "sponsor_name": "AMNEAL", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-09", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761445", "application_type": "BLA", "sponsor_name": "SANOFI-AVENTIS U.S. LLC", "brand_names": [ "SARCLISA ESCENA" ], "active_ingredients": [ "ISATUXIMAB-IRFC" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-DOSE" ], "approval_date": "2026-07-09", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218472", "application_type": "ANDA", "sponsor_name": "HUMANWELL PURACAP", "brand_names": [ "NINTEDANIB ESYLATE", "NINTEDANIB" ], "active_ingredients": [ "NINTEDANIB ESYLATE", "NINTEDANIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217461", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2026-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212555", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219820", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218335", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216740", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761486", "application_type": "BLA", "sponsor_name": "VERA THERAPEUTICS INC.", "brand_names": [ "TRUTAKNA" ], "active_ingredients": [ "ATACICEPT-VYMJ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-07-07", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220173", "application_type": "ANDA", "sponsor_name": "RENOVA PHARMS", "brand_names": [ "DIMETHYL SULFOXIDE" ], "active_ingredients": [ "DIMETHYL SULFOXIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVESICAL" ], "approval_date": "2026-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219670", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DESOGESTREL AND ETHINYL ESTRADIOL" ], "active_ingredients": [ "DESOGESTREL", "ETHINYL ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2026-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213892", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219382", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219089", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214565", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "INTRA-ANAL" ], "approval_date": "2026-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217896", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "LEVOCARNITINE" ], "active_ingredients": [ "LEVOCARNITINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220874", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219952", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217934", "application_type": "ANDA", "sponsor_name": "SABA ILAC SANAYIVE", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212972", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212229", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219565", "application_type": "ANDA", "sponsor_name": "UNIQUE", "brand_names": [ "ADAPALENE" ], "active_ingredients": [ "ADAPALENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219464", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219322", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208334", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219918", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "RIFAMPIN" ], "active_ingredients": [ "RIFAMPIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219180", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215957", "application_type": "ANDA", "sponsor_name": "GE HLTHCARE", "brand_names": [ "PIXXOSCAN" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213331", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761530", "application_type": "BLA", "sponsor_name": "VIRIDIAN THERAPEUTICS INC", "brand_names": [ "LUMVOA" ], "active_ingredients": [ "VELIGROTUG-VVZE" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2026-06-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219647", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "TRAMADOL HYDROCHLORIDE" ], "active_ingredients": [ "TRAMADOL HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219134", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "NILOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "NILOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218035", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220972", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218307", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217769", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "FERRIC CARBOXYMALTOSE" ], "active_ingredients": [ "FERRIC CARBOXYMALTOSE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217076", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "FERRIC CARBOXYMALTOSE" ], "active_ingredients": [ "FERRIC CARBOXYMALTOSE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213414", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212572", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "FERRIC CARBOXYMALTOSE" ], "active_ingredients": [ "FERRIC CARBOXYMALTOSE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220436", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "NAVITRUX" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218949", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217238", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220869", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "PROMETHAZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2026-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220768", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218567", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217042", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "RIFAPENTINE" ], "active_ingredients": [ "RIFAPENTINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203611", "application_type": "ANDA", "sponsor_name": "ACTAVIS ELIZABETH", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-23", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA219324", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "LO JUNEL FE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215960", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "UTEBZI" ], "active_ingredients": [ "TEBIPENEM PIVOXIL HYDROBROMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219470", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "ELIXIR" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218722", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "SOLRIAMFETOL HYDROCHLORIDE" ], "active_ingredients": [ "SOLRIAMFETOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218016", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SOLRIAMFETOL HYDROCHLORIDE" ], "active_ingredients": [ "SOLRIAMFETOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217449", "application_type": "ANDA", "sponsor_name": "NORWICH", "brand_names": [ "BALOXAVIR MARBOXIL" ], "active_ingredients": [ "BALOXAVIR MARBOXIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217329", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "FOSTAMATINIB DISODIUM" ], "active_ingredients": [ "FOSTAMATINIB DISODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208815", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218754", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "APREPITANT" ], "active_ingredients": [ "APREPITANT" ], "dosage_forms": [ "EMULSION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-16", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218875", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "ATOMOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "ATOMOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220309", "application_type": "ANDA", "sponsor_name": "RENATA", "brand_names": [ "CABERGOLINE" ], "active_ingredients": [ "CABERGOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219052", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217596", "application_type": "ANDA", "sponsor_name": "PROD DEVELOPMENT", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213155", "application_type": "ANDA", "sponsor_name": "MYLAN INSTITUTIONAL", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219627", "application_type": "NDA", "sponsor_name": "BAYER HEALTHCARE", "brand_names": [ "AMBELVIST" ], "active_ingredients": [ "GADOQUATRANE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA209624", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BOSUTINIB", "BOSUTINIB MONOHYDRATE" ], "active_ingredients": [ "BOSUTINIB MONOHYDRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "FILM COATED", "ORAL" ], "approval_date": "2026-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220271", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "HYDROXYZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROXYZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2026-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219287", "application_type": "ANDA", "sponsor_name": "VIWIT PHARM", "brand_names": [ "GADOBUTROL" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219166", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216272", "application_type": "ANDA", "sponsor_name": "NEPHRON", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214590", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219165", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219830", "application_type": "ANDA", "sponsor_name": "ORIENT PHARMA", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219370", "application_type": "ANDA", "sponsor_name": "PHARMACO", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218900", "application_type": "ANDA", "sponsor_name": "SAPTALIS PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218821", "application_type": "ANDA", "sponsor_name": "CONCORD BIOTECH LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215552", "application_type": "ANDA", "sponsor_name": "YAOPHARMA CO LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213568", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "CEPHALEXIN" ], "active_ingredients": [ "CEPHALEXIN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219146", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "GADOBUTROL" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216410", "application_type": "ANDA", "sponsor_name": "RADIOMEDIX", "brand_names": [ "GALLIUM GA 68 GOZETOTIDE" ], "active_ingredients": [ "GALLIUM GA-68 GOZETOTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211187", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211000", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219604", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "DALBAVANCIN HYDROCHLORIDE" ], "active_ingredients": [ "DALBAVANCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215485", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "RAMELTEON" ], "active_ingredients": [ "RAMELTEON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214470", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213703", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CANGRELOR" ], "active_ingredients": [ "CANGRELOR" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220458", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220137", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219530", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219395", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218407", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218096", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217299", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217298", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215356", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209633", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204196", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "QUINIDINE SULFATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212927", "application_type": "NDA", "sponsor_name": "CASPER PHARMA LLC", "brand_names": [ "TIOCYSTIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-02", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761480", "application_type": "BLA", "sponsor_name": "LUPIN LIMITED", "brand_names": [ "RANLUSPEC" ], "active_ingredients": [ "RANIBIZUMAB-HKDZ" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2026-06-02", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA219099", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ROMIDEPSIN" ], "active_ingredients": [ "ROMIDEPSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213511", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ELUXADOLINE" ], "active_ingredients": [ "ELUXADOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219288", "application_type": "ANDA", "sponsor_name": "JIANGSU ANBISON", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218651", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "FLUORESCEIN SODIUM" ], "active_ingredients": [ "FLUORESCEIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218566", "application_type": "ANDA", "sponsor_name": "NEOCUBES PHARMA", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217734", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217085", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220787", "application_type": "NDA", "sponsor_name": "WOCKHARDT BIO AG", "brand_names": [ "ZAYNICH" ], "active_ingredients": [ "CEFEPIME HYDROCHLORIDE", "ZIDEBACTAM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "NDA220482", "application_type": "NDA", "sponsor_name": "HAISCO", "brand_names": [ "CYPSEDO" ], "active_ingredients": [ "CIPEPOFOL" ], "dosage_forms": [ "EMULSION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA220442", "application_type": "NDA", "sponsor_name": "SHIONOGI", "brand_names": [ "XOCOVA" ], "active_ingredients": [ "ENSITRELVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA217379", "application_type": "NDA", "sponsor_name": "CYCLE", "brand_names": [ "CAVHANZA" ], "active_ingredients": [ "NILOTINIB" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2026-05-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220562", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209020", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220709", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216095", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM CHLORIDE", "SODIUM SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761460", "application_type": "BLA", "sponsor_name": "ABBVIE INC", "brand_names": [ "DECNUPAZ" ], "active_ingredients": [ "PIVEKIMAB SUNIRINE-PVZY" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-DOSE" ], "approval_date": "2026-05-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219869", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219529", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208433", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220041", "application_type": "ANDA", "sponsor_name": "RICONPHARMA LLC", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219722", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "L-GLUTAMINE" ], "active_ingredients": [ "L-GLUTAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215217", "application_type": "ANDA", "sponsor_name": "NEPHRON", "brand_names": [ "LEVALBUTEROL HYDROCHLORIDE" ], "active_ingredients": [ "LEVALBUTEROL HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2026-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220736", "application_type": "NDA", "sponsor_name": "GALDERMA LABS LP", "brand_names": [ "DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)", "DIFFERIN EPIDUO" ], "active_ingredients": [ "ADAPALENE, BENZOYL PEROXIDE", "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-05-22", "review_priority": "STANDARD", "submission_class": "Type 8 - Partial Rx to OTC Switch" }, { "application_number": "BLA761468", "application_type": "BLA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "HEPCLUDEX" ], "active_ingredients": [ "BULEVIRTIDE-GMOD" ], "dosage_forms": [ "INJECTION" ], "routes": [ "POWDER,FOR SOLUTION" ], "approval_date": "2026-05-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220366", "application_type": "ANDA", "sponsor_name": "STERANCO HLTHCARE", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216988", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CLONAZEPAM" ], "active_ingredients": [ "CLONAZEPAM" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2026-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216370", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220104", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "MIRTAZAPINE" ], "active_ingredients": [ "MIRTAZAPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220299", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216910", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219878", "application_type": "NDA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "BAXFENDY" ], "active_ingredients": [ "BAXDROSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761452", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "IMMGOLIS", "IMMGOLIS INTRI" ], "active_ingredients": [ "GOLIMUMAB-SLDI" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220673", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "CLOMIPHENE CITRATE" ], "active_ingredients": [ "CLOMIPHENE CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217758", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "AMMONIUM LACTATE" ], "active_ingredients": [ "AMMONIUM LACTATE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215820", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214733", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "VENETOCLAX" ], "active_ingredients": [ "VENETOCLAX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210329", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219622", "application_type": "NDA", "sponsor_name": "CHIESI", "brand_names": [ "TRIMBOW" ], "active_ingredients": [ "BECLOMETHASONE DIPROPIONATE", "FORMOTEROL FUMARATE", "GLYCOPYRROLATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-05-14", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA219750", "application_type": "ANDA", "sponsor_name": "RENOVA PHARMS", "brand_names": [ "L-GLUTAMINE" ], "active_ingredients": [ "L-GLUTAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219189", "application_type": "ANDA", "sponsor_name": "IONETIX", "brand_names": [ "GALLIUM GA 68 GOZETOTIDE" ], "active_ingredients": [ "GALLIUM GA-68 GOZETOTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218691", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "CEFIXIME" ], "active_ingredients": [ "CEFIXIME" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217497", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220711", "application_type": "NDA", "sponsor_name": "BEONE MEDICINES USA", "brand_names": [ "BEQALZI" ], "active_ingredients": [ "SONROTOCLAX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220068", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220717", "application_type": "ANDA", "sponsor_name": "UMEDICA LABS PVT", "brand_names": [ "ZOLPIDEM TARTRATE" ], "active_ingredients": [ "ZOLPIDEM TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218488", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217432", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218214", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2026-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218364", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761147", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "ENNUMO" ], "active_ingredients": [ "PEGFILGRASTIM-PCCG" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218558", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217191", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "active_ingredients": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205402", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212069", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212068", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220078", "application_type": "ANDA", "sponsor_name": "ZHEJIANG NOVUS", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220529", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218840", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "CALCIUM GLUCONATE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220837", "application_type": "NDA", "sponsor_name": "APOTEX", "brand_names": [ "EVDI" ], "active_ingredients": [ "TRABECTEDIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-05-01", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA219835", "application_type": "NDA", "sponsor_name": "RIGEL PHARMS", "brand_names": [ "VEPPANU" ], "active_ingredients": [ "VEPDEGESTRANT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-01", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA217180", "application_type": "NDA", "sponsor_name": "INCYTE CORP", "brand_names": [ "JAKAFI XR" ], "active_ingredients": [ "RUXOLITINIB PHOSPHATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-01", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219941", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217239", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TORSEMIDE" ], "active_ingredients": [ "TORSEMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203103", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-05-01", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA220328", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220046", "application_type": "ANDA", "sponsor_name": "BPI LABS", "brand_names": [ "FLUORESCEIN SODIUM" ], "active_ingredients": [ "FLUORESCEIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219865", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219593", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207694", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202426", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-30", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761412", "application_type": "BLA", "sponsor_name": "SUNSHINE LAKE PHARMA CO LTD", "brand_names": [ "LANGLARA" ], "active_ingredients": [ "INSULIN GLARGINE-ALDY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218740", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218341", "application_type": "ANDA", "sponsor_name": "UMEDICA LABS PVT", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220660", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213919", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208539", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761451", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "SAPHNELO" ], "active_ingredients": [ "ANIFROLUMAB-FNIA" ], "dosage_forms": [ "INJECTION", "VIAL" ], "routes": [ "SINGLE-USE" ], "approval_date": "2026-04-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA207974", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220568", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212212", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE" ], "active_ingredients": [ "BUDESONIDE", "FORMOTEROL FUMARATE DIHYDRATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204687", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "VALSARTAN AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-23", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA220493", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219973", "application_type": "ANDA", "sponsor_name": "SHUANGCHENG", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219409", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218093", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FLECAINIDE ACETATE" ], "active_ingredients": [ "FLECAINIDE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091655", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "ESCITALOPRAM OXALATE" ], "active_ingredients": [ "ESCITALOPRAM OXALATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-22", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA220147", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218897", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210671", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MULTIPLE VITAMINS INJECTION PEDIATRIC" ], "active_ingredients": [ "ASCORBIC ACID", "BIOTIN", "CHOLECALCIFEROL", "CYANOCOBALAMIN", "DEXPANTHENOL", "FOLIC ACID", "NIACINAMIDE", "PYRIDOXINE", "RIBOFLAVIN", "THIAMINE", "TOCOPHEROL ACETATE", "VITAMIN A", "VITAMIN K" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210456", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MULTIPLE VITAMINS INJECTION PEDIATRIC (PHARMACY BULK PACKAGE)" ], "active_ingredients": [ "ASCORBIC ACID", "BIOTIN", "CHOLECALCIFEROL", "CYANOCOBALAMIN", "DEXPANTHENOL", "FOLIC ACID", "NIACINAMIDE", "PYRIDOXINE", "RIBOFLAVIN", "THIAMINE", "TOCOPHEROL ACETATE", "VITAMIN A", "VITAMIN K" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216964", "application_type": "NDA", "sponsor_name": "MSD", "brand_names": [ "IDVYNSO" ], "active_ingredients": [ "DORAVIRINE", "ISLATRAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-20", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA216068", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "ENZALUTAMIDE" ], "active_ingredients": [ "ENZALUTAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212597", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210386", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CANAGLIFLOZIN" ], "active_ingredients": [ "CANAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220274", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SODIUM ACETATE" ], "active_ingredients": [ "SODIUM ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220398", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214055", "application_type": "ANDA", "sponsor_name": "RK PHARMA", "brand_names": [ "SELEXIPAG" ], "active_ingredients": [ "SELEXIPAG" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220788", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220313", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220225", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219540", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219013", "application_type": "ANDA", "sponsor_name": "EDENBRIDGE PHARMS", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218738", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218417", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DEXTROMETHORPHAN POLISTIREX" ], "active_ingredients": [ "DEXTROMETHORPHAN POLISTIREX" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208103", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210449", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CANAGLIFLOZIN" ], "active_ingredients": [ "CANAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219897", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PIMOZIDE" ], "active_ingredients": [ "PIMOZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206371", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217772", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210672", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MULTIPLE VITAMINS INJECTION ADULT" ], "active_ingredients": [ "ALPHA-TOCOPHEROL ACETATE", "ASCORBIC ACID", "BIOTIN", "CHOLECALCIFEROL", "CYANOCOBALAMIN", "DEXPANTHENOL", "FOLIC ACID", "NIACINAMIDE", "PYRIDOXINE HYDROCHLORIDE", "RIBOFLAVIN 5'-PHOSPHATE SODIUM", "THIAMINE HYDROCHLORIDE", "VITAMIN A PALMITATE", "VITAMIN K" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210273", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MULTIPLE VITAMINS INJECTION ADULT" ], "active_ingredients": [ "ALPHA-TOCOPHEROL ACETATE", "ASCORBIC ACID", "BIOTIN", "CHOLECALCIFEROL", "CYANOCOBALAMIN", "DEXPANTHENOL", "FOLIC ACID", "NIACINAMIDE", "PYRIDOXINE HYDROCHLORIDE", "RIBOFLAVIN 5'-PHOSPHATE SODIUM", "THIAMINE HYDROCHLORIDE", "VITAMIN A PALMITATE", "VITAMIN K" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220033", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218557", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216363", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS", "brand_names": [ "PROGESTERONE" ], "active_ingredients": [ "PROGESTERONE" ], "dosage_forms": [ "INSERT" ], "routes": [ "VAGINAL" ], "approval_date": "2026-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220269", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218509", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214216", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211595", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211583", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211582", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211579", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211563", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211560", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211559", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211545", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211541", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211537", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211536", "application_type": "ANDA", "sponsor_name": "CIPLA LTD", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211535", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211533", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211531", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211523", "application_type": "ANDA", "sponsor_name": "AIZANT", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211506", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211491", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211489", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE", "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET", "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211482", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211479", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211478", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211470", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211468", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211467", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211466", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "DAPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211312", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211156", "application_type": "ANDA", "sponsor_name": "INVENTIA", "brand_names": [ "DAPAGLIFLOZIN" ], "active_ingredients": [ "DAPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217032", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214448", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "GLYCOPYRRONIUM TOSYLATE" ], "active_ingredients": [ "GLYCOPYRRONIUM TOSYLATE" ], "dosage_forms": [ "CLOTH" ], "routes": [ "TOPICAL" ], "approval_date": "2026-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219819", "application_type": "ANDA", "sponsor_name": "DEXCEL", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219283", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219227", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216915", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212609", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "NINTEDANIB ESYLATE" ], "active_ingredients": [ "NINTEDANIB ESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220934", "application_type": "NDA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "FOUNDAYO" ], "active_ingredients": [ "ORFORGLIPRON CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-04-01", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220016", "application_type": "ANDA", "sponsor_name": "KLM LABS PVT", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "ENEMA" ], "routes": [ "RECTAL" ], "approval_date": "2026-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208465", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220626", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-03-30", "review_priority": "STANDARD", "submission_class": "New Combination and New Formulation or New Manufacturer" }, { "application_number": "ANDA220298", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "BENZONATATE" ], "active_ingredients": [ "BENZONATATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212552", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761385", "application_type": "BLA", "sponsor_name": "TEVA PHARMACEUTICALS, INC.", "brand_names": [ "PONLIMSI" ], "active_ingredients": [ "DENOSUMAB-ADET" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-03-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215547", "application_type": "ANDA", "sponsor_name": "HOPEWELL PHARMA", "brand_names": [ "CLADRIBINE" ], "active_ingredients": [ "CLADRIBINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761326", "application_type": "BLA", "sponsor_name": "NOVO NORDISK INC", "brand_names": [ "AWIQLI FLEXTOUCH" ], "active_ingredients": [ "INSULIN ICODEC" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2026-03-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220483", "application_type": "ANDA", "sponsor_name": "SAGENT", "brand_names": [ "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220641", "application_type": "NDA", "sponsor_name": "CORCEPT THERAP", "brand_names": [ "LIFYORLI (COPACKAGED)" ], "active_ingredients": [ "RELACORILANT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217832", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761485", "application_type": "BLA", "sponsor_name": "DENALI THERAPEUTICS INC.", "brand_names": [ "AVLAYAH" ], "active_ingredients": [ "TIVIDENOFUSP ALFA-EKNM" ], "dosage_forms": [ "INJECTION" ], "routes": [ "POWDER,FOR SOLUTION" ], "approval_date": "2026-03-24", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220675", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219489", "application_type": "ANDA", "sponsor_name": "UNIQUE PHARM", "brand_names": [ "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219006", "application_type": "ANDA", "sponsor_name": "ZHEJIANG JINGXIN", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219987", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218300", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "SWAB" ], "routes": [ "TOPICAL" ], "approval_date": "2026-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217607", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CEFIXIME" ], "active_ingredients": [ "CEFIXIME" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220320", "application_type": "NDA", "sponsor_name": "MAP77", "brand_names": [ "ATONCY" ], "active_ingredients": [ "ATOMOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-20", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218676", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216564", "application_type": "NDA", "sponsor_name": "DEPROCO", "brand_names": [ "FLAVALTA" ], "active_ingredients": [ "EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220071", "application_type": "ANDA", "sponsor_name": "VIWIT PHARM", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219991", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218838", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212430", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "RIFABUTIN" ], "active_ingredients": [ "RIFABUTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208959", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "RIFAXIMIN" ], "active_ingredients": [ "RIFAXIMIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219761", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DESOGESTREL AND ETHINYL ESTRADIOL" ], "active_ingredients": [ "DESOGESTREL", "ETHINYL ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2026-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218942", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220295", "application_type": "NDA", "sponsor_name": "INTERCEPT", "brand_names": [ "LYNAVOY" ], "active_ingredients": [ "LINERIXIBAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA220149", "application_type": "NDA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "ICOTYDE" ], "active_ingredients": [ "ICOTROKINRA HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220296", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219121", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ELTROMBOPAG", "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG", "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219054", "application_type": "ANDA", "sponsor_name": "XGEN PHARMS", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218984", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ACAMPROSATE CALCIUM" ], "active_ingredients": [ "ACAMPROSATE CALCIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218742", "application_type": "ANDA", "sponsor_name": "GLENMARK SPECLT", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2026-03-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219985", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CITALOPRAM HYDROBROMIDE" ], "active_ingredients": [ "CITALOPRAM HYDROBROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216298", "application_type": "ANDA", "sponsor_name": "ORBICULAR", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220373", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218264", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "PROMETHAZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2026-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220267", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "CEVIMELINE HYDROCHLORIDE" ], "active_ingredients": [ "CEVIMELINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219219", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215245", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212563", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "FERRIC CITRATE" ], "active_ingredients": [ "FERRIC CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220460", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "DESVENLAFAXINE SUCCINATE" ], "active_ingredients": [ "DESVENLAFAXINE SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219997", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220281", "application_type": "ANDA", "sponsor_name": "STERANCO HLTHCARE", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219603", "application_type": "ANDA", "sponsor_name": "CONTRACT PHARMACAL", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218675", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218303", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216808", "application_type": "ANDA", "sponsor_name": "E5 PHARMA", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220089", "application_type": "NDA", "sponsor_name": "APHELION", "brand_names": [ "PYLARIFY TRUVU" ], "active_ingredients": [ "PIFLUFOLASTAT F-18" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-06", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219814", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218459", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "SIPONIMOD" ], "active_ingredients": [ "SIPONIMOD" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220323", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2026-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220239", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219954", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219318", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "CHOLESTYRAMINE" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2026-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218851", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "APREPITANT" ], "active_ingredients": [ "APREPITANT" ], "dosage_forms": [ "EMULSION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220232", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "RILPIVIRINE HYDROCHLORIDE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220124", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219159", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "GLIPIZIDE" ], "active_ingredients": [ "GLIPIZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215864", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219602", "application_type": "ANDA", "sponsor_name": "GLENMARK SPECLT", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219556", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218427", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209143", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220092", "application_type": "NDA", "sponsor_name": "JANSSEN PRODS", "brand_names": [ "PREZCOBIX", "PREZCOBIX PED" ], "active_ingredients": [ "DARUNAVIR AND COBICISTAT", "COBICISTAT", "DARUNAVIR ETHANOLATE" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-27", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219164", "application_type": "NDA", "sponsor_name": "ASCENDIS", "brand_names": [ "YUVIWEL" ], "active_ingredients": [ "NAVEPEGRITIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-02-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA219131", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "DULOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "DULOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2026-02-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219981", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "DESMOPRESSIN ACETATE" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219796", "application_type": "ANDA", "sponsor_name": "HUMANWELL PURACAP", "brand_names": [ "CALCITRIOL" ], "active_ingredients": [ "CALCITRIOL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218744", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220454", "application_type": "ANDA", "sponsor_name": "NOVAX", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220427", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220103", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218602", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "DALBAVANCIN HYDROCHLORIDE" ], "active_ingredients": [ "DALBAVANCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216863", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216852", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219873", "application_type": "NDA", "sponsor_name": "ETON", "brand_names": [ "DESMODA" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA220335", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CETIRIZINE HYDROCHLORIDE" ], "active_ingredients": [ "CETIRIZINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220329", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220315", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219533", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217278", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2026-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219518", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218529", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217234", "application_type": "ANDA", "sponsor_name": "ORBICULAR", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217063", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761211", "application_type": "BLA", "sponsor_name": "IMMEDICA PHARMA AB", "brand_names": [ "LOARGYS" ], "active_ingredients": [ "PEGZILARGINASE-NBLN" ], "dosage_forms": [ "Injectable" ], "routes": [ "Injection" ], "approval_date": "2026-02-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220683", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "SODIUM PHOSPHATES" ], "active_ingredients": [ "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE", "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220470", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220385", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220164", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219772", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218494", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218249", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217953", "application_type": "ANDA", "sponsor_name": "ARMSTRONG PHARMS", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214924", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214880", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214875", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212027", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "EFINACONAZOLE" ], "active_ingredients": [ "EFINACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220358", "application_type": "NDA", "sponsor_name": "VANDA PHARMS INC", "brand_names": [ "BYSANTI" ], "active_ingredients": [ "MILSAPERIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-20", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA220201", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "FAVLYXA" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-20", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218768", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214922", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203276", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-19", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216208", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2026-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221337", "application_type": "NDA", "sponsor_name": "INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC", "brand_names": [ "MEDICAL AIR, USP" ], "active_ingredients": [], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2026-02-17", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA220418", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "SODIUM PHENYLBUTYRATE" ], "active_ingredients": [ "SODIUM PHENYLBUTYRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216921", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "IDELALISIB" ], "active_ingredients": [ "IDELALISIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213981", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "BOSENTAN" ], "active_ingredients": [ "BOSENTAN" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212880", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220200", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "AVOPEF" ], "active_ingredients": [ "ETOPOSIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-13", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761484", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "RYBREVANT FASPRO" ], "active_ingredients": [ "AMIVANTAMAB AND HYALURONIDASE-LPUJ" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-USE" ], "approval_date": "2026-02-13", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220095", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210633", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219474", "application_type": "NDA", "sponsor_name": "ACROTECH BIOPHARMA", "brand_names": [ "ADQUEY" ], "active_ingredients": [ "DIFAMILAST" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218819", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "FLUOROMETHOLONE" ], "active_ingredients": [ "FLUOROMETHOLONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217815", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "AMMONIUM LACTATE" ], "active_ingredients": [ "AMMONIUM LACTATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214022", "application_type": "ANDA", "sponsor_name": "HYBIO", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213382", "application_type": "ANDA", "sponsor_name": "HYBIO", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220308", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "FLUDROCORTISONE ACETATE" ], "active_ingredients": [ "FLUDROCORTISONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217833", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205057", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "TAPENTADOL HYDROCHLORIDE" ], "active_ingredients": [ "TAPENTADOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217408", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "METHAZOLAMIDE" ], "active_ingredients": [ "METHAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207059", "application_type": "ANDA", "sponsor_name": "USPHARMA", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "PATCH" ], "routes": [ "TOPICAL" ], "approval_date": "2026-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217679", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220367", "application_type": "ANDA", "sponsor_name": "STERANCO HLTHCARE", "brand_names": [ "NYSTATIN" ], "active_ingredients": [ "NYSTATIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219984", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ZOLEDRONIC ACID" ], "active_ingredients": [ "ZOLEDRONIC ACID" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219856", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "active_ingredients": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219071", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218535", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CARBIDOPA, LEVODOPA AND ENTACAPONE" ], "active_ingredients": [ "CARBIDOPA", "ENTACAPONE", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215362", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207069", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "AZTREONAM" ], "active_ingredients": [ "AZTREONAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219999", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "CARBOPLATIN" ], "active_ingredients": [ "CARBOPLATIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220406", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "VYKOURA" ], "active_ingredients": [ "LEUCOVORIN CALCIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2026-02-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219881", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "DOXORUBICIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXORUBICIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2026-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219472", "application_type": "ANDA", "sponsor_name": "EMERGE BIOSCIENCE", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221287", "application_type": "NDA", "sponsor_name": "GENERAL AIR SERVICE & SUPPLY COMPANY", "brand_names": [ "AIR" ], "active_ingredients": [ "AIR" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2026-02-02", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA219919", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "MIRTAZAPINE" ], "active_ingredients": [ "MIRTAZAPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219559", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "FIDAXOMICIN" ], "active_ingredients": [ "FIDAXOMICIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215096", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2026-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213165", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214095", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE" ], "active_ingredients": [ "EMTRICITABINE", "RILPIVIRINE HYDROCHLORIDE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220386", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220275", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218798", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "RILPIVIRINE HYDROCHLORIDE", "RILPIVIRINE" ], "active_ingredients": [ "RILPIVIRINE HYDROCHLORIDE", "RILPIVIRINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220142", "application_type": "NDA", "sponsor_name": "VISUS", "brand_names": [ "YUVEZZI" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "CARBACHOL" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-01-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "ANDA219655", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220518", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "MESNA" ], "active_ingredients": [ "MESNA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220374", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "FIDAXOMICIN" ], "active_ingredients": [ "FIDAXOMICIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219930", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216663", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214378", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "TAPENTADOL HYDROCHLORIDE" ], "active_ingredients": [ "TAPENTADOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216395", "application_type": "NDA", "sponsor_name": "SOLUBIOMIX", "brand_names": [ "QUIOFIC" ], "active_ingredients": [ "FOLIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA220556", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219702", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219348", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BETAMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BETAMETHASONE DIPROPIONATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219119", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "TAPENTADOL HYDROCHLORIDE" ], "active_ingredients": [ "TAPENTADOL HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217287", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CUPRIC CHLORIDE" ], "active_ingredients": [ "CUPRIC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216092", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213774", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203279", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA219048", "application_type": "ANDA", "sponsor_name": "OMNIVIUM PHARMS", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2026-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219686", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "AMLODIPINE BESYLATE" ], "active_ingredients": [ "AMLODIPINE BESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213437", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761498", "application_type": "BLA", "sponsor_name": "CELLTRION INC", "brand_names": [ "AVTOZMA" ], "active_ingredients": [ "TOCILIZUMAB-ANOH" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "IV (INFUSION)", "SUBCUTANEOUS" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220268", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219850", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "FILM" ], "routes": [ "BUCCAL, SUBLINGUAL" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219712", "application_type": "ANDA", "sponsor_name": "HISUN PHARM HANGZHOU", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217922", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210379", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209064", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219983", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219714", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219323", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218712", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218342", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202425", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "SITAGLIPTIN PHOSPHATE" ], "active_ingredients": [ "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-20", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA219220", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761027", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "FILKRI" ], "active_ingredients": [ "FILGRASTIM-LAHA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219765", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "OXALIPLATIN" ], "active_ingredients": [ "OXALIPLATIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220250", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219638", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217590", "application_type": "ANDA", "sponsor_name": "ORBICULAR", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216281", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212884", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202387", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "SITAGLIPTIN PHOSPHATE" ], "active_ingredients": [ "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-14", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217523", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2026-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211241", "application_type": "NDA", "sponsor_name": "SENTYNL THERAPS INC", "brand_names": [ "ZYCUBO" ], "active_ingredients": [ "COPPER HISTIDINATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-01-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217443", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214464", "application_type": "ANDA", "sponsor_name": "RESPIRENT PHARMS", "brand_names": [ "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2026-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218985", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217216", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215090", "application_type": "ANDA", "sponsor_name": "SUNNY", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219511", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218692", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "FLUCONAZOLE" ], "active_ingredients": [ "FLUCONAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218188", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217100", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2026-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218775", "application_type": "ANDA", "sponsor_name": "HEBEI CHANGSHAN", "brand_names": [ "ENOXAPARIN SODIUM (PRESERVATIVE FREE)" ], "active_ingredients": [ "ENOXAPARIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2026-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219167", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2026-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216487", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "CIPROFLOXACIN AND DEXAMETHASONE" ], "active_ingredients": [ "CIPROFLOXACIN", "DEXAMETHASONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2026-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213514", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "OLOPATADINE HYDROCHLORIDE" ], "active_ingredients": [ "OLOPATADINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2026-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213476", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2026-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212141", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2026-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219773", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "EXTENDED PHENYTOIN SODIUM" ], "active_ingredients": [ "PHENYTOIN SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2026-01-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219053", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2026-01-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218536", "application_type": "ANDA", "sponsor_name": "STIRA", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214741", "application_type": "ANDA", "sponsor_name": "SCINOPHARM TAIWAN", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220152", "application_type": "NDA", "sponsor_name": "VANDA PHARMS INC", "brand_names": [ "NEREUS" ], "active_ingredients": [ "TRADIPITANT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-30", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219619", "application_type": "ANDA", "sponsor_name": "SAGENT", "brand_names": [ "CALCIUM GLUCONATE IN SODIUM CHLORIDE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220372", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219237", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EPOPROSTENOL SODIUM" ], "active_ingredients": [ "EPOPROSTENOL SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218854", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202327", "application_type": "ANDA", "sponsor_name": "WATSON LABS INC", "brand_names": [ "SITAGLIPTIN PHOSPHATE" ], "active_ingredients": [ "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-29", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761152", "application_type": "BLA", "sponsor_name": "OMEROS CORP", "brand_names": [ "YARTEMLEA" ], "active_ingredients": [ "NARSOPLIMAB-WUUG" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2025-12-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220062", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219550", "application_type": "ANDA", "sponsor_name": "CHENGDU SHUODE", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215593", "application_type": "ANDA", "sponsor_name": "CIVICA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218316", "application_type": "NDA", "sponsor_name": "NOVO", "brand_names": [ "WEGOVY" ], "active_ingredients": [ "SEMAGLUTIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217338", "application_type": "NDA", "sponsor_name": "RECKITT BENCKISER", "brand_names": [ "MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "NAPROXEN SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-22", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA215716", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220449", "application_type": "NDA", "sponsor_name": "BOEHRINGER INGELHEIM", "brand_names": [ "JASCAYD" ], "active_ingredients": [ "NERANDOMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-19", "review_priority": "PRIORITY", "submission_class": "Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval" }, { "application_number": "NDA219083", "application_type": "NDA", "sponsor_name": "CYTOKINETICS", "brand_names": [ "MYQORZO" ], "active_ingredients": [ "AFICAMTEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-19", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761457", "application_type": "BLA", "sponsor_name": "AMNEAL PHARMS LLC", "brand_names": [ "OZILTUS" ], "active_ingredients": [ "DENOSUMAB-MOBZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761456", "application_type": "BLA", "sponsor_name": "AMNEAL PHARMS LLC", "brand_names": [ "BONCRESA" ], "active_ingredients": [ "DENOSUMAB-MOBZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217814", "application_type": "ANDA", "sponsor_name": "RELIANCE LIFE SCI", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761473", "application_type": "BLA", "sponsor_name": "FORMYCON AG", "brand_names": [ "NUFYMCO" ], "active_ingredients": [ "RANIBIZUMAB-LEYK" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2025-12-18", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA219401", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2025-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218756", "application_type": "ANDA", "sponsor_name": "AMVIKA", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "INTRA-ANAL" ], "approval_date": "2025-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218162", "application_type": "ANDA", "sponsor_name": "CREEKWOOD PHARMS", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206157", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761433", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "RYBREVANT FASPRO" ], "active_ingredients": [ "AMIVANTAMAB AND HYALURONIDASE-LPUJ" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2025-12-17", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA220360", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "LATANOPROST" ], "active_ingredients": [ "LATANOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216528", "application_type": "ANDA", "sponsor_name": "SHUANGCHENG", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214687", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TRAVOPROST" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA210858", "application_type": "NDA", "sponsor_name": "IBSA", "brand_names": [ "VYBRIQUE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FILM" ], "routes": [ "ORAL" ], "approval_date": "2025-12-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761458", "application_type": "BLA", "sponsor_name": "GLAXOSMITHKLINE LLC", "brand_names": [ "EXDENSUR" ], "active_ingredients": [ "DEPEMOKIMAB-ULAA" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2025-12-16", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219648", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "HYDROXYZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROXYZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2025-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213982", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CARIPRAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CARIPRAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213811", "application_type": "ANDA", "sponsor_name": "AMNEAL IRELAND LTD", "brand_names": [ "BECLOMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BECLOMETHASONE DIPROPIONATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2025-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219727", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2025-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218532", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "NILOTINIB", "NILOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "NILOTINIB", "NILOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219491", "application_type": "NDA", "sponsor_name": "ENTASIS THERAP", "brand_names": [ "NUZOLVENCE" ], "active_ingredients": [ "ZOLIFLODACIN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-12-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA218571", "application_type": "NDA", "sponsor_name": "MILESTONE PHARMS USA", "brand_names": [ "CARDAMYST" ], "active_ingredients": [ "ETRIPAMIL" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2025-12-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761427", "application_type": "BLA", "sponsor_name": "LIB THERAPEUTICS, INC.", "brand_names": [ "LEROCHOL" ], "active_ingredients": [ "LERODALCIBEP-LIGA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217173", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216589", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "OCTREOTIDE ACETATE" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213641", "application_type": "ANDA", "sponsor_name": "AMPHASTAR PHARMS INC", "brand_names": [ "TERIPARATIDE" ], "active_ingredients": [ "TERIPARATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219884", "application_type": "NDA", "sponsor_name": "ACADIA PHARMS INC", "brand_names": [ "DAYBUE STIX" ], "active_ingredients": [ "TROFINETIDE" ], "dosage_forms": [ "FOR SOLUTION", "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-12-11", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219776", "application_type": "NDA", "sponsor_name": "BIOCRYST", "brand_names": [ "ORLADEYO" ], "active_ingredients": [ "BEROTRALSTAT DIHYDROCHLORIDE" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2025-12-11", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA220132", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "DEFERIPRONE" ], "active_ingredients": [ "DEFERIPRONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220126", "application_type": "ANDA", "sponsor_name": "LNK INTL INC", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218595", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214696", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "LOPINAVIR AND RITONAVIR" ], "active_ingredients": [ "LOPINAVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219161", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "OMEPRAZOLE AND SODIUM BICARBONATE" ], "active_ingredients": [ "OMEPRAZOLE", "SODIUM BICARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218473", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2025-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217597", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LOTEPREDNOL ETABONATE AND TOBRAMYCIN" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE", "TOBRAMYCIN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213305", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211137", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219558", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "LINEZOLID" ], "active_ingredients": [ "LINEZOLID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218208", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214137", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "INSERT" ], "routes": [ "VAGINAL" ], "approval_date": "2025-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219096", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211161", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211026", "application_type": "ANDA", "sponsor_name": "LEPU PHARM", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217945", "application_type": "ANDA", "sponsor_name": "EMERGE BIOSCIENCE", "brand_names": [ "PROPOFOL" ], "active_ingredients": [ "PROPOFOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215465", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202388", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-12-02", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA211600", "application_type": "ANDA", "sponsor_name": "AMNEAL IRELAND LTD", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2025-12-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761212", "application_type": "BLA", "sponsor_name": "LUPIN LTD", "brand_names": [ "ARMLUPEG" ], "active_ingredients": [ "PEGFILGRASTIM-UNNE" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2025-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211909", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218929", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "DALBAVANCIN HYDROCHLORIDE" ], "active_ingredients": [ "DALBAVANCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761434", "application_type": "BLA", "sponsor_name": "OTSUKA PHARM CO LTD", "brand_names": [ "VOYXACT" ], "active_ingredients": [ "SIBEPRENLIMAB-SZSI" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219924", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218178", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209538", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219252", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218425", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CLADRIBINE" ], "active_ingredients": [ "CLADRIBINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214560", "application_type": "ANDA", "sponsor_name": "SOLARIS PHARMA CORP", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-11-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207437", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218080", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216536", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210638", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219972", "application_type": "NDA", "sponsor_name": "BAYER HEALTHCARE", "brand_names": [ "HYRNUO" ], "active_ingredients": [ "SEVABERTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218544", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "NILOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "NILOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218350", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "NILOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "NILOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211418", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209651", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "NILOTINIB HYDROCHLORIDE", "NILOTINIB HYDROCHLORIDE DIHYDRATE" ], "active_ingredients": [ "NILOTINIB HYDROCHLORIDE", "NILOTINIB HYDROCHLORIDE DIHYDRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219947", "application_type": "NDA", "sponsor_name": "ARROWHEAD", "brand_names": [ "REDEMPLO" ], "active_ingredients": [ "PLOZASIRAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-11-18", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218783", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "DICHLORPHENAMIDE" ], "active_ingredients": [ "DICHLORPHENAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218769", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220153", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219442", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220043", "application_type": "ANDA", "sponsor_name": "HAINAN POLY PHARM", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218872", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217633", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217608", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217468", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "GEL" ], "routes": [ "RECTAL" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208579", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205337", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220305", "application_type": "NDA", "sponsor_name": "KURA", "brand_names": [ "KOMZIFTI" ], "active_ingredients": [ "ZIFTOMENIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761450", "application_type": "BLA", "sponsor_name": "SHANGHAI HENLIUS BIOTECH", "brand_names": [ "POHERDY" ], "active_ingredients": [ "PERTUZUMAB-DPZB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220276", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218218", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217737", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "IOHEXOL" ], "active_ingredients": [ "IOHEXOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION, ORAL, RECTAL", "INJECTION, ORAL" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215826", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214921", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219115", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DEXLANSOPRAZOLE" ], "active_ingredients": [ "DEXLANSOPRAZOLE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218596", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "DIROXIMEL FUMARATE" ], "active_ingredients": [ "DIROXIMEL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218200", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LEUCOVORIN CALCIUM" ], "active_ingredients": [ "LEUCOVORIN CALCIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218381", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218273", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE" ], "active_ingredients": [ "CIPROFLOXACIN HYDROCHLORIDE", "HYDROCORTISONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2025-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217862", "application_type": "ANDA", "sponsor_name": "ELITE LABS INC", "brand_names": [ "ROPINIROLE HYDROCHLORIDE" ], "active_ingredients": [ "ROPINIROLE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217591", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "DALBAVANCIN HYDROCHLORIDE" ], "active_ingredients": [ "DALBAVANCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217972", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216261", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213518", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "SUMATRIPTAN SUCCINATE (AUTOINJECTOR)" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219945", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211120", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210523", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "SODIUM OXYBATE" ], "active_ingredients": [ "SODIUM OXYBATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219539", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "IRBESARTAN" ], "active_ingredients": [ "IRBESARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219046", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "SULFASALAZINE" ], "active_ingredients": [ "SULFASALAZINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218543", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216601", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216527", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "ISOFLURANE" ], "active_ingredients": [ "ISOFLURANE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "INHALATION" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216143", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "MARAVIROC" ], "active_ingredients": [ "MARAVIROC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219792", "application_type": "NDA", "sponsor_name": "UCB INC", "brand_names": [ "KYGEVVI" ], "active_ingredients": [ "DOXECITINE", "DOXRIBTIMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA211247", "application_type": "ANDA", "sponsor_name": "SPH ZHONGXI PHARM", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208459", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LINAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "LINAGLIPTIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208457", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208431", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208428", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208427", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LINAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "LINAGLIPTIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208415", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219955", "application_type": "ANDA", "sponsor_name": "NEOCUBES PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211650", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "AXITINIB" ], "active_ingredients": [ "AXITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761424", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "OSVYRTI", "JUBEREQ" ], "active_ingredients": [ "denosumab-desu" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218302", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217803", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2025-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219608", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218962", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218031", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "DROSPIRENONE AND ESTRADIOL" ], "active_ingredients": [ "DROSPIRENONE", "ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216187", "application_type": "ANDA", "sponsor_name": "CHANGZHOU PHARM", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212258", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211498", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210219", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219931", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219267", "application_type": "ANDA", "sponsor_name": "AJENAT PHARMS", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219265", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "LOMUSTINE" ], "active_ingredients": [ "LOMUSTINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA221021", "application_type": "NDA", "sponsor_name": "ROBERTS OXYGEN CO INC", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2025-10-25", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA219469", "application_type": "NDA", "sponsor_name": "BAYER HLTHCARE", "brand_names": [ "LYNKUET" ], "active_ingredients": [ "ELINZANETANT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-24", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA219108", "application_type": "NDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217345", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208546", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220256", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "JAVADIN" ], "active_ingredients": [ "CLONIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-10-23", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA214988", "application_type": "NDA", "sponsor_name": "BE PHARMS", "brand_names": [ "DEHYDRATED ALCOHOL" ], "active_ingredients": [ "DEHYDRATED ALCOHOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-23", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761440", "application_type": "BLA", "sponsor_name": "GLAXOSMITHKLINE LLC", "brand_names": [ "BLENREP" ], "active_ingredients": [ "BELANTAMAB MAFODOTIN-BLMF" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-23", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA219465", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "DALBAVANCIN HYDROCHLORIDE" ], "active_ingredients": [ "DALBAVANCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215505", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212271", "application_type": "NDA", "sponsor_name": "MEITHEAL", "brand_names": [ "CONTEPO" ], "active_ingredients": [ "FOSFOMYCIN DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-22", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA220243", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219917", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "LOFEXIDINE HYDROCHLORIDE" ], "active_ingredients": [ "LOFEXIDINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215582", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219294", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "PROPARACAINE HYDROCHLORIDE" ], "active_ingredients": [ "PROPARACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219910", "application_type": "NDA", "sponsor_name": "GLAUKOS", "brand_names": [ "EPIOXA HD/EPIOXA KIT" ], "active_ingredients": [ "RIBOFLAVIN 5'-PHOSPHATE SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-10-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219781", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "CLOMIPHENE CITRATE" ], "active_ingredients": [ "CLOMIPHENE CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218601", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219868", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "FERABRIGHT" ], "active_ingredients": [ "FERUMOXYTOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-16", "review_priority": "STANDARD", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA219606", "application_type": "ANDA", "sponsor_name": "BPI LABS", "brand_names": [ "TRIMETHOBENZAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "TRIMETHOBENZAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761495", "application_type": "BLA", "sponsor_name": "MERCK SHARP AND DOHME LLC", "brand_names": [], "active_ingredients": [], "dosage_forms": [], "routes": [], "approval_date": "2025-10-15", "review_priority": "PRIORITY", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA214025", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "CONJUGATED ESTROGENS" ], "active_ingredients": [ "ESTROGENS, CONJUGATED" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214023", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "CONJUGATED ESTROGENS" ], "active_ingredients": [ "ESTROGENS, CONJUGATED" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217485", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218845", "application_type": "ANDA", "sponsor_name": "METHODIST", "brand_names": [ "GALLIUM GA 68 EDOTREOTIDE" ], "active_ingredients": [ "GALLIUM GA-68 EDOTREOTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216678", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CONCENTRATE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218764", "application_type": "NDA", "sponsor_name": "BOEHRINGER INGELHEIM", "brand_names": [ "JASCAYD" ], "active_ingredients": [ "NERANDOMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-07", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA217294", "application_type": "NDA", "sponsor_name": "SQ INNOVATION", "brand_names": [ "LASIX ONYU" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-10-07", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219677", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2025-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216792", "application_type": "ANDA", "sponsor_name": "L PERRIGO CO", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216097", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS NY", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216484", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "PATCH" ], "routes": [ "TOPICAL" ], "approval_date": "2025-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209242", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220042", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219406", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CLOMIPHENE CITRATE" ], "active_ingredients": [ "CLOMIPHENE CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216504", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NAPROXEN" ], "active_ingredients": [ "NAPROXEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214613", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761377", "application_type": "BLA", "sponsor_name": "CELLTRION INC", "brand_names": [ "EYDENZELT" ], "active_ingredients": [ "AFLIBERCEPT-BOAV" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219721", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "MIRTAZAPINE" ], "active_ingredients": [ "MIRTAZAPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219152", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "ETRAVIRINE" ], "active_ingredients": [ "ETRAVIRINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218870", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LABETALOL HYDROCHLORIDE" ], "active_ingredients": [ "LABETALOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217052", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "PILOCARPINE HYDROCHLORIDE" ], "active_ingredients": [ "PILOCARPINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215324", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219978", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219477", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217898", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218436", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "RHAPSIDO" ], "active_ingredients": [ "REMIBRUTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-30", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219102", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "LEVONORGESTREL" ], "active_ingredients": [ "LEVONORGESTREL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217735", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2025-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216616", "application_type": "ANDA", "sponsor_name": "EVITA SOLUTIONS", "brand_names": [ "MIFEPRISTONE" ], "active_ingredients": [ "MIFEPRISTONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216001", "application_type": "ANDA", "sponsor_name": "SINOTHERAPEUTICS INC", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217463", "application_type": "ANDA", "sponsor_name": "SQUARE PHARMS PLC", "brand_names": [ "CALCIUM CHLORIDE 10%" ], "active_ingredients": [ "CALCIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217628", "application_type": "NDA", "sponsor_name": "CARWIN PHARM ASSOC", "brand_names": [ "CLOTIC" ], "active_ingredients": [ "CLOTRIMAZOLE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2025-09-26", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761439", "application_type": "BLA", "sponsor_name": "HIKMA PHARMACEUTICALS USA INC", "brand_names": [ "ENOBY", "XTRENBO" ], "active_ingredients": [ "DENOSUMAB-QBDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217398", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216294", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219070", "application_type": "NDA", "sponsor_name": "CRINETICS", "brand_names": [ "PALSONIFY" ], "active_ingredients": [ "PALTUSOTINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA218881", "application_type": "NDA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "INLURIYO" ], "active_ingredients": [ "IMLUNESTRANT TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218195", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215029", "application_type": "NDA", "sponsor_name": "MEDRX USA", "brand_names": [ "BONDLIDO" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-09-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217280", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219691", "application_type": "ANDA", "sponsor_name": "ABON PHARMS LLC", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217949", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS LTD", "brand_names": [ "LABETALOL HYDROCHLORIDE" ], "active_ingredients": [ "LABETALOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215445", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "RIVASTIGMINE" ], "active_ingredients": [ "RIVASTIGMINE" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2025-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217289", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "BIMATOPROST" ], "active_ingredients": [ "BIMATOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215244", "application_type": "NDA", "sponsor_name": "STEALTH BIOTHERAPS", "brand_names": [ "FORZINITY" ], "active_ingredients": [ "ELAMIPRETIDE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-09-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761467", "application_type": "BLA", "sponsor_name": "MERCK SHARP DOHME", "brand_names": [ "KEYTRUDA QLEX" ], "active_ingredients": [ "PEMBROLIZUMAB", "BERAHYALURONIDASE ALFA-PMPH" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA220100", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219859", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "LOSARTAN POTASSIUM" ], "active_ingredients": [ "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218491", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218391", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "PROGESTERONE" ], "active_ingredients": [ "PROGESTERONE" ], "dosage_forms": [ "INSERT" ], "routes": [ "VAGINAL" ], "approval_date": "2025-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219904", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "ACAMPROSATE CALCIUM" ], "active_ingredients": [ "ACAMPROSATE CALCIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219826", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "SODIUM ACETATE" ], "active_ingredients": [ "SODIUM ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219684", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "KETAMINE HYDROCHLORIDE" ], "active_ingredients": [ "KETAMINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2025-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218879", "application_type": "NDA", "sponsor_name": "OWP PHARMS", "brand_names": [ "SUBVENITE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761436", "application_type": "BLA", "sponsor_name": "BIOCON BIOLOGICS INC", "brand_names": [ "AUKELSO", "BOSAYA" ], "active_ingredients": [ "DENOSUMAB-KYQQ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214398", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA220012", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "COLESTIPOL HYDROCHLORIDE" ], "active_ingredients": [ "COLESTIPOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219049", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218813", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "GLUCAGON" ], "active_ingredients": [ "GLUCAGON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219500", "application_type": "NDA", "sponsor_name": "CORSTASIS THERAP", "brand_names": [ "ENBUMYST" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2025-09-12", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217459", "application_type": "ANDA", "sponsor_name": "HOSPIRA", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219943", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "KOSELUGO" ], "active_ingredients": [ "SELUMETINIB", "SELUMETINIB SULFATE" ], "dosage_forms": [ "CAPSULE", "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-10", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218733", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203631", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SODIUM OXYBATE" ], "active_ingredients": [ "SODIUM OXYBATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-10", "review_priority": "", "submission_class": "" }, { "application_number": "NDA219683", "application_type": "NDA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "INLEXZO" ], "active_ingredients": [ "GEMCITABINE HYDROCHLORIDE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "INTRAVESICAL" ], "approval_date": "2025-09-09", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217307", "application_type": "NDA", "sponsor_name": "THEA PHARMA", "brand_names": [ "ZOLYMBUS" ], "active_ingredients": [ "BIMATOPROST" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-09-09", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218805", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218734", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216444", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215137", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219922", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-09-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218755", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217595", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "ZIPRASIDONE MESYLATE" ], "active_ingredients": [ "ZIPRASIDONE MESYLATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2025-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216432", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219564", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219170", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "MILRINONE LACTATE IN DEXTROSE 5%" ], "active_ingredients": [ "MILRINONE LACTATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218586", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "RISPERIDONE" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2025-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211220", "application_type": "ANDA", "sponsor_name": "NANOMI", "brand_names": [ "RISPERIDONE" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2025-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219685", "application_type": "NDA", "sponsor_name": "GENZYME CORP", "brand_names": [ "WAYRILZ" ], "active_ingredients": [ "RILZABRUTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA219130", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "ESCITALOPRAM" ], "active_ingredients": [ "ESCITALOPRAM OXALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA210745", "application_type": "NDA", "sponsor_name": "AMGEN INC", "brand_names": [ "OTEZLA", "OTEZLA XR" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET", "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761444", "application_type": "BLA", "sponsor_name": "SHANGHAI HENLIUS BIOTECH", "brand_names": [ "BILPREVDA", "BILDYOS" ], "active_ingredients": [ "DENOSUMAB-NXXP" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761375", "application_type": "BLA", "sponsor_name": "EISAI INC", "brand_names": [ "LEQEMBI IQLIK" ], "active_ingredients": [ "LECANEMAB-IRMB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217010", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218698", "application_type": "NDA", "sponsor_name": "XTM CONSULTING", "brand_names": [ "LOPRESSOR" ], "active_ingredients": [ "METOPROLOL TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215374", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206310", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "MEMANTINE HYDROCHLORIDE" ], "active_ingredients": [ "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214568", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211094", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211123", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219745", "application_type": "NDA", "sponsor_name": "ACCORD", "brand_names": [ "CAMCEVI ETM" ], "active_ingredients": [ "LEUPROLIDE MESYLATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-08-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214350", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206688", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219845", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214100", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PENCICLOVIR" ], "active_ingredients": [ "PENCICLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219407", "application_type": "NDA", "sponsor_name": "IONIS PHARMS INC", "brand_names": [ "DAWNZERA (AUTOINJECTOR)" ], "active_ingredients": [ "DONIDALORSEN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-08-21", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214211", "application_type": "ANDA", "sponsor_name": "STERINOVA INC", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216819", "application_type": "ANDA", "sponsor_name": "NANJING KING FRIEND", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214427", "application_type": "ANDA", "sponsor_name": "HANGZHOU BINJIANG", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211136", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219542", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219123", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217877", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211128", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219428", "application_type": "NDA", "sponsor_name": "TONIX", "brand_names": [ "TONMYA" ], "active_ingredients": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2025-08-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA218643", "application_type": "NDA", "sponsor_name": "THEA PHARMA", "brand_names": [ "CYKLX" ], "active_ingredients": [ "ARTICAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-08-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "ANDA219060", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218399", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219864", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217673", "application_type": "NDA", "sponsor_name": "INSMED INC", "brand_names": [ "BRINSUPRI" ], "active_ingredients": [ "BRENSOCATIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217358", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "DIVALPROEX SODIUM" ], "active_ingredients": [ "DIVALPROEX SODIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2025-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219692", "application_type": "ANDA", "sponsor_name": "SAGENT", "brand_names": [ "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218445", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216992", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213551", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CANGRELOR" ], "active_ingredients": [ "CANGRELOR" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212596", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219921", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "KYXATA" ], "active_ingredients": [ "CARBOPLATIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA219042", "application_type": "NDA", "sponsor_name": "BOEHRINGER INGELHEIM", "brand_names": [ "HERNEXEOS" ], "active_ingredients": [ "ZONGERTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-08", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219253", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218469", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SODIUM ACETATE" ], "active_ingredients": [ "SODIUM ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217585", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OLUMIANT" ], "active_ingredients": [ "BARICITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212559", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "IRON SUCROSE" ], "active_ingredients": [ "IRON SUCROSE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212340", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "IRON SUCROSE" ], "active_ingredients": [ "IRON SUCROSE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211598", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208977", "application_type": "ANDA", "sponsor_name": "INTL MEDICATION SYS", "brand_names": [ "IRON SUCROSE" ], "active_ingredients": [ "IRON SUCROSE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219319", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218829", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "OMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "OMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218056", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217858", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "KETAMINE HYDROCHLORIDE" ], "active_ingredients": [ "KETAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217131", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ASCORBIC ACID" ], "active_ingredients": [ "ASCORBIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219876", "application_type": "NDA", "sponsor_name": "CHIMERIX", "brand_names": [ "MODEYSO" ], "active_ingredients": [ "DORDAVIPRONE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-06", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219156", "application_type": "ANDA", "sponsor_name": "XIAMEN LP PHARM CO", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219058", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218888", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218142", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214279", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212470", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219475", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211219", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219840", "application_type": "NDA", "sponsor_name": "BRACCO", "brand_names": [ "E-Z-DISK" ], "active_ingredients": [ "BARIUM SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-08-01", "review_priority": "STANDARD", "submission_class": "Type 7 - Drug Already Marketed without Approved NDA" }, { "application_number": "NDA218585", "application_type": "NDA", "sponsor_name": "LENZ THERAP", "brand_names": [ "VIZZ" ], "active_ingredients": [ "ACECLIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-07-31", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761428", "application_type": "BLA", "sponsor_name": "NOVO NORDISK INC", "brand_names": [ "ALHEMO" ], "active_ingredients": [ "CONCIZUMAB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-31", "review_priority": "STANDARD", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA218117", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219843", "application_type": "NDA", "sponsor_name": "ROSEMONT PHARMS", "brand_names": [ "ATMEKSI" ], "active_ingredients": [ "METHOCARBAMOL" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219363", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217599", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217024", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211759", "application_type": "NDA", "sponsor_name": "CARWIN PHARM ASSOC", "brand_names": [ "VYSCOXA" ], "active_ingredients": [ "CELECOXIB" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219759", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215393", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2025-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219666", "application_type": "NDA", "sponsor_name": "PTC THERAP", "brand_names": [ "SEPHIENCE" ], "active_ingredients": [ "SEPIAPTERIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2025-07-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219939", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217761", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "SPIRONOLACTONE" ], "active_ingredients": [ "SPIRONOLACTONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209199", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207726", "application_type": "ANDA", "sponsor_name": "MPP PHARMA", "brand_names": [ "NIACIN" ], "active_ingredients": [ "NIACIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219696", "application_type": "NDA", "sponsor_name": "AKARX INC", "brand_names": [ "DOPTELET SPRINKLE" ], "active_ingredients": [ "AVATROMBOPAG MALEATE" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-24", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219531", "application_type": "NDA", "sponsor_name": "BRILLIAN PHARMA", "brand_names": [ "SDAMLO" ], "active_ingredients": [ "AMLODIPINE BESYLATE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-24", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219863", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218597", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "LORAZEPAM" ], "active_ingredients": [ "LORAZEPAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219757", "application_type": "NDA", "sponsor_name": "ROSEMONT PHARMS", "brand_names": [ "VOSTALLY" ], "active_ingredients": [ "RAMIPRIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-23", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219155", "application_type": "NDA", "sponsor_name": "LEO PHARMA AS", "brand_names": [ "ANZUPGO" ], "active_ingredients": [ "DELGOCITINIB" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-07-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218005", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "FLUCYTOSINE" ], "active_ingredients": [ "FLUCYTOSINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218960", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215421", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214457", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "GLUCAGON" ], "active_ingredients": [ "GLUCAGON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202136", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-22", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218661", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216506", "application_type": "ANDA", "sponsor_name": "HANGZHOU ZHONGMEI", "brand_names": [ "CASPOFUNGIN ACETATE" ], "active_ingredients": [ "CASPOFUNGIN ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207088", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219797", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218831", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215276", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "HABITROL" ], "active_ingredients": [ "NICOTINE POLACRILEX" ], "dosage_forms": [ "TROCHE/LOZENGE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213668", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219935", "application_type": "NDA", "sponsor_name": "SAGENT", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-16", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218853", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213748", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213611", "application_type": "ANDA", "sponsor_name": "NOVUGEN PHARMA SDN", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761188", "application_type": "BLA", "sponsor_name": "BIOCON BIOLOGICS INC", "brand_names": [ "KIRSTY" ], "active_ingredients": [ "INSULIN ASPART-XJHZ" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216901", "application_type": "ANDA", "sponsor_name": "XIAMEN LP PHARM CO", "brand_names": [ "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE" ], "active_ingredients": [ "DONEPEZIL HYDROCHLORIDE", "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215177", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "ESCITALOPRAM OXALATE" ], "active_ingredients": [ "ESCITALOPRAM OXALATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215116", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "SIROLIMUS" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208672", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE" ], "active_ingredients": [ "DONEPEZIL HYDROCHLORIDE", "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206019", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "SUMATRIPTAN SUCCINATE" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217051", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "OLOPATADINE HYDROCHLORIDE" ], "active_ingredients": [ "OLOPATADINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205938", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "CELECOXIB" ], "active_ingredients": [ "CELECOXIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219009", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218152", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207300", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217831", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219569", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "DEHYDRATED ALCOHOL" ], "active_ingredients": [ "DEHYDRATED ALCOHOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2025-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219295", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219196", "application_type": "ANDA", "sponsor_name": "SAGENT", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219091", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217274", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219629", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219143", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "ELETRIPTAN HYDROBROMIDE" ], "active_ingredients": [ "ELETRIPTAN HYDROBROMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217583", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "MANGANESE CHLORIDE" ], "active_ingredients": [ "MANGANESE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219301", "application_type": "NDA", "sponsor_name": "KALVISTA", "brand_names": [ "EKTERLY" ], "active_ingredients": [ "SEBETRALSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-03", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA219014", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219129", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217473", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216905", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "INDOMETHACIN" ], "active_ingredients": [ "INDOMETHACIN" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2025-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219839", "application_type": "NDA", "sponsor_name": "DIZAL", "brand_names": [ "ZEGFROVY" ], "active_ingredients": [ "SUNVOZERTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-07-02", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761400", "application_type": "BLA", "sponsor_name": "RENGENERON PHARMACEUTICALS, INC.", "brand_names": [ "LYNOZYFIC" ], "active_ingredients": [ "LINVOSELTAMAB-GCPT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-02", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219495", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218032", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218753", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219538", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219417", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "PYQUVI" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218087", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217998", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "MINOXIDIL EXTRA STRENGTH (FOR MEN)" ], "active_ingredients": [ "MINOXIDIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217989", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217430", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "LEVOCARNITINE" ], "active_ingredients": [ "LEVOCARNITINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212967", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "AMPHOTERICIN B" ], "active_ingredients": [ "AMPHOTERICIN B" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219920", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "AVGEMSI" ], "active_ingredients": [ "GEMCITABINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219454", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219199", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)" ], "active_ingredients": [ "DOXORUBICIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219701", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219699", "application_type": "ANDA", "sponsor_name": "AJENAT PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218502", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218638", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206980", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219216", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219193", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219160", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219078", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAP", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218977", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218963", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218847", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218812", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218795", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218778", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218295", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218177", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217662", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205336", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761464", "application_type": "BLA", "sponsor_name": "DAIICHI SANKYO INC", "brand_names": [ "DATROWAY" ], "active_ingredients": [ "DATOPOTAMAB DERUXTECAN-DLNK" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219509", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "PREDNISOLONE" ], "active_ingredients": [ "PREDNISOLONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219444", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "DEHYDRATED ALCOHOL" ], "active_ingredients": [ "DEHYDRATED ALCOHOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219400", "application_type": "ANDA", "sponsor_name": "XGEN PHARMS", "brand_names": [ "DEHYDRATED ALCOHOL" ], "active_ingredients": [ "DEHYDRATED ALCOHOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219242", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219153", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219084", "application_type": "ANDA", "sponsor_name": "BROOKS STERISCIENCE", "brand_names": [ "MEROPENEM" ], "active_ingredients": [ "MEROPENEM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218389", "application_type": "ANDA", "sponsor_name": "UNIQUE PHARM", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217845", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "DEHYDRATED ALCOHOL" ], "active_ingredients": [ "DEHYDRATED ALCOHOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2025-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211834", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220020", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "YEZTUGO" ], "active_ingredients": [ "LENACAPAVIR SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-18", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "NDA220018", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "YEZTUGO" ], "active_ingredients": [ "LENACAPAVIR", "LENACAPAVIR SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-06-18", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA219775", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ACETAZOLAMIDE SODIUM" ], "active_ingredients": [ "ACETAZOLAMIDE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220634", "application_type": "NDA", "sponsor_name": "GENERAL DISTRIBUTING COMPANY", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [], "approval_date": "2025-06-16", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA219847", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "ARYNTA" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761367", "application_type": "BLA", "sponsor_name": "CSL BEHRING LLC", "brand_names": [ "ANDEMBRY" ], "active_ingredients": [ "GARADACIMAB-GXII" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-06-16", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217560", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219612", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "SWAB" ], "routes": [ "TOPICAL" ], "approval_date": "2025-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215913", "application_type": "ANDA", "sponsor_name": "ZENARA", "brand_names": [ "SAFINAMIDE MESYLATE" ], "active_ingredients": [ "SAFINAMIDE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215793", "application_type": "NDA", "sponsor_name": "UROGEN PHARMA", "brand_names": [ "ZUSDURI" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVESICAL" ], "approval_date": "2025-06-12", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213615", "application_type": "ANDA", "sponsor_name": "CARDINAL HLTH 414", "brand_names": [ "SODIUM IODIDE I 131" ], "active_ingredients": [ "SODIUM IODIDE I-131" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208175", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE" ], "active_ingredients": [ "PHENTERMINE HYDROCHLORIDE", "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219713", "application_type": "NDA", "sponsor_name": "NUVATION", "brand_names": [ "IBTROZI" ], "active_ingredients": [ "TALETRECTINIB ADIPATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-11", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219633", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218797", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218729", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218256", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PREDNISOLONE ACETATE" ], "active_ingredients": [ "PREDNISOLONE ACETATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211072", "application_type": "ANDA", "sponsor_name": "UBI", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2025-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218785", "application_type": "NDA", "sponsor_name": "BEONE MEDICINES USA", "brand_names": [ "BRUKINSA" ], "active_ingredients": [ "ZANUBRUTINIB" ], "dosage_forms": [ "CAPSULE", "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217624", "application_type": "ANDA", "sponsor_name": "STIRA", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214912", "application_type": "ANDA", "sponsor_name": "LYNE", "brand_names": [ "SODIUM POLYSTYRENE SULFONATE" ], "active_ingredients": [ "SODIUM POLYSTYRENE SULFONATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL, RECTAL" ], "approval_date": "2025-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217472", "application_type": "NDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-09", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761432", "application_type": "BLA", "sponsor_name": "MERCK SHARP DOHME", "brand_names": [ "ENFLONSIA" ], "active_ingredients": [ "CLESROVIMAB-CFOR" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2025-06-09", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218384", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SCOPOLAMINE" ], "active_ingredients": [ "SCOPOLAMINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2025-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217437", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216797", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214310", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218310", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219423", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "WIDAPLIK" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "INDAPAMIDE", "TELMISARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-06-05", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA218395", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "XIFYRM" ], "active_ingredients": [ "MELOXICAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218321", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216460", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204144", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN PHOSPHATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-06-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218144", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "INJECTION", "SOLUTION" ], "routes": [ "SOLUTION,CONCENTRATE", "INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2025-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218061", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217187", "application_type": "ANDA", "sponsor_name": "PRECISION DOSE INC", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216966", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ANGIOTENSIN ll ACETATE" ], "active_ingredients": [ "ANGIOTENSIN II ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218896", "application_type": "ANDA", "sponsor_name": "HERITAGE", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218688", "application_type": "ANDA", "sponsor_name": "VILIN BIO MED", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217982", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217501", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215354", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "AMPHOTERICIN B" ], "active_ingredients": [ "AMPHOTERICIN B" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2025-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216830", "application_type": "NDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212089", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219674", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218980", "application_type": "NDA", "sponsor_name": "ETON", "brand_names": [ "KHINDIVI" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-05-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217370", "application_type": "NDA", "sponsor_name": "ALCON LABS INC", "brand_names": [ "TRYPTYR" ], "active_ingredients": [ "ACOLTREMON" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-05-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219777", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2025-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208592", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "METHYLNALTREXONE BROMIDE" ], "active_ingredients": [ "METHYLNALTREXONE BROMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216683", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213005", "application_type": "NDA", "sponsor_name": "LIQUIDIA TECH", "brand_names": [ "YUTREPIA" ], "active_ingredients": [ "TREPROSTINIL SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2025-05-23", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218706", "application_type": "ANDA", "sponsor_name": "WESTMINSTER PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209801", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "PERAMPANEL" ], "active_ingredients": [ "PERAMPANEL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209543", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BOSUTINIB MONOHYDRATE" ], "active_ingredients": [ "BOSUTINIB MONOHYDRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761419", "application_type": "BLA", "sponsor_name": "BIO-THERA SOLUTIONS LTD", "brand_names": [ "STARJEMZA" ], "active_ingredients": [ "USTEKINUMAB-HMNY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-05-22", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217554", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217279", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216633", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219136", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PROPARACAINE HYDROCHLORIDE" ], "active_ingredients": [ "PROPARACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213268", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217484", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217453", "application_type": "ANDA", "sponsor_name": "RELIANCE LIFE", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209530", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208452", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "RILPIVIRINE HYDROCHLORIDE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217847", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216422", "application_type": "ANDA", "sponsor_name": "GALENICUM HLTH", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213216", "application_type": "ANDA", "sponsor_name": "APOZEAL PHARMS", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218116", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2025-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215074", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211826", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "GEFITINIB" ], "active_ingredients": [ "GEFITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206603", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "ROSUVASTATIN CALCIUM" ], "active_ingredients": [ "ROSUVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216355", "application_type": "ANDA", "sponsor_name": "SHUANGCHENG", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211706", "application_type": "ANDA", "sponsor_name": "NASPRESS", "brand_names": [ "MOMETASONE FUROATE" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208220", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215400", "application_type": "NDA", "sponsor_name": "AMNEAL", "brand_names": [ "BREKIYA (AUTOINJECTOR)" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761384", "application_type": "BLA", "sponsor_name": "ABBVIE INC", "brand_names": [ "EMRELIS" ], "active_ingredients": [ "TELISOTUZUMAB VEDOTIN-TLLV" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-DOSE" ], "approval_date": "2025-05-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219332", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218107", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216995", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213348", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213114", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210718", "application_type": "ANDA", "sponsor_name": "PIRAMAL", "brand_names": [ "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210301", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208543", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208534", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208039", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219168", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "HALOPERIDOL DECANOATE" ], "active_ingredients": [ "HALOPERIDOL DECANOATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217943", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "MUPIROCIN" ], "active_ingredients": [ "MUPIROCIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2025-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217880", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "MARAVIROC" ], "active_ingredients": [ "MARAVIROC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213768", "application_type": "ANDA", "sponsor_name": "GUANGDONG SUNHO", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219507", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ZONISAMIDE" ], "active_ingredients": [ "ZONISAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219482", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "TERAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "TERAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219616", "application_type": "NDA", "sponsor_name": "VERASTEM INC", "brand_names": [ "AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)" ], "active_ingredients": [ "AVUTOMETINIB POTASSIUM", "DEFACTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-08", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA208468", "application_type": "ANDA", "sponsor_name": "CHEMI SPA", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217990", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "RALTEGRAVIR POTASSIUM" ], "active_ingredients": [ "RALTEGRAVIR POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217061", "application_type": "ANDA", "sponsor_name": "SAWAI USA", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212879", "application_type": "ANDA", "sponsor_name": "VIWIT PHARM", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218609", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "METHADONE HYDROCHLORIDE" ], "active_ingredients": [ "METHADONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210150", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "RASAGILINE MESYLATE" ], "active_ingredients": [ "RASAGILINE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208537", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218933", "application_type": "ANDA", "sponsor_name": "AVION PHARMS", "brand_names": [ "AVERI" ], "active_ingredients": [ "DESOGESTREL", "ETHINYL ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28", "ORAL-21" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217881", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217810", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217190", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "HALOBETASOL PROPIONATE AND TAZAROTENE" ], "active_ingredients": [ "HALOBETASOL PROPIONATE", "TAZAROTENE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214595", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212981", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208576", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207874", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219767", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "TAMSULOSIN HYDROCHLORIDE" ], "active_ingredients": [ "TAMSULOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219585", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218454", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "MIDAZOLAM IN 0.8% SODIUM CHLORIDE" ], "active_ingredients": [ "MIDAZOLAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208584", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217901", "application_type": "NDA", "sponsor_name": "SATSUMA PHARMS", "brand_names": [ "ATZUMI" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "NASAL" ], "approval_date": "2025-04-30", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219241", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761430", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "IMAAVY" ], "active_ingredients": [ "NIPOCALIMAB-AAHU" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218645", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "ZELVYSIA" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217387", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LATANOPROSTENE BUNOD" ], "active_ingredients": [ "LATANOPROSTENE BUNOD" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213127", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "CELECOXIB" ], "active_ingredients": [ "CELECOXIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219289", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "HYDROXYZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROXYZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2025-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217733", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PILOCARPINE HYDROCHLORIDE" ], "active_ingredients": [ "PILOCARPINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213483", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203285", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "NIACIN" ], "active_ingredients": [ "NIACIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-28", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218429", "application_type": "ANDA", "sponsor_name": "SABA ILAC SANAYI", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216788", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216719", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2025-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761258", "application_type": "BLA", "sponsor_name": "AKESO BIOPHARMA", "brand_names": [ "PENPULIMAB-KCQX" ], "active_ingredients": [ "PENPULIMAB-KCQX" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218855", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217720", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216063", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217593", "application_type": "NDA", "sponsor_name": "NANJING DELOVA", "brand_names": [ "QAMZOVA" ], "active_ingredients": [ "MELOXICAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218444", "application_type": "ANDA", "sponsor_name": "RICONPHARMA LLC", "brand_names": [ "SIPONIMOD" ], "active_ingredients": [ "SIPONIMOD" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216547", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220461", "application_type": "NDA", "sponsor_name": "MITCHELL WEDLING SUPPLY", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2025-04-21", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA212193", "application_type": "ANDA", "sponsor_name": "CSPC OUYI", "brand_names": [ "IMATINIB MESYLATE" ], "active_ingredients": [ "IMATINIB MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204893", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "COLESEVELAM HYDROCHLORIDE" ], "active_ingredients": [ "COLESEVELAM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220073", "application_type": "NDA", "sponsor_name": "BRISTOL", "brand_names": [ "ELIQUIS", "ELIQUIS SPRINKLE" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "SUSPENSION", "TABLET", "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-17", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219212", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215232", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219145", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219044", "application_type": "ANDA", "sponsor_name": "UNIQUE PHARM", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218027", "application_type": "ANDA", "sponsor_name": "SPH ZHONGXI PHARM", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216998", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "FROVATRIPTAN SUCCINATE" ], "active_ingredients": [ "FROVATRIPTAN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216623", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215269", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "ENEMA" ], "routes": [ "RECTAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205412", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ABACAVIR SULFATE AND LAMIVUDINE" ], "active_ingredients": [ "ABACAVIR SULFATE", "LAMIVUDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211448", "application_type": "NDA", "sponsor_name": "CMG PHARM CO LTD", "brand_names": [ "MEZOFY" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "FILM" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219689", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219213", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218948", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218701", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "NITAZOXANIDE" ], "active_ingredients": [ "NITAZOXANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218235", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214817", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214495", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CARBIDOPA, LEVODOPA AND ENTACAPONE" ], "active_ingredients": [ "CARBIDOPA", "ENTACAPONE", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211361", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219306", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "LATANOPROST" ], "active_ingredients": [ "LATANOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219151", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219028", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217625", "application_type": "ANDA", "sponsor_name": "STIRA", "brand_names": [ "ZINC CHLORIDE" ], "active_ingredients": [ "ZINC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215091", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ALLOPURINOL" ], "active_ingredients": [ "ALLOPURINOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212975", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "IMATINIB MESYLATE" ], "active_ingredients": [ "IMATINIB MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211780", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218421", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211660", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219485", "application_type": "NDA", "sponsor_name": "MIRUM", "brand_names": [ "LIVMARLI" ], "active_ingredients": [ "MARALIXIBAT CHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219373", "application_type": "NDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "LOPRESSOR" ], "active_ingredients": [ "METOPROLOL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA209657", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208544", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761175", "application_type": "BLA", "sponsor_name": "BIOCON BIOLOGICS INC", "brand_names": [ "JOBEVNE" ], "active_ingredients": [ "BEVACIZUMAB-NWGD" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-09", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218620", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "METYROSINE" ], "active_ingredients": [ "METYROSINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217646", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2025-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216140", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211992", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219254", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "JAYTHARI" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216615", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216084", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208436", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE", "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218663", "application_type": "ANDA", "sponsor_name": "NEOCUBES PHARMA", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218457", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2025-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA206056", "application_type": "NDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER" ], "active_ingredients": [ "PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219422", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "BALSALAZIDE DISODIUM" ], "active_ingredients": [ "BALSALAZIDE DISODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219291", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219273", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219208", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "VANRAFIA" ], "active_ingredients": [ "ATRASENTAN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-04-02", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219535", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219215", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218115", "application_type": "ANDA", "sponsor_name": "NANJING KING FRIEND", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219230", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217923", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217458", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219019", "application_type": "NDA", "sponsor_name": "GENZYME CORP", "brand_names": [ "QFITLIA" ], "active_ingredients": [ "FITUSIRAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-03-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA210381", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216665", "application_type": "NDA", "sponsor_name": "SOLENO", "brand_names": [ "VYKAT XR" ], "active_ingredients": [ "DIAZOXIDE CHOLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-26", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA216748", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DEXRAZOXANE HYDROCHLORIDE" ], "active_ingredients": [ "DEXRAZOXANE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215146", "application_type": "ANDA", "sponsor_name": "CURIUM", "brand_names": [ "TECHNETIUM TC-99M PENTETATE KIT" ], "active_ingredients": [ "TECHNETIUM TC-99M PENTETATE KIT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218230", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "BLUJEPA" ], "active_ingredients": [ "GEPOTIDACIN MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761398", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA LLC", "brand_names": [ "CONEXXENCE", "BOMYNTRA" ], "active_ingredients": [ "DENOSUMAB-BNHT" ], "dosage_forms": [ "INJECTION" ], "routes": [], "approval_date": "2025-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218631", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217221", "application_type": "ANDA", "sponsor_name": "DIFGEN PHARMS", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "PATCH" ], "routes": [ "TOPICAL" ], "approval_date": "2025-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219073", "application_type": "ANDA", "sponsor_name": "UTOPIC PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219883", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219527", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NYSTATIN" ], "active_ingredients": [ "NYSTATIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219443", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218140", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219592", "application_type": "NDA", "sponsor_name": "TELIX INNOVATIONS", "brand_names": [ "GOZELLIX" ], "active_ingredients": [ "GALLIUM GA-68 GOZETOTIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-20", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212566", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218499", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FINASTERIDE AND TADALAFIL" ], "active_ingredients": [ "FINASTERIDE", "TADALAFIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217741", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213694", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "PERPHENAZINE" ], "active_ingredients": [ "PERPHENAZINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218647", "application_type": "NDA", "sponsor_name": "PRM PHARMA", "brand_names": [ "HEMICLOR" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-17", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219282", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "GRANISETRON HYDROCHLORIDE" ], "active_ingredients": [ "GRANISETRON HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218196", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "BIMATOPROST" ], "active_ingredients": [ "BIMATOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217113", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "APALUTAMIDE" ], "active_ingredients": [ "APALUTAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761449", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "TYENNE" ], "active_ingredients": [ "TOCILIZUMAB-AAZG" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219111", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "MIGLUSTAT" ], "active_ingredients": [ "MIGLUSTAT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217914", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "LACTULOSE" ], "active_ingredients": [ "LACTULOSE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214177", "application_type": "ANDA", "sponsor_name": "CONBA USA", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION, ORAL" ], "approval_date": "2025-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213522", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ELUXADOLINE" ], "active_ingredients": [ "ELUXADOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218772", "application_type": "NDA", "sponsor_name": "SCIENTURE", "brand_names": [ "ARBLI" ], "active_ingredients": [ "LOSARTAN POTASSIUM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-03-13", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215425", "application_type": "NDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-03-13", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218628", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "BUCAPSOL" ], "active_ingredients": [ "BUSPIRONE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215008", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202329", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LANTHANUM CARBONATE" ], "active_ingredients": [ "LANTHANUM CARBONATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-13", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218773", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218386", "application_type": "ANDA", "sponsor_name": "RITEDOSE CORP", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218271", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216125", "application_type": "ANDA", "sponsor_name": "BAMF", "brand_names": [ "FLUDEOXYGLUCOSE F18" ], "active_ingredients": [ "FLUDEOXYGLUCOSE F-18" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219661", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "METHENAMINE HIPPURATE" ], "active_ingredients": [ "METHENAMINE HIPPURATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206183", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PRALATREXATE" ], "active_ingredients": [ "PRALATREXATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761399", "application_type": "BLA", "sponsor_name": "CELLTRION INC", "brand_names": [ "OMLYCLO" ], "active_ingredients": [ "OMALIZUMAB-IGEC" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218559", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "SHAMPOO" ], "routes": [ "TOPICAL" ], "approval_date": "2025-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218555", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202954", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-06", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218507", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2025-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216729", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212652", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212651", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218743", "application_type": "ANDA", "sponsor_name": "CHIA TAI TIANQING", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209424", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761380", "application_type": "BLA", "sponsor_name": "BEIGENE", "brand_names": [ "TEVIMBRA" ], "active_ingredients": [ "islelizumab-jsgr" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA218719", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218406", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "TELMISARTAN AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "TELMISARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218261", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "OXAZEPAM" ], "active_ingredients": [ "OXAZEPAM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217588", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217587", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217217", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215759", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213695", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213383", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208557", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208555", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "RIVAROXABAN" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218475", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "EPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761404", "application_type": "BLA", "sponsor_name": "CELLTRION INC", "brand_names": [ "OSENVELT", "STOBOCLO" ], "active_ingredients": [ "DENOSUMAB-BMWO" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219557", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS", "brand_names": [ "OLOPATADINE HYDROCHLORIDE" ], "active_ingredients": [ "OLOPATADINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219032", "application_type": "ANDA", "sponsor_name": "CONTRACT PHARMACAL", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215127", "application_type": "ANDA", "sponsor_name": "CATALENT PHARMA", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218746", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218245", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2025-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215909", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210067", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216418", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "MERCAPTOPURINE" ], "active_ingredients": [ "MERCAPTOPURINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216389", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "FLUOCINONIDE" ], "active_ingredients": [ "FLUOCINONIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2025-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215228", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219093", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218201", "application_type": "NDA", "sponsor_name": "SEBELA WOMENS HLTH", "brand_names": [ "MIUDELLA" ], "active_ingredients": [ "COPPER" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "INTRAUTERINE" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218699", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LOFEXIDINE HYDROCHLORIDE" ], "active_ingredients": [ "LOFEXIDINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218434", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217800", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215399", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "INDOMETHACIN" ], "active_ingredients": [ "INDOMETHACIN" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213731", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219488", "application_type": "NDA", "sponsor_name": "MIRUM", "brand_names": [ "CTEXLI" ], "active_ingredients": [ "CHENODIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-21", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA218038", "application_type": "NDA", "sponsor_name": "HQ SPCLT PHARMA", "brand_names": [ "DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218085", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "SPIRONOLACTONE" ], "active_ingredients": [ "SPIRONOLACTONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-02-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217885", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217078", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206942", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091222", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-21", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA219547", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218684", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218922", "application_type": "NDA", "sponsor_name": "CIPLA", "brand_names": [ "NILOTINIB D-TARTRATE" ], "active_ingredients": [ "NILOTINIB D-TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-19", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA205559", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216308", "application_type": "ANDA", "sponsor_name": "ALEMBIC THERAP", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215067", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219304", "application_type": "NDA", "sponsor_name": "DECIPHERA PHARMS", "brand_names": [ "ROMVIMZA" ], "active_ingredients": [ "VIMSELTINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761325", "application_type": "BLA", "sponsor_name": "SANOFI-AVENTIS U.S. LLC", "brand_names": [ "MERILOG", "MERILOG SOLOSTAR" ], "active_ingredients": [ "INSULIN ASPART-SZJJ" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2025-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215617", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214824", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209810", "application_type": "ANDA", "sponsor_name": "IMPAX", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209591", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "AMLODIPINE AND OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761392", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "DENOSUMAB-DSSB", "OSPOMYV", "XBRYK" ], "active_ingredients": [ "DENOSUMAB-DSSB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219194", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION, ORAL" ], "approval_date": "2025-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217108", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "TACROLIMUS" ], "active_ingredients": [ "TACROLIMUS" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216942", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2025-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219389", "application_type": "NDA", "sponsor_name": "SPRINGWORKS", "brand_names": [ "GOMEKLI" ], "active_ingredients": [ "MIRDAMETINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-11", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA219379", "application_type": "NDA", "sponsor_name": "SPRINGWORKS", "brand_names": [ "GOMEKLI" ], "active_ingredients": [ "MIRDAMETINIB" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-02-11", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA219285", "application_type": "NDA", "sponsor_name": "GENENTECH INC", "brand_names": [ "EVRYSDI" ], "active_ingredients": [ "RISDIPLAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218749", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "GADOTERIDOL" ], "active_ingredients": [ "GADOTERIDOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218308", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218191", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217884", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215004", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212694", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BENZTROPINE MESYLATE" ], "active_ingredients": [ "BENZTROPINE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218779", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SELENIOUS ACID" ], "active_ingredients": [ "SELENIOUS ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210396", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SILODOSIN" ], "active_ingredients": [ "SILODOSIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217906", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "EMBLAVEO" ], "active_ingredients": [ "AVIBACTAM SODIUM", "AZTREONAM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-02-07", "review_priority": "PRIORITY", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA217912", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217841", "application_type": "ANDA", "sponsor_name": "ABON PHARMS LLC", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219239", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2025-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215699", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218830", "application_type": "ANDA", "sponsor_name": "SQUARE PHARMS PLC", "brand_names": [ "METHIMAZOLE" ], "active_ingredients": [ "METHIMAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213154", "application_type": "ANDA", "sponsor_name": "NATCO PHARMA LTD", "brand_names": [ "BOSENTAN" ], "active_ingredients": [ "BOSENTAN" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218674", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "PROCAINAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "PROCAINAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-02-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210407", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214056", "application_type": "NDA", "sponsor_name": "MDD US", "brand_names": [ "ONAPGO" ], "active_ingredients": [ "APOMORPHINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2025-02-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218966", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "SEVELAMER HYDROCHLORIDE" ], "active_ingredients": [ "SEVELAMER HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218380", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214844", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "NITAZOXANIDE" ], "active_ingredients": [ "NITAZOXANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208067", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220266", "application_type": "NDA", "sponsor_name": "WELDERS SUPPLY COMPANY OF LOUISVILLE INC", "brand_names": [ "Carbon Dioxide, USP" ], "active_ingredients": [ "Carbon Dioxide" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2025-02-02", "review_priority": "UNKNOWN", "submission_class": "Medical Gas" }, { "application_number": "ANDA219163", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216213", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209404", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TRAMADOL HYDROCHLORIDE" ], "active_ingredients": [ "TRAMADOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219209", "application_type": "NDA", "sponsor_name": "VERTEX PHARMS INC", "brand_names": [ "JOURNAVX" ], "active_ingredients": [ "SUZETRIGINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-30", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA215431", "application_type": "NDA", "sponsor_name": "AXSOME", "brand_names": [ "SYMBRAVO" ], "active_ingredients": [ "MELOXICAM", "RIZATRIPTAN BENZOATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-30", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA219302", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-01-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215907", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2025-01-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218987", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215204", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219141", "application_type": "NDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "INZIRQO" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218180", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217857", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217640", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214611", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TRIAMTERENE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "TRIAMTERENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212661", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208048", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217988", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217925", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "OXALIPLATIN" ], "active_ingredients": [ "OXALIPLATIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217886", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217098", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216561", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "AZELASTINE HYDROCHLORIDE ALLERGY" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212228", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "SORAFENIB TOSYLATE" ], "active_ingredients": [ "SORAFENIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209461", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "EZETIMIBE AND SIMVASTATIN" ], "active_ingredients": [ "EZETIMIBE", "SIMVASTATIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761420", "application_type": "BLA", "sponsor_name": "CELLTRION INC", "brand_names": [ "AVTOZMA" ], "active_ingredients": [ "TOCILIZUMAB-ANOH" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS", "SUBCUTANEOUS" ], "approval_date": "2025-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217892", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219494", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "SPIRONOLACTONE" ], "active_ingredients": [ "SPIRONOLACTONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217380", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215922", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215891", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213409", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "NIMODIPINE" ], "active_ingredients": [ "NIMODIPINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214759", "application_type": "NDA", "sponsor_name": "MEDEXUS", "brand_names": [ "GRAFAPEX" ], "active_ingredients": [ "TREOSULFAN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-21", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217490", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE" ], "active_ingredients": [ "AZILSARTAN KAMEDOXOMIL", "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216842", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ERTUGLIFLOZIN" ], "active_ingredients": [ "ERTUGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216168", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761394", "application_type": "BLA", "sponsor_name": "DAIICHI SANKYO INC", "brand_names": [ "DATROWAY" ], "active_ingredients": [ "DATOPOTAMAB DERUXTECAN-DLNK" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "IV (INFUSION)" ], "approval_date": "2025-01-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217241", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206788", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219122", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "BRYNOVIN" ], "active_ingredients": [ "SITAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA219562", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219087", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219072", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218211", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211427", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DESVENLAFAXINE SUCCINATE" ], "active_ingredients": [ "DESVENLAFAXINE SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203986", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TELMISARTAN" ], "active_ingredients": [ "TELMISARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-15", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA219222", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2025-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218939", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217277", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208909", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218871", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "MESNA" ], "active_ingredients": [ "MESNA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218401", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218246", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213683", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213627", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212524", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209728", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "REGORAFENIB" ], "active_ingredients": [ "REGORAFENIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218863", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2025-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215789", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "METOPROLOL TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214046", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "ESOMEPRAZOLE SODIUM" ], "active_ingredients": [ "ESOMEPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214024", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE" ], "active_ingredients": [ "TIPIRACIL HYDROCHLORIDE", "TRIFLURIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213808", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219118", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "NABUMETONE" ], "active_ingredients": [ "NABUMETONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217714", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216747", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207299", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "HYDROCHLOROTHIAZIDE", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2025-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210390", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216233", "application_type": "ANDA", "sponsor_name": "SCINOPHARM TAIWAN", "brand_names": [ "CLOFARABINE" ], "active_ingredients": [ "CLOFARABINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2025-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214966", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2025-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218640", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209434", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2025-01-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219036", "application_type": "ANDA", "sponsor_name": "VKT PHARMA", "brand_names": [ "SUMATRIPTAN SUCCINATE" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217178", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216750", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215978", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SAFINAMIDE MESYLATE" ], "active_ingredients": [ "SAFINAMIDE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214847", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213116", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "TROMETHAMINE" ], "active_ingredients": [ "TROMETHAMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217288", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761429", "application_type": "BLA", "sponsor_name": "BRISTOL-MYERS SQUIBB", "brand_names": [ "OPDIVO QVANTIG" ], "active_ingredients": [ "NIVOLUMAB", "HYALURONIDASE-NVHY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-27", "review_priority": "STANDARD", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "BLA761381", "application_type": "BLA", "sponsor_name": "BRISTOL-MYERS SQUIBB", "brand_names": [ "OPDIVO QVANTIG" ], "active_ingredients": [ "NIVOLUMAB", "HYALURONIDASE-NVHY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-12-27", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213942", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761417", "application_type": "BLA", "sponsor_name": "BEIGENE", "brand_names": [ "TEVIMBRA" ], "active_ingredients": [ "TISLELIZUMAB-JSGR" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-12-26", "review_priority": "STANDARD", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA218632", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218492", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PRUCALOPRIDE SUCCINATE" ], "active_ingredients": [ "PRUCALOPRIDE SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215971", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DEUTETRABENAZINE" ], "active_ingredients": [ "DEUTETRABENAZINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219057", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216902", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216857", "application_type": "ANDA", "sponsor_name": "CONBA USA", "brand_names": [ "ENTECAVIR" ], "active_ingredients": [ "ENTECAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215503", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "LIRAGLUTIDE" ], "active_ingredients": [ "LIRAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218730", "application_type": "NDA", "sponsor_name": "VERTEX PHARMS INC", "brand_names": [ "ALYFTREK" ], "active_ingredients": [ "DEUTIVACAFTOR", "TEZACAFTOR", "VANZACAFTOR CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761315", "application_type": "BLA", "sponsor_name": "NOVO NORDISK INC", "brand_names": [ "ALHEMO" ], "active_ingredients": [ "CONCIZUMAB-MTCI" ], "dosage_forms": [ "Injectable" ], "routes": [ "Subcutaneous" ], "approval_date": "2024-12-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218994", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217227", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TETRACAINE HYDROCHLORIDE" ], "active_ingredients": [ "TETRACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201156", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-20", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA218614", "application_type": "NDA", "sponsor_name": "IONIS PHARMS INC", "brand_names": [ "TRYNGOLZA (AUTOINJECTOR)" ], "active_ingredients": [ "OLEZARSEN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-12-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218793", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DIVALPROEX SODIUM" ], "active_ingredients": [ "DIVALPROEX SODIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218644", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215476", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "CARBINOXAMINE MALEATE" ], "active_ingredients": [ "CARBINOXAMINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212663", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ABACAVIR SULFATE AND LAMIVUDINE" ], "active_ingredients": [ "ABACAVIR SULFATE", "LAMIVUDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212112", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207922", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203540", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "RALTEGRAVIR POTASSIUM" ], "active_ingredients": [ "RALTEGRAVIR POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-19", "review_priority": "", "submission_class": "" }, { "application_number": "NDA218171", "application_type": "NDA", "sponsor_name": "XCOVERY", "brand_names": [ "ENSACOVE" ], "active_ingredients": [ "ENSARTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-18", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218312", "application_type": "ANDA", "sponsor_name": "BRIGHTGENE", "brand_names": [ "FONDAPARINUX SODIUM" ], "active_ingredients": [ "FONDAPARINUX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218129", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215006", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "OLOPATADINE HYDROCHLORIDE" ], "active_ingredients": [ "OLOPATADINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212748", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761338", "application_type": "BLA", "sponsor_name": "CELLTRION, INC.", "brand_names": [ "STEQEYMA" ], "active_ingredients": [ "USTEKINUMAB-STBA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS", "INTRAVENOUS" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA219120", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "LIDOCAINE AND PRILOCAINE" ], "active_ingredients": [ "LIDOCAINE", "PRILOCAINE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218850", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218133", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "CALCIUM CHLORIDE 10%" ], "active_ingredients": [ "CALCIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216959", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210156", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206358", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "CEFIXIME" ], "active_ingredients": [ "CEFIXIME" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219258", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218668", "application_type": "ANDA", "sponsor_name": "DEXCEL", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218252", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "METHADONE HYDROCHLORIDE" ], "active_ingredients": [ "METHADONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216452", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "INTRA-ANAL" ], "approval_date": "2024-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211887", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218820", "application_type": "NDA", "sponsor_name": "NEUROCRINE", "brand_names": [ "CRENESSITY" ], "active_ingredients": [ "CRINECERFONT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-12-13", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA218808", "application_type": "NDA", "sponsor_name": "NEUROCRINE", "brand_names": [ "CRENESSITY" ], "active_ingredients": [ "CRINECERFONT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761391", "application_type": "BLA", "sponsor_name": "GALDERMA LABS LP", "brand_names": [ "NEMLUVIO" ], "active_ingredients": [ "NEMOLIZUMAB-ILTO" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761297", "application_type": "BLA", "sponsor_name": "CHECKPOINT THERAPEUTICS INC", "brand_names": [ "UNLOXCYT" ], "active_ingredients": [ "COSIBELIMAB-IPDL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219441", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218858", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "LACTULOSE" ], "active_ingredients": [ "LACTULOSE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217557", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216345", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213926", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216190", "application_type": "NDA", "sponsor_name": "FIDELITY BIOPHARMA", "brand_names": [ "ONTRALFY" ], "active_ingredients": [ "TIZANIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-12-12", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA212923", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "CLOZAPINE" ], "active_ingredients": [ "CLOZAPINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2024-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204468", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "GLUCAGON" ], "active_ingredients": [ "GLUCAGON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-12", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217386", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216724", "application_type": "ANDA", "sponsor_name": "THINQ PHARM-CRO PVT", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212369", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211663", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "EZETIMIBE AND SIMVASTATIN" ], "active_ingredients": [ "EZETIMIBE", "SIMVASTATIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210352", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "BEXAROTENE" ], "active_ingredients": [ "BEXAROTENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215254", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215048", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213637", "application_type": "ANDA", "sponsor_name": "BWXT MEDCL", "brand_names": [ "IOBENGUANE I-123" ], "active_ingredients": [ "IOBENGUANE SULFATE I-123" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211558", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "TROMETHAMINE" ], "active_ingredients": [ "TROMETHAMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214445", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210388", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212675", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761352", "application_type": "BLA", "sponsor_name": "MERUS N.V.", "brand_names": [ "BIZENGRI" ], "active_ingredients": [ "ZENOCUTUZUMAB-ZBCO" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2024-12-04", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219034", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217487", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-12-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218695", "application_type": "ANDA", "sponsor_name": "AMTA", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218282", "application_type": "ANDA", "sponsor_name": "EIRGEN", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217462", "application_type": "ANDA", "sponsor_name": "RICONPHARMA LLC", "brand_names": [ "COLESTIPOL HYDROCHLORIDE" ], "active_ingredients": [ "COLESTIPOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217451", "application_type": "ANDA", "sponsor_name": "CEDIPROF INC", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216608", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2024-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214345", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "TOPICAL" ], "approval_date": "2024-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761406", "application_type": "BLA", "sponsor_name": "BIOCON BIOLOGICS INC", "brand_names": [ "YESINTEK" ], "active_ingredients": [ "USTEKINUMAB-KFCE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-29", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217495", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215005", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL" ], "approval_date": "2024-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212222", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "INTRA-ANAL" ], "approval_date": "2024-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216017", "application_type": "NDA", "sponsor_name": "BRACCO", "brand_names": [ "IOMERVU" ], "active_ingredients": [ "IOMEPROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216016", "application_type": "NDA", "sponsor_name": "BRACCO", "brand_names": [ "IOMERVU" ], "active_ingredients": [ "IOMEPROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2024-11-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219342", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "CALCIUM CHLORIDE 10%" ], "active_ingredients": [ "CALCIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217515", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POTASSIUM ACETATE" ], "active_ingredients": [ "POTASSIUM ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211394", "application_type": "ANDA", "sponsor_name": "YILING", "brand_names": [ "SIMVASTATIN" ], "active_ingredients": [ "SIMVASTATIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218637", "application_type": "NDA", "sponsor_name": "KAMAT", "brand_names": [ "RALDESY" ], "active_ingredients": [ "TRAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-11-26", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218257", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LATANOPROST" ], "active_ingredients": [ "LATANOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218175", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "MINOXIDIL (FOR WOMEN)" ], "active_ingredients": [ "MINOXIDIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2024-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211144", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217160", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211788", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219097", "application_type": "NDA", "sponsor_name": "SHORLA ONCOLOGY", "brand_names": [ "IMKELDI" ], "active_ingredients": [ "IMATINIB MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217202", "application_type": "NDA", "sponsor_name": "AOP HLTH US", "brand_names": [ "RAPIBLYK" ], "active_ingredients": [ "LANDIOLOL HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216540", "application_type": "NDA", "sponsor_name": "BRIDGEBIO PHARMA", "brand_names": [ "ATTRUBY" ], "active_ingredients": [ "ACORAMIDIS HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217498", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "MOMETASONE FUROATE" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216955", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215796", "application_type": "ANDA", "sponsor_name": "RICONPHARMA LLC", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217630", "application_type": "NDA", "sponsor_name": "MAIA PHARMS INC", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219223", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217561", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215651", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "SUMATRIPTAN SUCCINATE" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207294", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CHOLESTYRAMINE" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2024-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761416", "application_type": "BLA", "sponsor_name": "JAZZ PHARMS", "brand_names": [ "ZIIHERA" ], "active_ingredients": [ "ZANIDATAMAB-HRII" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218899", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213708", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2024-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219033", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216761", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ERYTHROMYCIN LACTOBIONATE" ], "active_ingredients": [ "ERYTHROMYCIN LACTOBIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215899", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "INDOMETHACIN" ], "active_ingredients": [ "INDOMETHACIN" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2024-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206697", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "EXENATIDE SYNTHETIC" ], "active_ingredients": [ "EXENATIDE SYNTHETIC" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218538", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "CHROMIC CHLORIDE" ], "active_ingredients": [ "CHROMIC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218272", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218156", "application_type": "ANDA", "sponsor_name": "LEXENPHARM", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217598", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "LORAZEPAM" ], "active_ingredients": [ "LORAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218944", "application_type": "NDA", "sponsor_name": "SYNDAX", "brand_names": [ "REVUFORJ" ], "active_ingredients": [ "REVUMENIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219221", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218952", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218604", "application_type": "ANDA", "sponsor_name": "ELITE LABS INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214316", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218464", "application_type": "ANDA", "sponsor_name": "ACELLA", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209698", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217126", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210248", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218997", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CIMETIDINE" ], "active_ingredients": [ "CIMETIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216545", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CLOMIPHENE CITRATE" ], "active_ingredients": [ "CLOMIPHENE CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209162", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205924", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA220050", "application_type": "NDA", "sponsor_name": "DJB GAS SERVICES, INC", "brand_names": [ "Carbon Dioxide, USP" ], "active_ingredients": [ "Carbon Dioxide, USP" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2024-11-09", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA216968", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216739", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "CLOMIPHENE CITRATE" ], "active_ingredients": [ "CLOMIPHENE CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215238", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214789", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS PHARM", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210682", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219293", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "DANZITEN" ], "active_ingredients": [ "NILOTINIB TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-07", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218220", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "CIMETIDINE" ], "active_ingredients": [ "CIMETIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214777", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214079", "application_type": "ANDA", "sponsor_name": "WUXI", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218471", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217563", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207296", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ROSUVASTATIN CALCIUM" ], "active_ingredients": [ "ROSUVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217887", "application_type": "ANDA", "sponsor_name": "ALEMBIC THERAP", "brand_names": [ "CIPROFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "CIPROFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2024-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216720", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215638", "application_type": "ANDA", "sponsor_name": "XIAMEN LP PHARM CO", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209426", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208671", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LANSOPRAZOLE" ], "active_ingredients": [ "LANSOPRAZOLE" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2024-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219015", "application_type": "NDA", "sponsor_name": "JOURNEY", "brand_names": [ "EMROSI" ], "active_ingredients": [ "MINOCYCLINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-11-01", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214333", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214332", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218067", "application_type": "ANDA", "sponsor_name": "QILU ANTIBIOTICS", "brand_names": [ "ERTAPENEM SODIUM" ], "active_ingredients": [ "ERTAPENEM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217795", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217565", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215406", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209109", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CHOLESTYRAMINE LIGHT" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205499", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217133", "application_type": "ANDA", "sponsor_name": "BEIJING JIALIN", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219106", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217181", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216783", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208541", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206523", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "MELPHALAN HYDROCHLORIDE" ], "active_ingredients": [ "MELPHALAN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218979", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "KLOR-CON" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218346", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218053", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213972", "application_type": "NDA", "sponsor_name": "ITERUM THERAP", "brand_names": [ "ORLYNVAH" ], "active_ingredients": [ "PROBENECID", "SULOPENEM ETZADROXIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA215998", "application_type": "ANDA", "sponsor_name": "SHANDONG XINHUA", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218711", "application_type": "NDA", "sponsor_name": "ZHUHAI", "brand_names": [ "BEIZRAY" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-23", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217882", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208511", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2024-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216426", "application_type": "ANDA", "sponsor_name": "LEXENPHARM", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215664", "application_type": "ANDA", "sponsor_name": "OSMOTICA PHARM US", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208119", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207022", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218770", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "LEVALBUTEROL HYDROCHLORIDE" ], "active_ingredients": [ "LEVALBUTEROL HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761365", "application_type": "BLA", "sponsor_name": "ASTELLAS", "brand_names": [ "VYLOY" ], "active_ingredients": [ "ZOLBETUXIMAB-CLZB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-18", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218587", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212903", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209694", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219055", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218385", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217957", "application_type": "ANDA", "sponsor_name": "UBI", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216962", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "VYALEV" ], "active_ingredients": [ "FOSCARBIDOPA", "FOSLEVODOPA" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "ANDA219251", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "FLUDROCORTISONE ACETATE" ], "active_ingredients": [ "FLUDROCORTISONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218344", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218324", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216152", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "ZINC CHLORIDE" ], "active_ingredients": [ "ZINC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213728", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218941", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218583", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2024-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218157", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "TELMISARTAN" ], "active_ingredients": [ "TELMISARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216328", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2024-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215765", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761369", "application_type": "BLA", "sponsor_name": "PFIZER INC", "brand_names": [ "HYMPAVZI" ], "active_ingredients": [ "MARSTACIMAB-HNCQ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-10-11", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217721", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207292", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "AMLODIPINE BESYLATE AND VALSARTAN" ], "active_ingredients": [ "AMLODIPINE BESYLATE", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219249", "application_type": "NDA", "sponsor_name": "GENENTECH INC", "brand_names": [ "ITOVEBI" ], "active_ingredients": [ "INAVOLISIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-10", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761364", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "IMULDOSA" ], "active_ingredients": [ "USTEKINUMAB-SRLF" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-10", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA218642", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216654", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "TIMOLOL" ], "active_ingredients": [ "TIMOLOL" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210378", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LINEZOLID" ], "active_ingredients": [ "LINEZOLID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214960", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217445", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212700", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216297", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217604", "application_type": "NDA", "sponsor_name": "AMNEAL", "brand_names": [ "PYRIDOSTIGMINE BROMIDE" ], "active_ingredients": [ "PYRIDOSTIGMINE BROMIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-04", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216911", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218895", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "CETIRIZINE HYDROCHLORIDE" ], "active_ingredients": [ "CETIRIZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218630", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CHLOROTHIAZIDE SODIUM" ], "active_ingredients": [ "CHLOROTHIAZIDE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217648", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215488", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "METHOHEXITAL SODIUM" ], "active_ingredients": [ "METHOHEXITAL SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215058", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "LIFITEGRAST" ], "active_ingredients": [ "LIFITEGRAST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205147", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "MILNACIPRAN HYDROCHLORIDE" ], "active_ingredients": [ "MILNACIPRAN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209290", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ALCAFTADINE" ], "active_ingredients": [ "ALCAFTADINE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205484", "application_type": "ANDA", "sponsor_name": "JUBILANT GENERICS", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217397", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217250", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215931", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211821", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218912", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215168", "application_type": "NDA", "sponsor_name": "GE HLTHCARE", "brand_names": [ "FLYRCADO" ], "active_ingredients": [ "FLURPIRIDAZ F-18" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA213224", "application_type": "NDA", "sponsor_name": "SUN PHARM", "brand_names": [ "BYNFEZIA PEN" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761379", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "OTULFI" ], "active_ingredients": [ "USTEKINUMAB-AAUZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA218947", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEPHALEXIN" ], "active_ingredients": [ "CEPHALEXIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218817", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CEPHALEXIN" ], "active_ingredients": [ "CEPHALEXIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212368", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "PENCICLOVIR" ], "active_ingredients": [ "PENCICLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216158", "application_type": "NDA", "sponsor_name": "BRISTOL-MYERS", "brand_names": [ "COBENFY" ], "active_ingredients": [ "TROSPIUM CHLORIDE", "XANOMELINE TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218598", "application_type": "ANDA", "sponsor_name": "ZHEJIANG JUTAI PHARM", "brand_names": [ "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218330", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218227", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215100", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210236", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209667", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ENZALUTAMIDE" ], "active_ingredients": [ "ENZALUTAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204499", "application_type": "ANDA", "sponsor_name": "IPCA LABS", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA206873", "application_type": "ANDA", "sponsor_name": "SYNTHON BV", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203857", "application_type": "ANDA", "sponsor_name": "SYNTHON BV", "brand_names": [ "GLATIRAMER ACETATE" ], "active_ingredients": [ "GLATIRAMER ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-09-25", "review_priority": "", "submission_class": "" }, { "application_number": "NDA219132", "application_type": "NDA", "sponsor_name": "INTRABIO", "brand_names": [ "AQNEURSA" ], "active_ingredients": [ "LEVACETYLLEUCINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-09-24", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218878", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218229", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218112", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216494", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215592", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217228", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TRAVOPROST" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214927", "application_type": "NDA", "sponsor_name": "ZEVRA DENMARK", "brand_names": [ "MIPLYFFA" ], "active_ingredients": [ "ARIMOCLOMOL CITRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215388", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CLOPIDOGREL BISULFATE" ], "active_ingredients": [ "CLOPIDOGREL BISULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213766", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212334", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206808", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CEVIMELINE HYDROCHLORIDE" ], "active_ingredients": [ "CEVIMELINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA219116", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218531", "application_type": "ANDA", "sponsor_name": "UNIQUE PHARM", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216050", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "NALBUPHINE HYDROCHLORIDE" ], "active_ingredients": [ "NALBUPHINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216049", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "NALBUPHINE HYDROCHLORIDE" ], "active_ingredients": [ "NALBUPHINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212931", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218372", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217153", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217071", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ERTUGLIFLOZIN" ], "active_ingredients": [ "ERTUGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216727", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215541", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "METYROSINE" ], "active_ingredients": [ "METYROSINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218498", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "SHAMPOO" ], "routes": [ "TOPICAL" ], "approval_date": "2024-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215080", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "SIROLIMUS" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213764", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210640", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION, GEL FORMING/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761371", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "OCREVUS ZUNOVO" ], "active_ingredients": [ "OCRELIZUMAB AND HYALURONIDASE-OCSQ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-13", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761306", "application_type": "BLA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "EBGLYSS" ], "active_ingredients": [ "LEBRIKIZUMAB-LBKZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216948", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212683", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212257", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203843", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "ERLOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "ERLOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-13", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761347", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "TECENTRIQ HYBREZA" ], "active_ingredients": [ "ATEZOLIZUMAB AND HYALURONIDASE-TQJS" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-12", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218936", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "active_ingredients": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218253", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "AMIODARONE HYDROCHLORIDE" ], "active_ingredients": [ "AMIODARONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217281", "application_type": "ANDA", "sponsor_name": "NOVUGEN", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215235", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "BUSULFAN" ], "active_ingredients": [ "BUSULFAN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216114", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210507", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "CETIRIZINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218109", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "CABERGOLINE" ], "active_ingredients": [ "CABERGOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203643", "application_type": "ANDA", "sponsor_name": "MLV", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-09", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217548", "application_type": "ANDA", "sponsor_name": "CHENGDU SHUODE", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217192", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212987", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208628", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "BEXAROTENE" ], "active_ingredients": [ "BEXAROTENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216510", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215312", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214050", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "active_ingredients": [ "HYDROCORTISONE SODIUM SUCCINATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213276", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209061", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EFAVIRENZ", "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215652", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ALBENDAZOLE" ], "active_ingredients": [ "ALBENDAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213109", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208423", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219104", "application_type": "NDA", "sponsor_name": "MSD", "brand_names": [ "PREVYMIS" ], "active_ingredients": [ "LETERMOVIR" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2024-08-30", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213680", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217893", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "SCOPOLAMINE" ], "active_ingredients": [ "SCOPOLAMINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217215", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218426", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "QUINIDINE SULFATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216368", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217740", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "TRAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "TRAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216917", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "TOLTERODINE TARTRATE" ], "active_ingredients": [ "TOLTERODINE TARTRATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216539", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "CISATRACURIUM BESYLATE PRESERVATIVE FREE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214732", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "active_ingredients": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212782", "application_type": "NDA", "sponsor_name": "SHILPA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-08-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214897", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "AMANTADINE", "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE", "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213636", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213215", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208112", "application_type": "ANDA", "sponsor_name": "ACTAVIS LLC", "brand_names": [ "METHYLNALTREXONE BROMIDE" ], "active_ingredients": [ "METHYLNALTREXONE BROMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761298", "application_type": "BLA", "sponsor_name": "AMGEN INC", "brand_names": [ "PAVBLU" ], "active_ingredients": [ "AFLIBERCEPT-AYYH" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218247", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210030", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "TEMOZOLOMIDE" ], "active_ingredients": [ "TEMOZOLOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218410", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218054", "application_type": "ANDA", "sponsor_name": "INDIES PHARMA", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216035", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "RILUZOLE" ], "active_ingredients": [ "RILUZOLE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215832", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BETAMETHASONE VALERATE" ], "active_ingredients": [ "BETAMETHASONE VALERATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213604", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213191", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218174", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211010", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218613", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "LOFEXIDINE HYDROCHLORIDE" ], "active_ingredients": [ "LOFEXIDINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217559", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "THIOTEPA" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRACAVITARY, INTRAVENOUS, INTRAVESICAL" ], "approval_date": "2024-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209610", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "BENZOYL PEROXIDE", "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205961", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS NY", "brand_names": [ "PITAVASTATIN CALCIUM" ], "active_ingredients": [ "PITAVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219008", "application_type": "NDA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "LAZCLUZE" ], "active_ingredients": [ "LAZERTINIB MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218745", "application_type": "ANDA", "sponsor_name": "APOTEX CORP", "brand_names": [ "CUPRIC SULFATE" ], "active_ingredients": [ "CUPRIC SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216493", "application_type": "ANDA", "sponsor_name": "HANGZHOU ZHONGMEI", "brand_names": [ "FONDAPARINUX SODIUM" ], "active_ingredients": [ "FONDAPARINUX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214735", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217968", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "LAPATINIB DITOSYLATE" ], "active_ingredients": [ "LAPATINIB DITOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217667", "application_type": "ANDA", "sponsor_name": "EDENBRIDGE PHARMS", "brand_names": [ "COLESTIPOL HYDROCHLORIDE" ], "active_ingredients": [ "COLESTIPOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208599", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218242", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217525", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PROPOFOL" ], "active_ingredients": [ "PROPOFOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211907", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217899", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "LIVDELZI" ], "active_ingredients": [ "SELADELPAR LYSINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761411", "application_type": "BLA", "sponsor_name": "INCYTE CORP", "brand_names": [ "NIKTIMVO" ], "active_ingredients": [ "axatilimab-csfr" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217770", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "BEPOTASTINE BESILATE" ], "active_ingredients": [ "BEPOTASTINE BESILATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214717", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "URSODIOL" ], "active_ingredients": [ "URSODIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217606", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761390", "application_type": "BLA", "sponsor_name": "GALDERMA LABS LP", "brand_names": [ "NEMLUVIO" ], "active_ingredients": [ "NEMOLIZUMAB-ILTO" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218993", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "MIDAZOLAM IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "MIDAZOLAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216123", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "STERILE WATER FOR IRRIGATION" ], "active_ingredients": [ "STERILE WATER FOR IRRIGATION" ], "dosage_forms": [ "LIQUID" ], "routes": [ "IRRIGATION" ], "approval_date": "2024-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219779", "application_type": "NDA", "sponsor_name": "CENTRAL WELDING SUPPLY", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2024-08-10", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA216490", "application_type": "NDA", "sponsor_name": "ASCENDIS PHARMA BONE", "brand_names": [ "YORVIPATH" ], "active_ingredients": [ "PALOPEGTERIPARATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-08-09", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214697", "application_type": "NDA", "sponsor_name": "ARS PHARMS OPERATION", "brand_names": [ "NEFFY" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2024-08-09", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761382", "application_type": "BLA", "sponsor_name": "SANDOZ INC", "brand_names": [ "ENZEEVU" ], "active_ingredients": [ "AFLIBERCEPT-ABZV" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216906", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215816", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "PROPARACAINE HYDROCHLORIDE" ], "active_ingredients": [ "PROPARACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218988", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "TRAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "TRAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218590", "application_type": "NDA", "sponsor_name": "KNOA PHARMA", "brand_names": [ "ZURNAI (AUTOINJECTOR)" ], "active_ingredients": [ "NALMEFENE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2024-08-07", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217186", "application_type": "NDA", "sponsor_name": "IMPAX", "brand_names": [ "CREXONT" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-07", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761312", "application_type": "BLA", "sponsor_name": "CITIUS PHARMS", "brand_names": [ "LYMPHIR" ], "active_ingredients": [ "DENILEUKIN DIFTITOX-CXDL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218920", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "TIZANIDINE HYDROCHLORIDE" ], "active_ingredients": [ "TIZANIDINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218460", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216137", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "VALBENAZINE TOSYLATE" ], "active_ingredients": [ "VALBENAZINE TOSYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218784", "application_type": "NDA", "sponsor_name": "SERVIER", "brand_names": [ "VORANIGO" ], "active_ingredients": [ "VORASIDENIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-06", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA219002", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "TRAMETINIB DIMETHYL SULFOXIDE" ], "active_ingredients": [ "TRAMETINIB DIMETHYL SULFOXIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217400", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211590", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218169", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217774", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ACITRETIN" ], "active_ingredients": [ "ACITRETIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215955", "application_type": "ANDA", "sponsor_name": "GE HEALTHCARE", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211572", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE" ], "active_ingredients": [ "POLYMYXIN B SULFATE", "TRIMETHOPRIM SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211107", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216935", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PREDNISOLONE ACETATE" ], "active_ingredients": [ "PREDNISOLONE ACETATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216550", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "VAGINAL" ], "approval_date": "2024-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218554", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216021", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213597", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213396", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205448", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "ETODOLAC" ], "active_ingredients": [ "ETODOLAC" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218713", "application_type": "ANDA", "sponsor_name": "KINDOS", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218139", "application_type": "NDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "TEZRULY" ], "active_ingredients": [ "TERAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA210962", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218549", "application_type": "NDA", "sponsor_name": "ALPHA COGNITION", "brand_names": [ "ZUNVEYL" ], "active_ingredients": [ "BENZGALANTAMINE GLUCONATE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-26", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form" }, { "application_number": "NDA218343", "application_type": "NDA", "sponsor_name": "AMNEAL", "brand_names": [ "POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216352", "application_type": "NDA", "sponsor_name": "LUYE INNOMIND PHARMA", "brand_names": [ "ERZOFRI" ], "active_ingredients": [ "PALIPERIDONE PALMITATE" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2024-07-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214110", "application_type": "ANDA", "sponsor_name": "ZHEJIANG JUTAI PHARM", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202836", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-26", "review_priority": "", "submission_class": "" }, { "application_number": "NDA217900", "application_type": "NDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "LEQSELVI" ], "active_ingredients": [ "DEURUXOLITINIB PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216041", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204739", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LOPINAVIR AND RITONAVIR" ], "active_ingredients": [ "LOPINAVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218173", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217854", "application_type": "ANDA", "sponsor_name": "HERITAGE", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217115", "application_type": "ANDA", "sponsor_name": "PIRAMAL", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212769", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218718", "application_type": "NDA", "sponsor_name": "MILLICENT MFG PR", "brand_names": [ "FEMLYV" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA216655", "application_type": "NDA", "sponsor_name": "XIAMEN LP PHARM CO", "brand_names": [ "OPIPZA" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "FILM" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218991", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218135", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PROCAINAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "PROCAINAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217542", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BARICITINIB" ], "active_ingredients": [ "BARICITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217092", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216456", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "TIOPRONIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216424", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "MEROPENEM" ], "active_ingredients": [ "MEROPENEM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207314", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "active_ingredients": [ "CYCLOBENZAPRINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761340", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "EPYSQLI" ], "active_ingredients": [ "ECULIZUMAB-AAGH" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2024-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216778", "application_type": "NDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ZITUVIMET XR" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA219050", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218422", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217119", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214850", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213300", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE" ], "active_ingredients": [ "DUTASTERIDE", "TAMSULOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218710", "application_type": "NDA", "sponsor_name": "PHATHOM PHARMACEUTICALS INC", "brand_names": [ "VOQUEZNA" ], "active_ingredients": [ "VONOPRAZAN FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-17", "review_priority": "STANDARD", "submission_class": "Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval" }, { "application_number": "ANDA216135", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217869", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216414", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215178", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)" ], "active_ingredients": [ "DOXORUBICIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217075", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209941", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219709", "application_type": "NDA", "sponsor_name": "WSM SUPPLIER LLC", "brand_names": [ "MEDICAL AIR, USP" ], "active_ingredients": [ "MEDICAL AIR" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2024-07-13", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA218159", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TRAVOPROST" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217863", "application_type": "ANDA", "sponsor_name": "AMVIKA", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216055", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215684", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206234", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204918", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217766", "application_type": "NDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "VASOPRESSIN IN SODIUM CHLORIDE 0.9%" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-11", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217726", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217170", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215561", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207037", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217839", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215203", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212696", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212425", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217873", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2024-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216937", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "NIMODIPINE" ], "active_ingredients": [ "NIMODIPINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213719", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217524", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CALCIUM CHLORIDE 10%" ], "active_ingredients": [ "CALCIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215647", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "L-GLUTAMINE" ], "active_ingredients": [ "L-GLUTAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214340", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212344", "application_type": "ANDA", "sponsor_name": "WINDER LABS LLC", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207334", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218673", "application_type": "ANDA", "sponsor_name": "HARMAN FINOCHEM", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214597", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211943", "application_type": "ANDA", "sponsor_name": "SAPTALIS PHARMS", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217764", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216653", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215969", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761248", "application_type": "BLA", "sponsor_name": "ELI LILLY CO", "brand_names": [ "KISUNLA" ], "active_ingredients": [ "DONANEMAB-AZBT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-02", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA217303", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218564", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218018", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215618", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214348", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "BUPIVACAINE LIPOSOME" ], "active_ingredients": [ "BUPIVACAINE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212785", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "INDIUM IN-111 PENTETREOTIDE KIT" ], "active_ingredients": [ "INDIUM IN-111 PENTETREOTIDE KIT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218527", "application_type": "NDA", "sponsor_name": "B BETTER", "brand_names": [ "CHEWTADZY" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA210661", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "AXTLE" ], "active_ingredients": [ "PEMETREXED DIPOTASSIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "BLA761425", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "PYZCHIVA" ], "active_ingredients": [ "USTEKINUMAB-TTWE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761378", "application_type": "BLA", "sponsor_name": "FORMYCON AG", "brand_names": [ "AHZANTIVE" ], "active_ingredients": [ "AFLIBERCEPT-MRBB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761373", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "PYZCHIVA" ], "active_ingredients": [ "USTEKINUMAB-TTWE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "BLA761126", "application_type": "BLA", "sponsor_name": "TANVEX BIOPHARMA USA INC", "brand_names": [ "NYPOZI" ], "active_ingredients": [ "FILGRASTIM-TXID" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218281", "application_type": "ANDA", "sponsor_name": "JIANGXI KVVIT PHARM", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215921", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "MIDOSTAURIN" ], "active_ingredients": [ "MIDOSTAURIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215635", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "REMIFENTANIL HYDROCHLORIDE" ], "active_ingredients": [ "REMIFENTANIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208866", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "RASAGILINE MESYLATE" ], "active_ingredients": [ "RASAGILINE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207498", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID" ], "active_ingredients": [ "ASCORBIC ACID", "POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM ASCORBATE", "SODIUM CHLORIDE", "SODIUM SULFATE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217674", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217389", "application_type": "NDA", "sponsor_name": "MSD", "brand_names": [ "OHTUVAYRE" ], "active_ingredients": [ "ENSIFENTRINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "INHALATION" ], "approval_date": "2024-06-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218514", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218304", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210377", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205104", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "RISPERIDONE" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216984", "application_type": "NDA", "sponsor_name": "SHORLA", "brand_names": [ "TEPYLUTE" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-25", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218618", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CABERGOLINE" ], "active_ingredients": [ "CABERGOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215404", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ACYCLOVIR SODIUM" ], "active_ingredients": [ "ACYCLOVIR SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215102", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BUSULFAN" ], "active_ingredients": [ "BUSULFAN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204982", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE" ], "active_ingredients": [ "PHENTERMINE HYDROCHLORIDE", "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213688", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER" ], "active_ingredients": [ "SODIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "IRRIGATION" ], "approval_date": "2024-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204135", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-06-24", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218314", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "SODIUM PHOSPHATES" ], "active_ingredients": [ "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE", "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217685", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761388", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "PIASKY" ], "active_ingredients": [ "CROVALIMAB-AKKZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-20", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217013", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "PROPOFOL" ], "active_ingredients": [ "PROPOFOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217347", "application_type": "NDA", "sponsor_name": "BOTANIX SB", "brand_names": [ "SOFDRA" ], "active_ingredients": [ "SOFPIRONIUM BROMIDE" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TOPICAL" ], "approval_date": "2024-06-18", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217117", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2024-06-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206472", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TROSPIUM CHLORIDE" ], "active_ingredients": [ "TROSPIUM CHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217684", "application_type": "NDA", "sponsor_name": "PYROS PHARMS", "brand_names": [ "VIGAFYDE" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-06-17", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218073", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "GADOTERATE MEGLUMINE" ], "active_ingredients": [ "GADOTERATE MEGLUMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218011", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215460", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215233", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213773", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ICATIBANT ACETATE" ], "active_ingredients": [ "ICATIBANT ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209266", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "AVANAFIL" ], "active_ingredients": [ "AVANAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218482", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218497", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "NAPROXEN" ], "active_ingredients": [ "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217638", "application_type": "ANDA", "sponsor_name": "FOSUN WANBANG", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216772", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213913", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "EPOPROSTENOL SODIUM" ], "active_ingredients": [ "EPOPROSTENOL SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205470", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218320", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218092", "application_type": "ANDA", "sponsor_name": "GLENMARK SPECLT", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212876", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210164", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218860", "application_type": "NDA", "sponsor_name": "IPSEN", "brand_names": [ "IQIRVO" ], "active_ingredients": [ "ELAFIBRANOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-10", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218059", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218397", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218283", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217779", "application_type": "NDA", "sponsor_name": "GERON", "brand_names": [ "RYTELO" ], "active_ingredients": [ "IMETELSTAT SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-06-06", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217767", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216576", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "AZELASTINE HYDROCHLORIDE" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215570", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "PALBOCICLIB" ], "active_ingredients": [ "PALBOCICLIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218771", "application_type": "NDA", "sponsor_name": "ALMAJECT", "brand_names": [ "TERIPARATIDE" ], "active_ingredients": [ "TERIPARATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-06-04", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218551", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LOSARTAN POTASSIUM" ], "active_ingredients": [ "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217482", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206387", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "ALENDRONATE SODIUM" ], "active_ingredients": [ "ALENDRONATE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218462", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217552", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215032", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208480", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217671", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "HALCINONIDE" ], "active_ingredients": [ "HALCINONIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2024-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216637", "application_type": "ANDA", "sponsor_name": "FOSUN WANBANG", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216438", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216421", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "AZELASTINE HYDROCHLORIDE CHILDREN'S ALLERGY", "AZELASTINE HYDROCHLORIDE ALLERGY" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209855", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761333", "application_type": "BLA", "sponsor_name": "AMGEN INC", "brand_names": [ "BKEMV" ], "active_ingredients": [ "ECULIZUMAB-AEEB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-28", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA218003", "application_type": "ANDA", "sponsor_name": "CONTRACT PHARMACAL", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213682", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213676", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213605", "application_type": "ANDA", "sponsor_name": "CRYSTAL", "brand_names": [ "SACUBITRIL AND VALSARTAN" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217645", "application_type": "NDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "ONYDA XR" ], "active_ingredients": [ "CLONIDINE HYDROCHLORIDE" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-24", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA209267", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ERLOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "ERLOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208466", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216343", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION, GEL FORMING/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215183", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215024", "application_type": "ANDA", "sponsor_name": "HETERO LABS", "brand_names": [ "MELPHALAN HYDROCHLORIDE" ], "active_ingredients": [ "MELPHALAN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214402", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "CEFEPIME HYDROCHLORIDE" ], "active_ingredients": [ "CEFEPIME HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213879", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211056", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "IRBESARTAN" ], "active_ingredients": [ "IRBESARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218063", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217193", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "LANREOTIDE ACETATE" ], "active_ingredients": [ "LANREOTIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216474", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212447", "application_type": "ANDA", "sponsor_name": "ARMSTRONG PHARMS", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2024-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209811", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761350", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "OPUVIZ" ], "active_ingredients": [ "AFLIBERCEPT-YSZY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-20", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761274", "application_type": "BLA", "sponsor_name": "BIOCON BIOLOGICS INC", "brand_names": [ "YESAFILI" ], "active_ingredients": [ "AFLIBERCEPT-JBVF" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211116", "application_type": "ANDA", "sponsor_name": "CROSSMEDIKA SA", "brand_names": [ "TRAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "TRAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205983", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216303", "application_type": "ANDA", "sponsor_name": "NEOCUBES PHARMA", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214053", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208113", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206585", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761344", "application_type": "BLA", "sponsor_name": "AMGEN INC", "brand_names": [ "IMDELLTRA" ], "active_ingredients": [ "TARLATAMAB-DLLE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216453", "application_type": "ANDA", "sponsor_name": "ELITE LABS INC", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214987", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212580", "application_type": "ANDA", "sponsor_name": "MSN LABS PVT LTD", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215154", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218023", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218017", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "LORATADINE AND PSEUDOEPHEDRINE SULFATE" ], "active_ingredients": [ "LORATADINE", "PSEUDOEPHEDRINE SULFATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207284", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218758", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213365", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "TIZANIDINE HYDROCHLORIDE" ], "active_ingredients": [ "TIZANIDINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218868", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "CISPLATIN" ], "active_ingredients": [ "CISPLATIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218131", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218110", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217088", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216611", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CALCIUM GLUCONATE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216015", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "MIDOSTAURIN" ], "active_ingredients": [ "MIDOSTAURIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215355", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091579", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "EFAVIRENZ" ], "active_ingredients": [ "EFAVIRENZ" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-10", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218515", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217784", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "OMEPRAZOLE AND SODIUM BICARBONATE" ], "active_ingredients": [ "OMEPRAZOLE", "SODIUM BICARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216284", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216269", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213599", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "EPTIFIBATIDE" ], "active_ingredients": [ "EPTIFIBATIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211915", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216801", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "AZELASTINE HYDROCHLORIDE" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214019", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213988", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "VASOPRESSIN IN DEXTROSE 5%", "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217566", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218354", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216199", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215917", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215508", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "EDARAVONE" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "INJECTION", "SOLUTION" ], "routes": [ "SOLUTION", "INTRAVENOUS" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215329", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "SCOPOLAMINE" ], "active_ingredients": [ "SCOPOLAMINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212545", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "PERPHENAZINE" ], "active_ingredients": [ "PERPHENAZINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204626", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "LEVOCETIRIZINE DIHYDROCHLORIDE" ], "active_ingredients": [ "LEVOCETIRIZINE DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-06", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215571", "application_type": "ANDA", "sponsor_name": "LEXENPHARM", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213146", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212204", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD VI", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2024-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207040", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TRAVOPROST" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206644", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218083", "application_type": "ANDA", "sponsor_name": "ZHEJIANG XIANJU", "brand_names": [ "PREDNISOLONE" ], "active_ingredients": [ "PREDNISOLONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217860", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "OCTREOTIDE ACETATE" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216482", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "MYHIBBIN" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-05-01", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218565", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204729", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "ETODOLAC" ], "active_ingredients": [ "ETODOLAC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-05-01", "review_priority": "", "submission_class": "" }, { "application_number": "NDA218390", "application_type": "NDA", "sponsor_name": "NEUROCRINE", "brand_names": [ "INGREZZA SPRINKLE" ], "active_ingredients": [ "VALBENAZINE TOSYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-30", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217626", "application_type": "ANDA", "sponsor_name": "STIRA", "brand_names": [ "CUPRIC CHLORIDE" ], "active_ingredients": [ "CUPRIC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216113", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "CUPRIC CHLORIDE" ], "active_ingredients": [ "CUPRIC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207198", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205977", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "PITAVASTATIN CALCIUM" ], "active_ingredients": [ "PITAVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218411", "application_type": "ANDA", "sponsor_name": "THE J MOLNER", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217804", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217791", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217620", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216076", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "MIDOSTAURIN" ], "active_ingredients": [ "MIDOSTAURIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215463", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211159", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "EZETIMIBE" ], "active_ingredients": [ "EZETIMIBE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210757", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218709", "application_type": "NDA", "sponsor_name": "X4 PHARMS", "brand_names": [ "XOLREMDI" ], "active_ingredients": [ "MAVORIXAFOR" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA218347", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "RINVOQ LQ" ], "active_ingredients": [ "UPADACITINIB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-26", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218311", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761346", "application_type": "BLA", "sponsor_name": "ACCORD BIOPHARMA INC.", "brand_names": [ "HERCESSI" ], "active_ingredients": [ "TRASTUZUMAB-STRF" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218561", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218450", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218150", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217813", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215739", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "SAFINAMIDE MESYLATE" ], "active_ingredients": [ "SAFINAMIDE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207291", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218466", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "VIJOICE" ], "active_ingredients": [ "ALPELISIB" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-24", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA216483", "application_type": "NDA", "sponsor_name": "ALEMBIC THERAP", "brand_names": [ "PIVYA" ], "active_ingredients": [ "PIVMECILLINAM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-24", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA218548", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215719", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214540", "application_type": "ANDA", "sponsor_name": "LIVZON GRP", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218033", "application_type": "NDA", "sponsor_name": "DAY ONE BIOPHARMS", "brand_names": [ "OJEMDA" ], "active_ingredients": [ "TOVORAFENIB" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-23", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217700", "application_type": "NDA", "sponsor_name": "DAY ONE BIOPHARMS", "brand_names": [ "OJEMDA" ], "active_ingredients": [ "TOVORAFENIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218231", "application_type": "ANDA", "sponsor_name": "NOVUGEN", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217992", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217438", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MOMETASONE FUROATE" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216471", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761336", "application_type": "BLA", "sponsor_name": "ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU", "brand_names": [ "ANKTIVA" ], "active_ingredients": [ "nogapendekin alfa inbakicept-pmln" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVESICAL" ], "approval_date": "2024-04-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218616", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "MINOXIDIL (FOR WOMEN)", "MINOXIDIL (FOR MEN)" ], "active_ingredients": [ "MINOXIDIL" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216160", "application_type": "ANDA", "sponsor_name": "SOLARIS PHARMA CORP", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2024-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218424", "application_type": "NDA", "sponsor_name": "BAUSCH AND LOMB INC", "brand_names": [ "LUMIFY PRESERVATIVE FREE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-04-19", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA215487", "application_type": "NDA", "sponsor_name": "SCIENTURE", "brand_names": [ "REZENOPY" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2024-04-19", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218789", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761359", "application_type": "BLA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "ENTYVIO" ], "active_ingredients": [ "VEDOLIZUMAB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS", "SUBCUTANEOUS" ], "approval_date": "2024-04-18", "review_priority": "STANDARD", "submission_class": "Efficacy" }, { "application_number": "ANDA216620", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "ELTROMBOPAG OLAMINE" ], "active_ingredients": [ "ELTROMBOPAG OLAMINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214511", "application_type": "NDA", "sponsor_name": "LUMICELL", "brand_names": [ "LUMISIGHT" ], "active_ingredients": [ "PEGULICIANINE ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218606", "application_type": "ANDA", "sponsor_name": "ACERTIS PHARMS", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203978", "application_type": "ANDA", "sponsor_name": "INFORLIFE", "brand_names": [ "NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE", "NICARDIPINE HYDROCHLORIDE IN 0.83% SODIUM CHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761343", "application_type": "BLA", "sponsor_name": "ALVOTECH USA INC", "brand_names": [ "SELARSDI" ], "active_ingredients": [ "USTEKINUMAB-AEKN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218599", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217776", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216877", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214356", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209560", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218591", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "ENTRESTO SPRINKLE" ], "active_ingredients": [ "SACUBITRIL", "VALSARTAN" ], "dosage_forms": [ "CAPSULE, PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2024-04-12", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217904", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216918", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215715", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211404", "application_type": "ANDA", "sponsor_name": "PLD ACQUISITIONS LLC", "brand_names": [ "IBUPROFEN AND DIPHENHYDRAMINE CITRATE" ], "active_ingredients": [ "DIPHENHYDRAMINE CITRATE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218160", "application_type": "NDA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "RETEVMO" ], "active_ingredients": [ "SELPERCATINIB" ], "dosage_forms": [ "CAPSULE", "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218289", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BETAMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BETAMETHASONE DIPROPIONATE" ], "dosage_forms": [ "OINTMENT, AUGMENTED" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218202", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218163", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "RASAGILINE MESYLATE" ], "active_ingredients": [ "RASAGILINE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090857", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEFPROZIL" ], "active_ingredients": [ "CEFPROZIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-09", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218034", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217965", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217263", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "DEXTROSE 5%" ], "active_ingredients": [ "DEXTROSE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216631", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213506", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "ORAL" ], "approval_date": "2024-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218047", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ERIBULIN MESYLATE" ], "active_ingredients": [ "ERIBULIN MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218002", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "TAFLUPROST" ], "active_ingredients": [ "TAFLUPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216806", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216064", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "VALBENAZINE TOSYLATE" ], "active_ingredients": [ "VALBENAZINE TOSYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212684", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211269", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216593", "application_type": "NDA", "sponsor_name": "NOVA LABS LTD", "brand_names": [ "XROMI" ], "active_ingredients": [ "HYDROXYUREA" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-04-04", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA209697", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218275", "application_type": "NDA", "sponsor_name": "ISTX", "brand_names": [ "ZEVTERA" ], "active_ingredients": [ "CEFTOBIPROLE MEDOCARIL SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-03", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218533", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218013", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218014", "application_type": "ANDA", "sponsor_name": "KANCHAN HLTHCARE", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215856", "application_type": "ANDA", "sponsor_name": "SABA ILAC SANAYIVE", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214901", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2024-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213573", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212466", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204146", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "IBUTILIDE FUMARATE" ], "active_ingredients": [ "IBUTILIDE FUMARATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-04-01", "review_priority": "", "submission_class": "" }, { "application_number": "NDA218037", "application_type": "NDA", "sponsor_name": "ALEXION PHARMS INC", "brand_names": [ "VOYDEYA" ], "active_ingredients": [ "DANICOPAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214835", "application_type": "NDA", "sponsor_name": "LABS FARMS ROVI SA", "brand_names": [ "RISVAN" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2024-03-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215192", "application_type": "NDA", "sponsor_name": "AKEBIA", "brand_names": [ "VAFSEO" ], "active_ingredients": [ "VADADUSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217821", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217797", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "active_ingredients": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211246", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204839", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761363", "application_type": "BLA", "sponsor_name": "MERCK SHARP DOHME", "brand_names": [ "WINREVAIR" ], "active_ingredients": [ "SOTATERCEPT-CSRK" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218359", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218204", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217718", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216600", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218490", "application_type": "NDA", "sponsor_name": "ACTELION", "brand_names": [ "OPSYNVI" ], "active_ingredients": [ "MACITENTAN", "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-22", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA216501", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CIPROFLOXACIN AND DEXAMETHASONE" ], "active_ingredients": [ "CIPROFLOXACIN", "DEXAMETHASONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2024-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211395", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203658", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-22", "review_priority": "", "submission_class": "" }, { "application_number": "NDA217865", "application_type": "NDA", "sponsor_name": "ITALFARMACO SPA", "brand_names": [ "DUVYZAT" ], "active_ingredients": [ "GIVINOSTAT HYDROCHLORIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-21", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216726", "application_type": "ANDA", "sponsor_name": "ABON PHARMS LLC", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213867", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TENOFOVIR ALAFENAMIDE FUMARATE" ], "active_ingredients": [ "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213095", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DESMOPRESSIN ACETATE" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218448", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DIPHENHYDRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217686", "application_type": "NDA", "sponsor_name": "IDORSIA", "brand_names": [ "TRYVIO" ], "active_ingredients": [ "APROCITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-19", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218146", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "AMIKACIN SULFATE" ], "active_ingredients": [ "AMIKACIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213019", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206431", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217183", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "LITHIUM CITRATE" ], "active_ingredients": [ "LITHIUM CITRATE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216795", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215925", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215878", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "MOMETASONE FUROATE" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213183", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205589", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA219016", "application_type": "NDA", "sponsor_name": "JANSSEN PRODS", "brand_names": [ "EDURANT PED" ], "active_ingredients": [ "RILPIVIRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-15", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218232", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "FINASTERIDE AND TADALAFIL" ], "active_ingredients": [ "FINASTERIDE", "TADALAFIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216920", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "SODIUM ACETATE" ], "active_ingredients": [ "SODIUM ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217785", "application_type": "NDA", "sponsor_name": "MADRIGAL", "brand_names": [ "REZDIFFRA" ], "active_ingredients": [ "RESMETIROM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA207970", "application_type": "NDA", "sponsor_name": "ACTAVIS", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218615", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218461", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218412", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217794", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208563", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761232", "application_type": "BLA", "sponsor_name": "BEIGENE", "brand_names": [ "TEVIMBRA" ], "active_ingredients": [ "TISLELIZUMAB-JSGR" ], "dosage_forms": [ "INJECTION" ], "routes": [ "SOLUTION" ], "approval_date": "2024-03-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217275", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211163", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216376", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216538", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213159", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217439", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "TALZENNA" ], "active_ingredients": [ "TALAZOPARIB TOSYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA218021", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "HYDROXYUREA" ], "active_ingredients": [ "HYDROXYUREA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217283", "application_type": "ANDA", "sponsor_name": "NE RX PHARMA", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761362", "application_type": "BLA", "sponsor_name": "SANDOZ INC", "brand_names": [ "JUBBONTI", "WYOST" ], "active_ingredients": [ "DENOSUMAB-BBDZ" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2024-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761275", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "TYENNE" ], "active_ingredients": [ "TOCILIZUMAB-AAZG" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210203", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "CAPECITABINE" ], "active_ingredients": [ "CAPECITABINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207717", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218158", "application_type": "NDA", "sponsor_name": "HARROW EYE", "brand_names": [ "BYQLOVI" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-03-04", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216279", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211313", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203172", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-03-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218278", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217090", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2024-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216602", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211524", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209706", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ALCAFTADINE" ], "active_ingredients": [ "ALCAFTADINE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761225", "application_type": "BLA", "sponsor_name": "HUGEL INC", "brand_names": [ "LETYBO" ], "active_ingredients": [ "LETIBOTULINUMTOXINA-WLBG" ], "dosage_forms": [ "POWDER, FOR SOLUTION" ], "routes": [], "approval_date": "2024-02-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218404", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-02-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215641", "application_type": "ANDA", "sponsor_name": "THINQ PHARM-CRO PVT", "brand_names": [ "CLOTRIMAZOLE" ], "active_ingredients": [ "CLOTRIMAZOLE" ], "dosage_forms": [ "TROCHE/LOZENGE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202019", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-29", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA079071", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-29", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216677", "application_type": "ANDA", "sponsor_name": "HERITAGE", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212659", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TESTOSTERONE ENANTHATE" ], "active_ingredients": [ "TESTOSTERONE ENANTHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207983", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218603", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216042", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211227", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209741", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209705", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218075", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216252", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761299", "application_type": "BLA", "sponsor_name": "ALVOTECH USA INC", "brand_names": [ "SIMLANDI" ], "active_ingredients": [ "ADALIMUMAB-RYVK" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218326", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216165", "application_type": "NDA", "sponsor_name": "ORCHID PHARMA", "brand_names": [ "EXBLIFEP" ], "active_ingredients": [ "CEFEPIME HYDROCHLORIDE", "ENMETAZOBACTAM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA217659", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217265", "application_type": "ANDA", "sponsor_name": "QILU", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218138", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS PHARM", "brand_names": [ "LIDOCAINE HYDROCHLORIDE VISCOUS" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-02-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217937", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204374", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-20", "review_priority": "", "submission_class": "" }, { "application_number": "NDA219303", "application_type": "NDA", "sponsor_name": "HAUN SPECIALTY GASES INC", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2024-02-17", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA218221", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216361", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216103", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "INTRA-ANAL" ], "approval_date": "2024-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210091", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205024", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "RITONAVIR" ], "active_ingredients": [ "RITONAVIR" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218255", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ISOSORBIDE MONONITRATE" ], "active_ingredients": [ "ISOSORBIDE MONONITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217087", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "MINZOYA" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "LEVONORGESTREL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217512", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-14", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217782", "application_type": "ANDA", "sponsor_name": "KANCHAN HLTHCARE", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217933", "application_type": "NDA", "sponsor_name": "BTG INTL", "brand_names": [ "AURLUMYN" ], "active_ingredients": [ "ILOPROST" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-13", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215040", "application_type": "NDA", "sponsor_name": "GALEPHAR", "brand_names": [ "LEGUBETI" ], "active_ingredients": [ "ACETYLCYSTEINE LYSINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-02-13", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form" }, { "application_number": "ANDA217311", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217236", "application_type": "ANDA", "sponsor_name": "PATHEON SOFTGELS", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217118", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215574", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "OSPEMIFENE" ], "active_ingredients": [ "OSPEMIFENE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215948", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211356", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213976", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "EOHILIA" ], "active_ingredients": [ "BUDESONIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-02-09", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217123", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DEFLAZACORT" ], "active_ingredients": [ "DEFLAZACORT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216963", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "VASOPRESSIN IN DEXTROSE 5%", "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216899", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "HYDROMORPHONE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROMORPHONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214288", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207796", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "FENOFIBRIC ACID" ], "active_ingredients": [ "CHOLINE FENOFIBRATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216283", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216282", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211734", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209986", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "COBICISTAT" ], "active_ingredients": [ "COBICISTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA079074", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "LOPINAVIR AND RITONAVIR" ], "active_ingredients": [ "LOPINAVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-07", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218070", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "LIOTHYRONINE SODIUM" ], "active_ingredients": [ "LIOTHYRONINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213986", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "POTASSIUM CITRATE" ], "active_ingredients": [ "POTASSIUM CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216334", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218306", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2024-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211239", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216786", "application_type": "ANDA", "sponsor_name": "NE RX PHARMA", "brand_names": [ "METHSCOPOLAMINE BROMIDE" ], "active_ingredients": [ "METHSCOPOLAMINE BROMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214305", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BUTALBITAL AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218371", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL LACTATE" ], "dosage_forms": [ "CONCENTRATE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211407", "application_type": "ANDA", "sponsor_name": "CHARTWELL", "brand_names": [ "FENOFIBRATE (MICRONIZED)" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205904", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DRONEDARONE HYDROCHLORIDE" ], "active_ingredients": [ "DRONEDARONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216990", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "VENXXIVA" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218194", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216164", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER" ], "active_ingredients": [ "LEVOFLOXACIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213706", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215901", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215012", "application_type": "ANDA", "sponsor_name": "CHENGDU", "brand_names": [ "TACROLIMUS" ], "active_ingredients": [ "TACROLIMUS" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211886", "application_type": "ANDA", "sponsor_name": "SHANDONG XINHUA", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206227", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209883", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209224", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203934", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-24", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218366", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "PRIMIDONE" ], "active_ingredients": [ "PRIMIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217917", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "FLUVOXAMINE MALEATE" ], "active_ingredients": [ "FLUVOXAMINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217094", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214513", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210961", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205205", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "DEXLANSOPRAZOLE" ], "active_ingredients": [ "DEXLANSOPRAZOLE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217617", "application_type": "ANDA", "sponsor_name": "HARMAN FINOCHEM", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214291", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BUTALBITAL AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214287", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218467", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2024-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217682", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215988", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE", "ISOSORBIDE DINITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213549", "application_type": "ANDA", "sponsor_name": "PD PARTNERS", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205406", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217605", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214925", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PIMAVANSERIN" ], "active_ingredients": [ "PIMAVANSERIN TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214502", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "PIMAVANSERIN" ], "active_ingredients": [ "PIMAVANSERIN TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214493", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "PIMAVANSERIN" ], "active_ingredients": [ "PIMAVANSERIN TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208443", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "FIDAXOMICIN" ], "active_ingredients": [ "FIDAXOMICIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217883", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "INDOMETHACIN" ], "active_ingredients": [ "INDOMETHACIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210197", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "CEFTRIAXONE" ], "active_ingredients": [ "CEFTRIAXONE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2024-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204349", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PROPRANOLOL HYDROCHLORIDE" ], "active_ingredients": [ "PROPRANOLOL HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-12", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217348", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "OXALIPLATIN" ], "active_ingredients": [ "OXALIPLATIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-01-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217788", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212329", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "DOXAZOSIN MESYLATE" ], "active_ingredients": [ "DOXAZOSIN MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216348", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "FLUOROMETHOLONE" ], "active_ingredients": [ "FLUOROMETHOLONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211195", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204792", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218148", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2024-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218111", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "ACYCLOVIR SODIUM" ], "active_ingredients": [ "ACYCLOVIR SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216458", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215237", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "GENTAMICIN SULFATE" ], "active_ingredients": [ "GENTAMICIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215236", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "GENTAMICIN SULFATE" ], "active_ingredients": [ "GENTAMICIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2024-01-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217424", "application_type": "NDA", "sponsor_name": "LNHC", "brand_names": [ "ZELSUVMI" ], "active_ingredients": [ "BERDAZIMER SODIUM" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2024-01-05", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217903", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2024-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217828", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217081", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203640", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "NILOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "NILOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209748", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205504", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ESZOPICLONE" ], "active_ingredients": [ "ESZOPICLONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2024-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214083", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2024-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212605", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2024-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216805", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2024-01-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213924", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206222", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "ESZOPICLONE" ], "active_ingredients": [ "ESZOPICLONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215990", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2023-12-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217022", "application_type": "ANDA", "sponsor_name": "ZHEJIANG YONGTAI", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2023-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216040", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213213", "application_type": "ANDA", "sponsor_name": "SUNNY", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217553", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216037", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "THIOTEPA" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRACAVITARY, INTRAVENOUS, INTRAVESICAL" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215550", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214842", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211500", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209983", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA204311", "application_type": "NDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "ABACAVIR SULFATE AND LAMIVUDINE" ], "active_ingredients": [ "ABACAVIR SULFATE", "LAMIVUDINE" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218181", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217919", "application_type": "ANDA", "sponsor_name": "HUMANWELL PURACAP", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215379", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217388", "application_type": "NDA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "WAINUA (AUTOINJECTOR)", "WAINUA" ], "active_ingredients": [ "EPLONTERSEN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-12-21", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217634", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217669", "application_type": "ANDA", "sponsor_name": "CONTRACT PHARMACAL", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217412", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211837", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215064", "application_type": "NDA", "sponsor_name": "CHIESI", "brand_names": [ "FILSUVEZ" ], "active_ingredients": [ "BIRCH TRITERPENES" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-12-18", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216958", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-12-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217242", "application_type": "NDA", "sponsor_name": "ARCUTIS", "brand_names": [ "ZORYVE" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-12-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "ANDA208237", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE" ], "active_ingredients": [ "DONEPEZIL HYDROCHLORIDE", "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208070", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "DABIGATRAN ETEXILATE MESYLATE" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204947", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217812", "application_type": "NDA", "sponsor_name": "HIKMA", "brand_names": [ "HYDROMORPHONE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROMORPHONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-12-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217843", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217385", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211807", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "ALLOPURINOL" ], "active_ingredients": [ "ALLOPURINOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203880", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-12-14", "review_priority": "", "submission_class": "" }, { "application_number": "NDA218010", "application_type": "NDA", "sponsor_name": "GLAUKOS", "brand_names": [ "IDOSE TR" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "IMPLANT" ], "routes": [ "INTRACAMERAL" ], "approval_date": "2023-12-13", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215500", "application_type": "NDA", "sponsor_name": "USWM", "brand_names": [ "IWILFIN" ], "active_ingredients": [ "EFLORNITHINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-13", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214085", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211552", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217961", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "CARBIDOPA" ], "active_ingredients": [ "CARBIDOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217282", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216582", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210416", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217805", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212493", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203632", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CLOPIDOGREL BISULFATE" ], "active_ingredients": [ "CLOPIDOGREL BISULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-08", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA218182", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216811", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211345", "application_type": "ANDA", "sponsor_name": "WILSHIRE PHARMS INC", "brand_names": [ "OMEGA-3-ACID ETHYL ESTERS" ], "active_ingredients": [ "OMEGA-3-ACID ETHYL ESTERS" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211236", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761198", "application_type": "BLA", "sponsor_name": "BIO-THERA SOLUTIONS LTD", "brand_names": [ "AVZIVI" ], "active_ingredients": [ "BEVACIZUMAB-TNJN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-12-06", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217987", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216558", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "OSHIH" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207945", "application_type": "ANDA", "sponsor_name": "EZRA VENTURES", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218276", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "FABHALTA" ], "active_ingredients": [ "IPTACOPAN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-05", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216099", "application_type": "NDA", "sponsor_name": "HANDA THERAP", "brand_names": [ "PHYRAGO" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217970", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217694", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216841", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215636", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "METHYLENE BLUE" ], "active_ingredients": [ "METHYLENE BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214068", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "RISPERIDONE" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212629", "application_type": "ANDA", "sponsor_name": "POINTVIEW HLDINGS", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210317", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "OCTREOTIDE ACETATE" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-12-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211862", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217675", "application_type": "ANDA", "sponsor_name": "JUBILANT CADISTA", "brand_names": [ "METHENAMINE HIPPURATE" ], "active_ingredients": [ "METHENAMINE HIPPURATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-12-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214556", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-12-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216774", "application_type": "NDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "ALVAIZ" ], "active_ingredients": [ "ELTROMBOPAG CHOLINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217031", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216667", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BUDESONIDE" ], "active_ingredients": [ "BUDESONIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "INHALATION" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213987", "application_type": "ANDA", "sponsor_name": "SCIECURE", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213956", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213442", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210374", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218045", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215389", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213782", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211578", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210677", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206288", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217677", "application_type": "NDA", "sponsor_name": "SPRINGWORKS", "brand_names": [ "OGSIVEO" ], "active_ingredients": [ "NIROGACESTAT HYDROBROMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213163", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ZAFIRLUKAST" ], "active_ingredients": [ "ZAFIRLUKAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218009", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217846", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215469", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA INTL", "brand_names": [ "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POTASSIUM SULFATE", "SODIUM SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211871", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "PODOFILOX" ], "active_ingredients": [ "PODOFILOX" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206027", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217707", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PROGESTERONE" ], "active_ingredients": [ "PROGESTERONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212361", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210066", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205950", "application_type": "ANDA", "sponsor_name": "HERITAGE PHARMA AVET", "brand_names": [ "TRIMETHOBENZAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "TRIMETHOBENZAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217792", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217020", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "PROBENECID" ], "active_ingredients": [ "PROBENECID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214673", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213669", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208928", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206029", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PITAVASTATIN CALCIUM" ], "active_ingredients": [ "PITAVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217231", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215049", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM" ], "active_ingredients": [ "DIATRIZOATE MEGLUMINE", "DIATRIZOATE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL, RECTAL" ], "approval_date": "2023-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218197", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "TRUQAP" ], "active_ingredients": [ "CAPIVASERTIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761134", "application_type": "BLA", "sponsor_name": "EVIVE BIOTECHNOLOGY", "brand_names": [ "RYZNEUTA" ], "active_ingredients": [ "EFBEMALENOGRASTIM ALFA-VUXW" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-16", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216075", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211097", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TERIPARATIDE" ], "active_ingredients": [ "TERIPARATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208569", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "TERIPARATIDE" ], "active_ingredients": [ "TERIPARATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218213", "application_type": "NDA", "sponsor_name": "BRISTOL", "brand_names": [ "AUGTYRO" ], "active_ingredients": [ "REPOTRECTINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214520", "application_type": "NDA", "sponsor_name": "CORMEDIX", "brand_names": [ "DEFENCATH" ], "active_ingredients": [ "HEPARIN SODIUM", "TAUROLIDINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "N/A" ], "approval_date": "2023-11-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA216007", "application_type": "ANDA", "sponsor_name": "CHENGDU SHUODE", "brand_names": [ "NALMEFENE HYDROCHLORIDE" ], "active_ingredients": [ "NALMEFENE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216524", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216670", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-11-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213516", "application_type": "ANDA", "sponsor_name": "JUBILANT", "brand_names": [ "TECHNETIUM TC-99M SULFUR COLLOID KIT" ], "active_ingredients": [ "TECHNETIUM TC-99M SULFUR COLLOID KIT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION, ORAL" ], "approval_date": "2023-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217806", "application_type": "NDA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "ZEPBOUND", "ZEPBOUND KWIKPEN", "ZEPBOUND (AUTOINJECTOR)" ], "active_ingredients": [ "TIRZEPATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-11-08", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "NDA217564", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "FRUZAQLA" ], "active_ingredients": [ "FRUQUINTINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-08", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218290", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "CEVIMELINE HYDROCHLORIDE" ], "active_ingredients": [ "CEVIMELINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217687", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215063", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "LIFITEGRAST" ], "active_ingredients": [ "LIFITEGRAST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216350", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216743", "application_type": "NDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ZITUVIMET" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217073", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216502", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215612", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215365", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "FLUPHENAZINE DECANOATE" ], "active_ingredients": [ "FLUPHENAZINE DECANOATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213659", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213244", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "INJECTABLE", "SOLUTION" ], "routes": [ "INJECTION", "INTRAVENOUS" ], "approval_date": "2023-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215151", "application_type": "NDA", "sponsor_name": "PHATHOM", "brand_names": [ "VOQUEZNA" ], "active_ingredients": [ "VONOPRAZAN FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-01", "review_priority": "STANDARD", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA217271", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "MIDODRINE HYDROCHLORIDE" ], "active_ingredients": [ "MIDODRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216150", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212657", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205643", "application_type": "ANDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION, ORAL" ], "approval_date": "2023-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761331", "application_type": "BLA", "sponsor_name": "AMGEN INC", "brand_names": [ "WEZLANA" ], "active_ingredients": [ "USTEKINUMAB-AUUB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761285", "application_type": "BLA", "sponsor_name": "AMGEN INC", "brand_names": [ "WEZLANA" ], "active_ingredients": [ "USTEKINUMAB-AUUB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216554", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "AMPICILLIN TRIHYDRATE" ], "active_ingredients": [ "AMPICILLIN/AMPICILLIN TRIHYDRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215087", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216732", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209389", "application_type": "ANDA", "sponsor_name": "IPCA LABS LTD", "brand_names": [ "ONDANSETRON" ], "active_ingredients": [ "ONDANSETRON" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2023-10-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761240", "application_type": "BLA", "sponsor_name": "COHERUS BIOSCIENCES INC", "brand_names": [ "LOQTORZI" ], "active_ingredients": [ "TORIPALIMAB-TPZI" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216139", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215718", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215239", "application_type": "NDA", "sponsor_name": "CATALYST PHARMS", "brand_names": [ "AGAMREE" ], "active_ingredients": [ "VAMOROLONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761279", "application_type": "BLA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "OMVOH" ], "active_ingredients": [ "MIRIKIZUMAB-MRKZ" ], "dosage_forms": [ "INJECTABLE", "VIAL" ], "routes": [ "SUBCUTANEOUS", "SINGLE-USE" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217879", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215089", "application_type": "ANDA", "sponsor_name": "SUNNY", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214454", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206091", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213758", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210741", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218024", "application_type": "ANDA", "sponsor_name": "NATCO PHARMA", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217030", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "PROBENECID AND COLCHICINE" ], "active_ingredients": [ "COLCHICINE", "PROBENECID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214806", "application_type": "ANDA", "sponsor_name": "HARMAN FINOCHEM", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217237", "application_type": "ANDA", "sponsor_name": "TEYRO LABS", "brand_names": [ "CAPECITABINE" ], "active_ingredients": [ "CAPECITABINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214571", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA218550", "application_type": "NDA", "sponsor_name": "GENENTECH INC", "brand_names": [ "ROZLYTREK" ], "active_ingredients": [ "ENTRECTINIB" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2023-10-20", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA217927", "application_type": "NDA", "sponsor_name": "SOLUBIOMIX", "brand_names": [ "COXANTO" ], "active_ingredients": [ "OXAPROZIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA216632", "application_type": "NDA", "sponsor_name": "BAUSCH", "brand_names": [ "CABTREO" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE", "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "BLA761358", "application_type": "BLA", "sponsor_name": "CELLTRION", "brand_names": [ "ZYMFENTRA" ], "active_ingredients": [ "INFLIXIMAB-DYYB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216749", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215730", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211817", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TESTOSTERONE CYPIONATE" ], "active_ingredients": [ "TESTOSTERONE CYPIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209146", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "FLUCONAZOLE" ], "active_ingredients": [ "FLUCONAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217713", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217689", "application_type": "ANDA", "sponsor_name": "SOMERSET", "brand_names": [ "CALCIUM GLUCONATE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217517", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215837", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "PAZOPANIB HYDROCHLORIDE" ], "active_ingredients": [ "PAZOPANIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209890", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211566", "application_type": "NDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ZITUVIO" ], "active_ingredients": [ "SITAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-18", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217676", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217427", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2023-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217836", "application_type": "NDA", "sponsor_name": "ORASIS PHARMS", "brand_names": [ "QLOSI" ], "active_ingredients": [ "PILOCARPINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA216834", "application_type": "NDA", "sponsor_name": "UCB INC", "brand_names": [ "ZILBRYSQ" ], "active_ingredients": [ "ZILUCOPLAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA215320", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "COMBOGESIC IV" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA213931", "application_type": "NDA", "sponsor_name": "ARDELYX INC", "brand_names": [ "XPHOZAH" ], "active_ingredients": [ "TENAPANOR HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "BLA761151", "application_type": "BLA", "sponsor_name": "UCB INC", "brand_names": [ "BIMZELX" ], "active_ingredients": [ "BIMEKIZUMAB-BKZX" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA216762", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211973", "application_type": "ANDA", "sponsor_name": "NOVUGEN", "brand_names": [ "MIDODRINE HYDROCHLORIDE" ], "active_ingredients": [ "MIDODRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217808", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217155", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "TRANEXAMIC ACID" ], "active_ingredients": [ "TRANEXAMIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216569", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "CLOTRIMAZOLE" ], "active_ingredients": [ "CLOTRIMAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214474", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212103", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211674", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214926", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "FOSPHENYTOIN SODIUM" ], "active_ingredients": [ "FOSPHENYTOIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212383", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216956", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "VELSIPITY" ], "active_ingredients": [ "ETRASIMOD ARGININE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217409", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PIPERACILLIN AND TAZOBACTAM" ], "active_ingredients": [ "PIPERACILLIN,TAZOBACTAM", "PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM" ], "dosage_forms": [ "INJECTION", "INJECTABLE" ], "routes": [ "POWDER,FOR SOLUTION", "INJECTION" ], "approval_date": "2023-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213336", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217738", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "NAPROXEN AND ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM", "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214414", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "SELEXIPAG" ], "active_ingredients": [ "SELEXIPAG" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216344", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212387", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TACROLIMUS" ], "active_ingredients": [ "TACROLIMUS" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2023-10-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761349", "application_type": "BLA", "sponsor_name": "NOVARTIS PHARMS CORP", "brand_names": [ "COSENTYX" ], "active_ingredients": [ "SECUKINUMAB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-06", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217787", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216977", "application_type": "ANDA", "sponsor_name": "BPI LABS", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211199", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091475", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "LAMIVUDINE" ], "active_ingredients": [ "LAMIVUDINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-10-06", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217631", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216828", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214290", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217467", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214874", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "GLIPIZIDE" ], "active_ingredients": [ "GLIPIZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201802", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EFAVIRENZ", "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-03", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA217059", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216274", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "POTASSIUM PHOSPHATES" ], "active_ingredients": [ "POTASSIUM PHOSPHATE, DIBASIC", "POTASSIUM PHOSPHATE, MONOBASIC" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213037", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-10-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217569", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "VASOPRESSIN IN SODIUM CHLORIDE 0.9%" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216142", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "MICAFUNGIN IN SODIUM CHLORIDE 0.9%" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA215842", "application_type": "NDA", "sponsor_name": "NOVO", "brand_names": [ "RIVFLOZA" ], "active_ingredients": [ "NEDOSIRAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA022335", "application_type": "NDA", "sponsor_name": "CYCLOMEDICA", "brand_names": [ "TECHNEGAS KIT" ], "active_ingredients": [ "TECHNETIUM TC-99M LABELED CARBON" ], "dosage_forms": [ "AEROSOL" ], "routes": [ "INHALATION" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761354", "application_type": "BLA", "sponsor_name": "BIOGEN MA", "brand_names": [ "TOFIDENCE" ], "active_ingredients": [ "TOCILIZUMAB-BAVI" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218015", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217264", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215211", "application_type": "NDA", "sponsor_name": "AMICUS THERAP US", "brand_names": [ "OPFOLDA" ], "active_ingredients": [ "MIGLUSTAT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761204", "application_type": "BLA", "sponsor_name": "AMICUS THERAP US", "brand_names": [ "POMBILITI" ], "active_ingredients": [ "CIPAGLUCOSIDASE ALFA-ATGA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-09-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA207293", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761133", "application_type": "BLA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "ENTYVIO" ], "active_ingredients": [ "VEDOLIZUMAB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS", "INJECTION" ], "approval_date": "2023-09-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217134", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "IOPAMIDOL" ], "active_ingredients": [ "IOPAMIDOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215997", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215449", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210668", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217729", "application_type": "NDA", "sponsor_name": "PF PRISM CV", "brand_names": [ "BOSULIF" ], "active_ingredients": [ "BOSUTINIB MONOHYDRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-26", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216912", "application_type": "ANDA", "sponsor_name": "SCINOPHARM TAIWAN", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215527", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DIVALPROEX SODIUM" ], "active_ingredients": [ "DIVALPROEX SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217064", "application_type": "NDA", "sponsor_name": "FAMYGEN LIFE SCI", "brand_names": [ "RYZUMVI" ], "active_ingredients": [ "PHENTOLAMINE MESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-09-25", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA218149", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "METHIMAZOLE" ], "active_ingredients": [ "METHIMAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216878", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215709", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "FLUORESCEIN SODIUM" ], "active_ingredients": [ "FLUORESCEIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216755", "application_type": "NDA", "sponsor_name": "SAPTALIS PHARMS", "brand_names": [ "LIKMEZ" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA021164", "application_type": "NDA", "sponsor_name": "FABRE KRAMER", "brand_names": [ "EXXUA" ], "active_ingredients": [ "GEPIRONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217844", "application_type": "ANDA", "sponsor_name": "ONESOURCE", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212704", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216512", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PYRIDOSTIGMINE BROMIDE" ], "active_ingredients": [ "PYRIDOSTIGMINE BROMIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2023-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215738", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "FLUCONAZOLE" ], "active_ingredients": [ "FLUCONAZOLE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216587", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217529", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216873", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "OJJAARA" ], "active_ingredients": [ "MOMELOTINIB DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-15", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217575", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216969", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209992", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209991", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217842", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216419", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215777", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214594", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ETHINYL ESTRADIOL AND NORELGESTROMIN" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORELGESTROMIN" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202083", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-14", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA209351", "application_type": "ANDA", "sponsor_name": "DEVA HOLDING AS", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217150", "application_type": "NDA", "sponsor_name": "SANDOZ", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-12", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214344", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217189", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213955", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211151", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217159", "application_type": "NDA", "sponsor_name": "AYRMID PHARMA", "brand_names": [ "APHEXDA" ], "active_ingredients": [ "MOTIXAFORTIDE ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-09-08", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217422", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216081", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "GADOBUTROL" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211917", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA INTL", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217581", "application_type": "NDA", "sponsor_name": "PF PRISM CV", "brand_names": [ "XALKORI" ], "active_ingredients": [ "CRIZOTINIB" ], "dosage_forms": [ "CAPSULE, PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2023-09-07", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217732", "application_type": "ANDA", "sponsor_name": "CREEKWOOD PHARMS", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217334", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218122", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217174", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CALCIUM GLUCONATE IN SODIUM CHLORIDE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215572", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SPIRONOLACTONE" ], "active_ingredients": [ "SPIRONOLACTONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211755", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "THIOTEPA" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRACAVITARY, INTRAVENOUS, INTRAVESICAL" ], "approval_date": "2023-09-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216943", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "CLINDAMYCIN PHOSPHATE AND TRETINOIN" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE", "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-09-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215343", "application_type": "ANDA", "sponsor_name": "BRIGHT", "brand_names": [ "FLUTICASONE PROPIONATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2023-09-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217753", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ALVIMOPAN" ], "active_ingredients": [ "ALVIMOPAN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215440", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211546", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217531", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217341", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "STERILE WATER FOR INJECTION" ], "active_ingredients": [ "STERILE WATER FOR INJECTION" ], "dosage_forms": [ "LIQUID" ], "routes": [ "N/A" ], "approval_date": "2023-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216383", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212634", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA INTL", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211568", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216488", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213315", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "PRASUGREL HYDROCHLORIDE" ], "active_ingredients": [ "PRASUGREL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212404", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217442", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217229", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217194", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217068", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216944", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216266", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215802", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215415", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215330", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215230", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214547", "application_type": "ANDA", "sponsor_name": "NORWICH", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214484", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214134", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213090", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "NIACIN" ], "active_ingredients": [ "NIACIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211840", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202835", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202830", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202827", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202802", "application_type": "ANDA", "sponsor_name": "ACTAVIS ELIZABETH", "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE" ], "active_ingredients": [ "LISDEXAMFETAMINE DIMESYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-25", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761322", "application_type": "BLA", "sponsor_name": "SANDOZ INC", "brand_names": [ "TYRUKO" ], "active_ingredients": [ "NATALIZUMAB-SZTN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-24", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217875", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TEMAZEPAM" ], "active_ingredients": [ "TEMAZEPAM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217610", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215661", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217695", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217535", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "SODIUM CHLORIDE 0.9%" ], "active_ingredients": [ "SODIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216174", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214557", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212403", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216686", "application_type": "NDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "FOCINVEZ" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217074", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215609", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TRETINOIN MICROSPHERE" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA218012", "application_type": "ANDA", "sponsor_name": "FOSUN WANBANG", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217975", "application_type": "ANDA", "sponsor_name": "UNIQUE", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217780", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "GUAIFENESIN" ], "active_ingredients": [ "GUAIFENESIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217504", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "MIDAZOLAM HYDROCHLORIDE" ], "active_ingredients": [ "MIDAZOLAM HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216541", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "CALCIUM GLUCONATE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215194", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206233", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "CANDESARTAN CILEXETIL" ], "active_ingredients": [ "CANDESARTAN CILEXETIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217110", "application_type": "NDA", "sponsor_name": "APOTEX", "brand_names": [ "IVRA" ], "active_ingredients": [ "MELPHALAN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-18", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761355", "application_type": "BLA", "sponsor_name": "REGENERON PHARMACEUTICALS", "brand_names": [ "EYLEA HD" ], "active_ingredients": [ "AFLIBERCEPT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-18", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761339", "application_type": "BLA", "sponsor_name": "REGENERON PHARMACEUTICALS", "brand_names": [ "VEOPOZ" ], "active_ingredients": [ "POZELIMAB-BBFG" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-18", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218055", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216625", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215623", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214382", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "SEVOFLURANE" ], "active_ingredients": [ "SEVOFLURANE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "INHALATION" ], "approval_date": "2023-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217652", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "HYDROXYZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDROXYZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217330", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217114", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "MARAVIROC" ], "active_ingredients": [ "MARAVIROC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215559", "application_type": "NDA", "sponsor_name": "IPSEN", "brand_names": [ "SOHONOS" ], "active_ingredients": [ "PALOVAROTENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214640", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "LEVONORGESTREL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212357", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202761", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-16", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217731", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "NORTRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "NORTRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216278", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "TIOPRONIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215663", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209272", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202903", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-08-15", "review_priority": "", "submission_class": "" }, { "application_number": "NDA201848", "application_type": "NDA", "sponsor_name": "DELCATH SYSTEMS INC", "brand_names": [ "HEPZATO" ], "active_ingredients": [ "MELPHALAN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRA-ARTERIAL" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "BLA761345", "application_type": "BLA", "sponsor_name": "PFIZER INC", "brand_names": [ "ELREXFIO" ], "active_ingredients": [ "ELRANATAMAB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA218036", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "LITHIUM CITRATE" ], "active_ingredients": [ "LITHIUM CITRATE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217704", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217396", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LOSARTAN POTASSIUM" ], "active_ingredients": [ "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215861", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "PALONOSETRON HYDROCHLORIDE" ], "active_ingredients": [ "PALONOSETRON HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213521", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ICATIBANT ACETATE" ], "active_ingredients": [ "ICATIBANT ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-08-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216793", "application_type": "NDA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "AKEEGA" ], "active_ingredients": [ "ABIRATERONE ACETATE", "NIRAPARIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-11", "review_priority": "PRIORITY", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA215266", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "HALOBETASOL PROPIONATE" ], "active_ingredients": [ "HALOBETASOL PROPIONATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208741", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204382", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "VALSARTAN AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-11", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216309", "application_type": "ANDA", "sponsor_name": "HERITAGE", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRATHECAL" ], "approval_date": "2023-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761342", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "TALVEY" ], "active_ingredients": [ "TALQUETAMAB-TGVS" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-09", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216925", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215384", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207678", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217261", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "ORAL" ], "approval_date": "2023-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217657", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217269", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216981", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "PENCICLOVIR" ], "active_ingredients": [ "PENCICLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216509", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213966", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213362", "application_type": "ANDA", "sponsor_name": "DAITO", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207347", "application_type": "ANDA", "sponsor_name": "NOVEL LABS INC", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217369", "application_type": "NDA", "sponsor_name": "BIOGEN", "brand_names": [ "ZURZUVAE" ], "active_ingredients": [ "ZURANOLONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-04", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA217225", "application_type": "NDA", "sponsor_name": "ASTELLAS", "brand_names": [ "IZERVAY" ], "active_ingredients": [ "AVACINCAPTAD PEGOL SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVITREAL" ], "approval_date": "2023-08-04", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217916", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217401", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217000", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE" ], "active_ingredients": [ "DOXYLAMINE SUCCINATE", "PYRIDOXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215081", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "LIFITEGRAST" ], "active_ingredients": [ "LIFITEGRAST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205345", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "CLOPIDOGREL BISULFATE" ], "active_ingredients": [ "CLOPIDOGREL BISULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217748", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ALLOPURINOL" ], "active_ingredients": [ "ALLOPURINOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211186", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216184", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "INDOMETHACIN" ], "active_ingredients": [ "INDOMETHACIN" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2023-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217340", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216999", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216909", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214255", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211451", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "active_ingredients": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209732", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS EU", "brand_names": [ "PERMETHRIN" ], "active_ingredients": [ "PERMETHRIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217848", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ARGATROBAN" ], "active_ingredients": [ "ARGATROBAN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207345", "application_type": "ANDA", "sponsor_name": "NOVEL LABS INC", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206081", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206078", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "SAXAGLIPTIN" ], "active_ingredients": [ "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205994", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "SAXAGLIPTIN" ], "active_ingredients": [ "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205981", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE", "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205980", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "SAXAGLIPTIN" ], "active_ingredients": [ "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205972", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "SAXAGLIPTIN" ], "active_ingredients": [ "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205941", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "SAXAGLIPTIN" ], "active_ingredients": [ "SAXAGLIPTIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202980", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TURQOZ" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORGESTREL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2023-07-31", "review_priority": "", "submission_class": "" }, { "application_number": "NDA217722", "application_type": "NDA", "sponsor_name": "HARM REDUCTION THERP", "brand_names": [ "RIVIVE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-07-28", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA213329", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211914", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "BRINZOLAMIDE" ], "active_ingredients": [ "BRINZOLAMIDE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211718", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203973", "application_type": "ANDA", "sponsor_name": "ANDA REPOSITORY", "brand_names": [ "CALCITRIOL" ], "active_ingredients": [ "CALCITRIOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-07-28", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217344", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2023-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217036", "application_type": "ANDA", "sponsor_name": "ZHEJIANG POLY PHARM", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203144", "application_type": "ANDA", "sponsor_name": "AIRGAS THERAP", "brand_names": [ "ULSPIRA" ], "active_ingredients": [ "NITRIC OXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2023-07-27", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215212", "application_type": "NDA", "sponsor_name": "HQ SPCLT PHARMA", "brand_names": [ "MEROPENEM" ], "active_ingredients": [ "MEROPENEM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-07-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA211878", "application_type": "ANDA", "sponsor_name": "ANNORA", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208980", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217151", "application_type": "ANDA", "sponsor_name": "KANCHAN HLTHCARE", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216897", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213085", "application_type": "ANDA", "sponsor_name": "PIRAMAL", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217603", "application_type": "NDA", "sponsor_name": "TARSUS", "brand_names": [ "XDEMVY" ], "active_ingredients": [ "LOTILANER" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215698", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215334", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213672", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213458", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211901", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205197", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205182", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PLERIXAFOR" ], "active_ingredients": [ "PLERIXAFOR" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-07-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212905", "application_type": "NDA", "sponsor_name": "VERRICA PHARMS", "brand_names": [ "YCANTH" ], "active_ingredients": [ "CANTHARIDIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-07-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216993", "application_type": "NDA", "sponsor_name": "DAIICHI SANKYO INC", "brand_names": [ "VANFLYTA" ], "active_ingredients": [ "QUIZARTINIB DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217995", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216590", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "LEUCOVORIN CALCIUM" ], "active_ingredients": [ "LEUCOVORIN CALCIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211716", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217350", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761328", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "BEYFORTUS" ], "active_ingredients": [ "NIRSEVIMAB-ALIP" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215377", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214649", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "HYDROCORTISONE" ], "active_ingredients": [ "HYDROCORTISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214529", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217526", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "SODIUM PHENYLACETATE AND SODIUM BENZOATE" ], "active_ingredients": [ "SODIUM BENZOATE", "SODIUM PHENYLACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217368", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215893", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PONATINIB HYDROCHLORIDE" ], "active_ingredients": [ "PONATINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211756", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216947", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ERTUGLIFLOZIN" ], "active_ingredients": [ "ERTUGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216592", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213369", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213327", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216323", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2023-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214473", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212816", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206452", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217796", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM CHLORIDE 23.4%" ], "active_ingredients": [ "SODIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217693", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217536", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "STERILE WATER FOR INJECTION" ], "active_ingredients": [ "STERILE WATER FOR INJECTION" ], "dosage_forms": [ "LIQUID" ], "routes": [ "N/A" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217357", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212599", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "SEVELAMER HYDROCHLORIDE" ], "active_ingredients": [ "SEVELAMER HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207480", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217021", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "LEUCOVORIN CALCIUM" ], "active_ingredients": [ "LEUCOVORIN CALCIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216994", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215972", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "RAMELTEON" ], "active_ingredients": [ "RAMELTEON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217137", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216420", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214890", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "active_ingredients": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208228", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "VILAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "VILAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216791", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "FOMEPIZOLE" ], "active_ingredients": [ "FOMEPIZOLE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213195", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "NALTREXONE" ], "active_ingredients": [ "NALTREXONE" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217840", "application_type": "ANDA", "sponsor_name": "JUBILANT CADISTA", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207381", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217511", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE" ], "active_ingredients": [ "BISMUTH SUBCITRATE POTASSIUM", "METRONIDAZOLE", "TETRACYCLINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211747", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-07-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215169", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214729", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ETYQA" ], "active_ingredients": [ "ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214478", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2023-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210629", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217489", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214749", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211157", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "ENILLORING" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "ETONOGESTREL" ], "dosage_forms": [ "RING" ], "routes": [ "VAGINAL" ], "approval_date": "2023-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217594", "application_type": "ANDA", "sponsor_name": "STERISCIENCE", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215905", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2023-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217651", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761184", "application_type": "BLA", "sponsor_name": "PFIZER IRELAND PHARMACEUTICALS", "brand_names": [ "NGENLA" ], "active_ingredients": [ "SOMATROGON-GHLA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217688", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761286", "application_type": "BLA", "sponsor_name": "UCB INC", "brand_names": [ "RYSTIGGO" ], "active_ingredients": [ "ROZANOLIXIZUMAB-NOLI" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-06-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217521", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215830", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "LITFULO" ], "active_ingredients": [ "RITLECITINIB TOSYLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216039", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215338", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210659", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ALCAFTADINE" ], "active_ingredients": [ "ALCAFTADINE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216881", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216839", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "OCTREOTIDE ACETATE" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209253", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "AMPHETAMINE" ], "active_ingredients": [ "AMPHETAMINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217519", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TOBRAMYCIN SULFATE" ], "active_ingredients": [ "TOBRAMYCIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216949", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761313", "application_type": "BLA", "sponsor_name": "HALOZYME THERAP", "brand_names": [], "active_ingredients": [], "dosage_forms": [], "routes": [], "approval_date": "2023-06-20", "review_priority": "N/A", "submission_class": "" }, { "application_number": "BLA761304", "application_type": "BLA", "sponsor_name": "ARGENX BV", "brand_names": [ "VYVGART HYTRULO" ], "active_ingredients": [ "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-20", "review_priority": "PRIORITY", "submission_class": "" }, { "application_number": "ANDA217248", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217166", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216326", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215629", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211287", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TIOTROPIUM BROMIDE" ], "active_ingredients": [ "TIOTROPIUM BROMIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2023-06-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204551", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-20", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215727", "application_type": "NDA", "sponsor_name": "AGEPHA PHARMA FZ", "brand_names": [ "LODOCO" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-16", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217692", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217655", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217230", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216321", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216247", "application_type": "ANDA", "sponsor_name": "DEXCEL", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215610", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2023-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215344", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "SUFLAVE" ], "active_ingredients": [ "MAGNESIUM SULFATE", "POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM SULFATE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-06-15", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "BLA761309", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "COLUMVI" ], "active_ingredients": [ "GLOFITAMAB-GXBM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217198", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216364", "application_type": "ANDA", "sponsor_name": "OMNIVIUM PHARMS", "brand_names": [ "SODIUM BICARBONATE" ], "active_ingredients": [ "SODIUM BICARBONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215810", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOXERCALCIFEROL" ], "active_ingredients": [ "DOXERCALCIFEROL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217460", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MOMETASONE FUROATE" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215902", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "SAFINAMIDE MESYLATE" ], "active_ingredients": [ "SAFINAMIDE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217878", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216807", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "OCTREOTIDE ACETATE" ], "active_ingredients": [ "OCTREOTIDE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215035", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "AMLODIPINE BENZOATE" ], "active_ingredients": [ "AMLODIPINE BENZOATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214008", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE" ], "active_ingredients": [ "TIPIRACIL HYDROCHLORIDE", "TRIFLURIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216916", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216723", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212707", "application_type": "ANDA", "sponsor_name": "MIKART", "brand_names": [ "METHOCARBAMOL" ], "active_ingredients": [ "METHOCARBAMOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206771", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "DICLOFENAC SODIUM AND MISOPROSTOL" ], "active_ingredients": [ "DICLOFENAC SODIUM", "MISOPROSTOL" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217725", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215768", "application_type": "ANDA", "sponsor_name": "SENTISS", "brand_names": [ "CIPROFLOXACIN AND DEXAMETHASONE" ], "active_ingredients": [ "CIPROFLOXACIN", "DEXAMETHASONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2023-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214337", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "SUGAMMADEX SODIUM" ], "active_ingredients": [ "SUGAMMADEX SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212687", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212124", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217592", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "BALSALAZIDE DISODIUM" ], "active_ingredients": [ "BALSALAZIDE DISODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217252", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA210852", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "FRINDOVYX" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217579", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "MELOXICAM" ], "active_ingredients": [ "MELOXICAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217308", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215397", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MEDROXYPROGESTERONE ACETATE" ], "active_ingredients": [ "MEDROXYPROGESTERONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206554", "application_type": "ANDA", "sponsor_name": "NANG KUANG PHARM CO", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206055", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217533", "application_type": "ANDA", "sponsor_name": "AMTA", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214646", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "ENOXAPARIN SODIUM (PRESERVATIVE FREE)" ], "active_ingredients": [ "ENOXAPARIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213907", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212515", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211622", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214739", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213807", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213371", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "ZOLEDRONIC ACID" ], "active_ingredients": [ "ZOLEDRONIC ACID" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211001", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204230", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215057", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213812", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "EPLERENONE" ], "active_ingredients": [ "EPLERENONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211763", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NADOLOL" ], "active_ingredients": [ "NADOLOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216782", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214496", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214283", "application_type": "ANDA", "sponsor_name": "BPI LABS", "brand_names": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204801", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-06-01", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216908", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "NAPROXEN" ], "active_ingredients": [ "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216800", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212827", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "GEFITINIB" ], "active_ingredients": [ "GEFITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212709", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212701", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217469", "application_type": "NDA", "sponsor_name": "HARROW EYE", "brand_names": [ "VEVYE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216941", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "ENEMA" ], "routes": [ "RECTAL" ], "approval_date": "2023-05-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215017", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OBETICHOLIC ACID" ], "active_ingredients": [ "OBETICHOLIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214980", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "OBETICHOLIC ACID" ], "active_ingredients": [ "OBETICHOLIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214862", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "OBETICHOLIC ACID" ], "active_ingredients": [ "OBETICHOLIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091076", "application_type": "ANDA", "sponsor_name": "NOVEL LABS INC", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "GEL" ], "routes": [ "RECTAL" ], "approval_date": "2023-05-30", "review_priority": "", "submission_class": "" }, { "application_number": "NDA216203", "application_type": "NDA", "sponsor_name": "LEXICON PHARMS INC", "brand_names": [ "INPEFA" ], "active_ingredients": [ "SOTAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-26", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217343", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213206", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210026", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206883", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SEVELAMER HYDROCHLORIDE" ], "active_ingredients": [ "SEVELAMER HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217188", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "PAXLOVID (COPACKAGED)" ], "active_ingredients": [ "NIRMATRELVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216023", "application_type": "NDA", "sponsor_name": "BLUE EARTH", "brand_names": [ "POSLUMA" ], "active_ingredients": [ "FLOTUFOLASTAT F-18 GALLIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216939", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216201", "application_type": "ANDA", "sponsor_name": "ETON", "brand_names": [ "NITISINONE" ], "active_ingredients": [ "NITISINONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217665", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "METRONIDAZOLE IN PLASTIC CONTAINER" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217034", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210252", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209827", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "METHIMAZOLE" ], "active_ingredients": [ "METHIMAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216974", "application_type": "NDA", "sponsor_name": "ENTASIS THERAP", "brand_names": [ "XACDURO (COPACKAGED)" ], "active_ingredients": [ "DURLOBACTAM SODIUM", "SULBACTAM SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "NDA210136", "application_type": "NDA", "sponsor_name": "BRAEBURN", "brand_names": [ "BRIXADI" ], "active_ingredients": [ "BUPRENORPHINE" ], "dosage_forms": [ "SOLUTION, EXTENDED RELEASE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-05-23", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761219", "application_type": "BLA", "sponsor_name": "CELLTRION", "brand_names": [ "YUFLYMA" ], "active_ingredients": [ "ADALIMUMAB-AATY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-23", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA217455", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216730", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "HALOPERIDOL DECANOATE" ], "active_ingredients": [ "HALOPERIDOL DECANOATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214447", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213466", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217470", "application_type": "NDA", "sponsor_name": "INDIVIOR", "brand_names": [ "OPVEE" ], "active_ingredients": [ "NALMEFENE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2023-05-22", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215179", "application_type": "NDA", "sponsor_name": "SHILPA", "brand_names": [ "PEMETREXED" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217314", "application_type": "ANDA", "sponsor_name": "HAINAN POLY PHARM", "brand_names": [ "LEVOLEUCOVORIN CALCIUM" ], "active_ingredients": [ "LEVOLEUCOVORIN CALCIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761324", "application_type": "BLA", "sponsor_name": "GENMAB US, INC.", "brand_names": [ "EPKINLY" ], "active_ingredients": [ "EPCORITAMAB-BYSP" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-05-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217411", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216824", "application_type": "ANDA", "sponsor_name": "SOLA PHARMS", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216675", "application_type": "NDA", "sponsor_name": "BAUSCH AND LOMB INC", "brand_names": [ "MIEBO" ], "active_ingredients": [ "PERFLUOROHEXYLOCTANE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-18", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217390", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210294", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "ISOSULFAN BLUE" ], "active_ingredients": [ "ISOSULFAN BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217276", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215548", "application_type": "ANDA", "sponsor_name": "MISEMER", "brand_names": [ "FENOPROFEN CALCIUM" ], "active_ingredients": [ "FENOPROFEN CALCIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214683", "application_type": "ANDA", "sponsor_name": "PIRAMAL CRITICAL", "brand_names": [ "FOSAPREPITANT DIMEGLUMINE" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216688", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216604", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216400", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209555", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216578", "application_type": "NDA", "sponsor_name": "ASTELLAS", "brand_names": [ "VEOZAH" ], "active_ingredients": [ "FEZOLINETANT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217546", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217337", "application_type": "ANDA", "sponsor_name": "SINOTHERAPEUTICS INC", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216338", "application_type": "NDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216548", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214814", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214512", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ALENDRONATE SODIUM" ], "active_ingredients": [ "ALENDRONATE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214113", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212607", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212414", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203892", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-11", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217789", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208867", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "PROPYLTHIOURACIL" ], "active_ingredients": [ "PROPYLTHIOURACIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215721", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "ZOLPIDEM TARTRATE" ], "active_ingredients": [ "ZOLPIDEM TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-09", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761161", "application_type": "BLA", "sponsor_name": "CHIESI FARMACEUTICI SPA", "brand_names": [ "ELFABRIO" ], "active_ingredients": [ "PEGUNIGALSIDASE ALFA-IWXJ" ], "dosage_forms": [ "VIAL" ], "routes": [ "SINGLE-USE" ], "approval_date": "2023-05-09", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217696", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217197", "application_type": "ANDA", "sponsor_name": "NE RX PHARMA", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211413", "application_type": "NDA", "sponsor_name": "HQ SPCLT PHARMA", "brand_names": [ "CEFAZOLIN SODIUM" ], "active_ingredients": [ "CEFAZOLIN SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-08", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217195", "application_type": "ANDA", "sponsor_name": "SENTISS PHARMA", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215600", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213453", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215352", "application_type": "NDA", "sponsor_name": "EYENOVIA", "brand_names": [ "MYDCOMBI" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE", "TROPICAMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-05", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216185", "application_type": "NDA", "sponsor_name": "AUCTA", "brand_names": [ "MOTPOLY XR" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-04", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217555", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216435", "application_type": "ANDA", "sponsor_name": "CASPER PHARMA LLC", "brand_names": [ "EDETATE CALCIUM DISODIUM" ], "active_ingredients": [ "EDETATE CALCIUM DISODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215705", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215403", "application_type": "ANDA", "sponsor_name": "INFORLIFE", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212420", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209145", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "ERTAPENEM SODIUM" ], "active_ingredients": [ "ERTAPENEM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2023-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214755", "application_type": "NDA", "sponsor_name": "ALKERMES INC", "brand_names": [ "LUMRYZ" ], "active_ingredients": [ "SODIUM OXYBATE" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-01", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217260", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217213", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "METHSUXIMIDE" ], "active_ingredients": [ "METHSUXIMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216379", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TIROFIBAN HYDROCHLORIDE" ], "active_ingredients": [ "TIROFIBAN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215376", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-05-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216579", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "SYMBICORT AEROSPHERE" ], "active_ingredients": [ "BUDESONIDE", "FORMOTEROL FUMARATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "Efficacy" }, { "application_number": "NDA214952", "application_type": "NDA", "sponsor_name": "CMP DEV LLC", "brand_names": [ "LIQREV" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA213586", "application_type": "NDA", "sponsor_name": "TEVA", "brand_names": [ "UZEDY" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216656", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "ESTRADIOL VALERATE" ], "active_ingredients": [ "ESTRADIOL VALERATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215519", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213201", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "OMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "OMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204104", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217006", "application_type": "NDA", "sponsor_name": "OTSUKA", "brand_names": [ "ABILIFY ASIMTUFII" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-04-27", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217293", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214365", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213267", "application_type": "ANDA", "sponsor_name": "NATCO", "brand_names": [ "THALIDOMIDE" ], "active_ingredients": [ "THALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217660", "application_type": "NDA", "sponsor_name": "VERTEX PHARMS INC", "brand_names": [ "TRIKAFTA (COPACKAGED)" ], "active_ingredients": [ "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR", "IVACAFTOR" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA214876", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "ZEJULA" ], "active_ingredients": [ "NIRAPARIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217538", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216300", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215755", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211703", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208913", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "GEFITINIB" ], "active_ingredients": [ "GEFITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215887", "application_type": "NDA", "sponsor_name": "BIOGEN MA", "brand_names": [ "QALSODY" ], "active_ingredients": [ "TOFERSEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRATHECAL" ], "approval_date": "2023-04-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213079", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-04-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217375", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215875", "application_type": "NDA", "sponsor_name": "PH HEALTH", "brand_names": [ "ADRENALIN" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217128", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208567", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217656", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217413", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ARSENIC TRIOXIDE" ], "active_ingredients": [ "ARSENIC TRIOXIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217182", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217001", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212402", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "METOPROLOL TARTRATE" ], "active_ingredients": [ "METOPROLOL TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206100", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203079", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-19", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202255", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-19", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215056", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "CEVIMELINE HYDROCHLORIDE" ], "active_ingredients": [ "CEVIMELINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212490", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "ROFLUMILAST" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211198", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210639", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "BETAMETHASONE VALERATE" ], "active_ingredients": [ "BETAMETHASONE VALERATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205746", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216598", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216159", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "MIDAZOLAM IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "MIDAZOLAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213298", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ROFLUMILAST" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210929", "application_type": "ANDA", "sponsor_name": "HANGZHOU ZHONGMEI", "brand_names": [ "TACROLIMUS" ], "active_ingredients": [ "TACROLIMUS" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204379", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-04-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA205394", "application_type": "NDA", "sponsor_name": "GENSCO", "brand_names": [ "RIZAFILM" ], "active_ingredients": [ "RIZATRIPTAN BENZOATE" ], "dosage_forms": [ "FILM" ], "routes": [ "ORAL" ], "approval_date": "2023-04-14", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217243", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "PIPERACILLIN AND TAZOBACTAM" ], "active_ingredients": [ "PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216385", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215557", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215351", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "TESTOSTERONE CYPIONATE" ], "active_ingredients": [ "TESTOSTERONE CYPIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211930", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217095", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SORAFENIB TOSYLATE" ], "active_ingredients": [ "SORAFENIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215933", "application_type": "ANDA", "sponsor_name": "SENTISS", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215583", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215328", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "BUDESONIDE" ], "active_ingredients": [ "BUDESONIDE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "RECTAL" ], "approval_date": "2023-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214691", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216317", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213275", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216606", "application_type": "ANDA", "sponsor_name": "AMTA", "brand_names": [ "NISOLDIPINE" ], "active_ingredients": [ "NISOLDIPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214702", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212564", "application_type": "ANDA", "sponsor_name": "YABAO PHARM", "brand_names": [ "CELECOXIB" ], "active_ingredients": [ "CELECOXIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212294", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "TAVABOROLE" ], "active_ingredients": [ "TAVABOROLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-04-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213056", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211774", "application_type": "ANDA", "sponsor_name": "SHILPA", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216682", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CEVIMELINE HYDROCHLORIDE" ], "active_ingredients": [ "CEVIMELINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216327", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214588", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BEPOTASTINE BESILATE" ], "active_ingredients": [ "BEPOTASTINE BESILATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214401", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217478", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216346", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215999", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213856", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211069", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA200430", "application_type": "ANDA", "sponsor_name": "NOSTRUM PHARMS LLC", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-04-04", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA214823", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-04-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214477", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213052", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216568", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215509", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "FLUPHENAZINE DECANOATE" ], "active_ingredients": [ "FLUPHENAZINE DECANOATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214226", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TENOFOVIR ALAFENAMIDE" ], "active_ingredients": [ "TENOFOVIR ALAFENAMIDE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209225", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208449", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LINAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "LINAGLIPTIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208448", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216552", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215225", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205321", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202985", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-03-29", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217116", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216780", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214920", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2023-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207167", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LANSOPRAZOLE" ], "active_ingredients": [ "LANSOPRAZOLE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217759", "application_type": "NDA", "sponsor_name": "PHARMING", "brand_names": [ "JOENJA" ], "active_ingredients": [ "LENIOLISIB PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-24", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217066", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216639", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216193", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214458", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211900", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217471", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215086", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "ABIRATERONE ACETATE" ], "active_ingredients": [ "ABIRATERONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214131", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213540", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION, GEL FORMING/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210700", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217417", "application_type": "NDA", "sponsor_name": "MUNDIPHARMA", "brand_names": [ "REZZAYO" ], "active_ingredients": [ "REZAFUNGIN ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761334", "application_type": "BLA", "sponsor_name": "INCYTE CORP", "brand_names": [ "ZYNYZ" ], "active_ingredients": [ "RETIFANLIMAB-DLWR" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217466", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215883", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2023-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207209", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "REPAGLINIDE" ], "active_ingredients": [ "REPAGLINIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217272", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214688", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BETAMETHASONE DIPROPIONATE", "CALCIPOTRIENE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210140", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216904", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DESMOPRESSIN ACETATE" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216440", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "CLOMIPRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "CLOMIPRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216276", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213644", "application_type": "ANDA", "sponsor_name": "SOLARIS PHARMA CORP", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210771", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "LEVOMILNACIPRAN HYDROCHLORIDE" ], "active_ingredients": [ "LEVOMILNACIPRAN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213512", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216595", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215673", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PREDNISOLONE" ], "active_ingredients": [ "PREDNISOLONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217514", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "TAFINLAR" ], "active_ingredients": [ "DABRAFENIB MESYLATE" ], "dosage_forms": [ "CAPSULE", "TABLET", "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL", "ORAL SUSPENSION" ], "approval_date": "2023-03-16", "review_priority": "PRIORITY", "submission_class": "New Combination and New Formulation or New Manufacturer" }, { "application_number": "NDA217513", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "MEKINIST" ], "active_ingredients": [ "TRAMETINIB", "TRAMETINIB DIMETHYL SULFOXIDE" ], "dosage_forms": [ "SOLUTION", "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-16", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA213083", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217480", "application_type": "ANDA", "sponsor_name": "HAINAN POLY PHARM", "brand_names": [ "GADOBUTROL" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216814", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216149", "application_type": "ANDA", "sponsor_name": "GUARDIAN DRUG", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215787", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205660", "application_type": "ANDA", "sponsor_name": "SHENZHEN TECHDOW", "brand_names": [ "ENOXAPARIN SODIUM (PRESERVATIVE FREE)" ], "active_ingredients": [ "ENOXAPARIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA079188", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "EMTRICITABINE" ], "active_ingredients": [ "EMTRICITABINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-15", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA209829", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217205", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "CALCIUM ACETATE" ], "active_ingredients": [ "CALCIUM ACETATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209738", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209639", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209598", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217026", "application_type": "NDA", "sponsor_name": "ACADIA PHARMS INC", "brand_names": [ "DAYBUE" ], "active_ingredients": [ "TROFINETIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216957", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "CLINDAMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "CLINDAMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216517", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "COLESTIPOL HYDROCHLORIDE" ], "active_ingredients": [ "COLESTIPOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213565", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "IBUPROFEN", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208045", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206210", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203628", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-10", "review_priority": "", "submission_class": "" }, { "application_number": "NDA216386", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "ZAVZPRET" ], "active_ingredients": [ "ZAVEGEPANT HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-03-09", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217393", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214528", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211640", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211264", "application_type": "ANDA", "sponsor_name": "UBI", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202889", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2023-03-09", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA217543", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216605", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212409", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "CETIRIZINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA208969", "application_type": "NDA", "sponsor_name": "AMPHASTAR PHARMS INC", "brand_names": [ "REXTOVY" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-03-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216439", "application_type": "ANDA", "sponsor_name": "AMTA", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216156", "application_type": "ANDA", "sponsor_name": "AJENAT PHARMS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213175", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "GEMCITABINE HYDROCHLORIDE" ], "active_ingredients": [ "GEMCITABINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212693", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217268", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215692", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214618", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213885", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205770", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE" ], "active_ingredients": [ "BISMUTH SUBCITRATE POTASSIUM", "METRONIDAZOLE", "TETRACYCLINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217295", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215949", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215368", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214809", "application_type": "ANDA", "sponsor_name": "SHORLA", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217319", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216235", "application_type": "ANDA", "sponsor_name": "SCIECURE PHARMA INC", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216234", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214671", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211337", "application_type": "ANDA", "sponsor_name": "REYOUNG", "brand_names": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204836", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA209471", "application_type": "NDA", "sponsor_name": "AFT PHARMS US", "brand_names": [ "COMBOGESIC" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-03-01", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA217377", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205976", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216718", "application_type": "NDA", "sponsor_name": "BIOGEN US", "brand_names": [ "SKYCLARYS" ], "active_ingredients": [ "OMAVELOXOLONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215744", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215658", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214836", "application_type": "ANDA", "sponsor_name": "L PERRIGO CO", "brand_names": [ "ACETAMINOPHEN AND IBUPROFEN" ], "active_ingredients": [ "ACETAMINOPHEN", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209968", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206770", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217354", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215876", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215382", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "IOPAMIDOL" ], "active_ingredients": [ "IOPAMIDOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210185", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217219", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "TIOPRONIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210022", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "OLANZAPINE" ], "active_ingredients": [ "OLANZAPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206377", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216903", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "PREVDUO" ], "active_ingredients": [ "GLYCOPYRROLATE", "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-23", "review_priority": "STANDARD", "submission_class": "New Combination and New Formulation or New Manufacturer" }, { "application_number": "ANDA216759", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215959", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LOSARTAN POTASSIUM" ], "active_ingredients": [ "LOSARTAN POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215745", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217324", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRATHECAL" ], "approval_date": "2023-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206047", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PITAVASTATIN CALCIUM" ], "active_ingredients": [ "PITAVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213096", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PROPAFENONE HYDROCHLORIDE" ], "active_ingredients": [ "PROPAFENONE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217171", "application_type": "NDA", "sponsor_name": "APELLIS PHARMS", "brand_names": [ "SYFOVRE" ], "active_ingredients": [ "PEGCETACOPLAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVITREAL" ], "approval_date": "2023-02-17", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA216403", "application_type": "NDA", "sponsor_name": "TRAVERE", "brand_names": [ "FILSPARI" ], "active_ingredients": [ "SPARSENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216354", "application_type": "NDA", "sponsor_name": "TEVA", "brand_names": [ "AUSTEDO XR" ], "active_ingredients": [ "DEUTETRABENAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-17", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216542", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215408", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213405", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761278", "application_type": "BLA", "sponsor_name": "CHIESI FARMACEUTICI SPA", "brand_names": [ "LAMZEDE" ], "active_ingredients": [ "VELMANASE ALFA-TYCV" ], "dosage_forms": [ "POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER" ], "routes": [], "approval_date": "2023-02-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216597", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MAGNESIUM SULFATE IN PLASTIC CONTAINER" ], "active_ingredients": [ "MAGNESIUM SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215538", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205447", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216882", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215147", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212298", "application_type": "ANDA", "sponsor_name": "HETERO LABS", "brand_names": [ "LEVONORGESTREL AND ETHINYL ESTRADIOL" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "LEVONORGESTREL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2023-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211591", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "GEFITINIB" ], "active_ingredients": [ "GEFITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207736", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207718", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217416", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216167", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215979", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215243", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "RAMELTEON" ], "active_ingredients": [ "RAMELTEON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215870", "application_type": "NDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "FENTANYL CITRATE" ], "active_ingredients": [ "FENTANYL CITRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-08", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA211846", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213947", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "TIROFIBAN HYDROCHLORIDE" ], "active_ingredients": [ "TIROFIBAN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213655", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209611", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "LINACLOTIDE" ], "active_ingredients": [ "LINACLOTIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216461", "application_type": "ANDA", "sponsor_name": "KANCHAN HLTHCARE", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-02-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213718", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213040", "application_type": "ANDA", "sponsor_name": "AUROLIFE PHARMA LLC", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2023-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216127", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215827", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212162", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216951", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "JESDUVROQ" ], "active_ingredients": [ "DAPRODUSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-02-01", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA213260", "application_type": "NDA", "sponsor_name": "CMP DEV LLC", "brand_names": [ "ATORVALIQ" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-02-01", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA217029", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "TOBRAMYCIN SULFATE" ], "active_ingredients": [ "TOBRAMYCIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213562", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212735", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "STERILE WATER FOR INJECTION" ], "active_ingredients": [ "STERILE WATER FOR INJECTION" ], "dosage_forms": [ "LIQUID" ], "routes": [ "N/A" ], "approval_date": "2023-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208619", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "LEVETIRACETAM IN SODIUM CHLORIDE" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217415", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-01-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216820", "application_type": "NDA", "sponsor_name": "JUBILANT DRAXIMAGE", "brand_names": [ "TECHNETIUM TC 99M MERTIATIDE KIT" ], "active_ingredients": [ "TECHNETIUM TC-99M MERTIATIDE KIT" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-01-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214950", "application_type": "ANDA", "sponsor_name": "VELZEN PHARMA PVT", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217639", "application_type": "NDA", "sponsor_name": "STEMLINE THERAP", "brand_names": [ "ORSERDU" ], "active_ingredients": [ "ELACESTRANT HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA216059", "application_type": "NDA", "sponsor_name": "LOXO ONCOL", "brand_names": [ "JAYPIRCA" ], "active_ingredients": [ "PIRTOBRUTINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-27", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214532", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2023-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214442", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "CAPTOPRIL" ], "active_ingredients": [ "CAPTOPRIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212047", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216876", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210726", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ABIRATERONE ACETATE" ], "active_ingredients": [ "ABIRATERONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201962", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-25", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA216843", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "ALVIMOPAN" ], "active_ingredients": [ "ALVIMOPAN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216809", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "KETAMINE HYDROCHLORIDE" ], "active_ingredients": [ "KETAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215540", "application_type": "ANDA", "sponsor_name": "AJENAT PHARMS", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209655", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "FENTANYL-100", "FENTANYL-75", "FENTANYL-50", "FENTANYL-25", "FENTANYL-87", "FENTANYL-62", "FENTANYL-37", "FENTANYL-12" ], "active_ingredients": [ "FENTANYL" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2023-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217027", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216692", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2023-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216373", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "MILRINONE LACTATE" ], "active_ingredients": [ "MILRINONE LACTATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214373", "application_type": "NDA", "sponsor_name": "THERACOSBIO", "brand_names": [ "BRENZAVVY" ], "active_ingredients": [ "BEXAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-20", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA210274", "application_type": "NDA", "sponsor_name": "ZHEJIANG NOVUS PHARM", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, ORAL" ], "approval_date": "2023-01-20", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA206983", "application_type": "ANDA", "sponsor_name": "X-GEN PHARMS INC", "brand_names": [ "PENTAMIDINE ISETHIONATE" ], "active_ingredients": [ "PENTAMIDINE ISETHIONATE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2023-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216728", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SIROLIMUS" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214615", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2023-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207101", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "SUMATRIPTAN SUCCINATE" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2023-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217399", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216751", "application_type": "ANDA", "sponsor_name": "PRASCO", "brand_names": [ "MIRTAZAPINE" ], "active_ingredients": [ "MIRTAZAPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216492", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2023-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215259", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212886", "application_type": "ANDA", "sponsor_name": "IMPAX", "brand_names": [ "COLESEVELAM HYDROCHLORIDE" ], "active_ingredients": [ "COLESEVELAM HYDROCHLORIDE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2023-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA077838", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE" ], "active_ingredients": [ "BETAMETHASONE ACETATE", "BETAMETHASONE SODIUM PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-17", "review_priority": "", "submission_class": "" }, { "application_number": "NDA212849", "application_type": "NDA", "sponsor_name": "SHANDONG LUYE", "brand_names": [ "RYKINDO" ], "active_ingredients": [ "RISPERIDONE" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2023-01-13", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215808", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "KETAMINE HYDROCHLORIDE" ], "active_ingredients": [ "KETAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211654", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TASIMELTEON" ], "active_ingredients": [ "TASIMELTEON" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211452", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207606", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216496", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2023-01-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214070", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "AIRSUPRA" ], "active_ingredients": [ "ALBUTEROL SULFATE", "BUDESONIDE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2023-01-10", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA216038", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2023-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214463", "application_type": "ANDA", "sponsor_name": "PATHEON SOFTGELS", "brand_names": [ "NAPROXEN SODIUM" ], "active_ingredients": [ "NAPROXEN SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213660", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212448", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216766", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215908", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "NITISINONE" ], "active_ingredients": [ "NITISINONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205930", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PRASUGREL" ], "active_ingredients": [ "PRASUGREL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205443", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761269", "application_type": "BLA", "sponsor_name": "EISAI INC", "brand_names": [ "LEQEMBI" ], "active_ingredients": [ "LECANEMAB-IRMB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-06", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216796", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "EMZAHH" ], "active_ingredients": [ "NORETHINDRONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2023-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214848", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210826", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LEVOMILNACIPRAN HYDROCHLORIDE" ], "active_ingredients": [ "LEVOMILNACIPRAN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217410", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215713", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "TRETINOIN" ], "active_ingredients": [ "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214309", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "MEDROXYPROGESTERONE ACETATE" ], "active_ingredients": [ "MEDROXYPROGESTERONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204994", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204983", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204855", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2023-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205012", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205002", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS NY", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204973", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204868", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204504", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "FESOTERODINE FUMARATE" ], "active_ingredients": [ "FESOTERODINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2023-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214870", "application_type": "ANDA", "sponsor_name": "WILSHIRE PHARMS INC", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2023-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215697", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215066", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214892", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215924", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ORMALVI" ], "active_ingredients": [ "DICHLORPHENAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761238", "application_type": "BLA", "sponsor_name": "TG THERAPEUTICS, INC", "brand_names": [ "BRIUMVI" ], "active_ingredients": [ "UBLITUXIMAB-XIIY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761192", "application_type": "BLA", "sponsor_name": "MEDIWOUND, LTD", "brand_names": [ "NEXOBRID" ], "active_ingredients": [ "ANACAULASE-BCDB" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-12-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213003", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "TRIAZOLAM" ], "active_ingredients": [ "TRIAZOLAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA217054", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216145", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214117", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206817", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214375", "application_type": "NDA", "sponsor_name": "POLAREAN", "brand_names": [ "XENOVIEW" ], "active_ingredients": [ "XENON XE-129 HYPERPOLARIZED" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2022-12-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216445", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216390", "application_type": "ANDA", "sponsor_name": "ONESOURCE SPECIALTY", "brand_names": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214773", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209081", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215974", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "SUNLENCA" ], "active_ingredients": [ "LENACAPAVIR SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA215973", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "SUNLENCA" ], "active_ingredients": [ "LENACAPAVIR SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-12-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214860", "application_type": "NDA", "sponsor_name": "ACER", "brand_names": [ "OLPRUVA" ], "active_ingredients": [ "SODIUM PHENYLBUTYRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-12-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761263", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "LUNSUMIO VELO", "LUNSUMIO" ], "active_ingredients": [ "MOSUNETUZUMAB-AXGB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216934", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216626", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215077", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2022-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210385", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216662", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "LINCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "LINCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216131", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "DOBUTAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DOBUTAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214354", "application_type": "ANDA", "sponsor_name": "FERTIN PHARMA", "brand_names": [ "NICOTINE POLACRILEX" ], "active_ingredients": [ "NICOTINE POLACRILEX" ], "dosage_forms": [ "GUM, CHEWING" ], "routes": [ "BUCCAL" ], "approval_date": "2022-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214302", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "SELEXIPAG" ], "active_ingredients": [ "SELEXIPAG" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211417", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA078480", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-12-21", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214918", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214580", "application_type": "ANDA", "sponsor_name": "HUMANWELL PURACAP", "brand_names": [ "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211607", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "TASIMELTEON" ], "active_ingredients": [ "TASIMELTEON" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216860", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216357", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216324", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "CUPRIC SULFATE" ], "active_ingredients": [ "CUPRIC SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216078", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA211530", "application_type": "NDA", "sponsor_name": "HOSPIRA", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216736", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216472", "application_type": "NDA", "sponsor_name": "THEA PHARMA", "brand_names": [ "IYUZEH" ], "active_ingredients": [ "LATANOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761255", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "IDACIO" ], "active_ingredients": [ "ADALIMUMAB-AACF" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA216603", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ESMOLOL HYDROCHLORIDE" ], "active_ingredients": [ "ESMOLOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215621", "application_type": "ANDA", "sponsor_name": "WILSHIRE PHARMS INC", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215479", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212244", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216340", "application_type": "NDA", "sponsor_name": "BRISTOL", "brand_names": [ "KRAZATI" ], "active_ingredients": [ "ADAGRASIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215598", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211601", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "TASIMELTEON" ], "active_ingredients": [ "TASIMELTEON" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216384", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "LEVOCARNITINE" ], "active_ingredients": [ "LEVOCARNITINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214582", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "PASTE" ], "routes": [ "DENTAL" ], "approval_date": "2022-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206752", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214396", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DESONIDE" ], "active_ingredients": [ "DESONIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214321", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204816", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "SILODOSIN" ], "active_ingredients": [ "SILODOSIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215033", "application_type": "NDA", "sponsor_name": "APOTEX", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA212209", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "VIVIMUSTA" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216690", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205574", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205376", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "BENDAMUSTINE HYDROCHLORIDE" ], "active_ingredients": [ "BENDAMUSTINE HYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216126", "application_type": "ANDA", "sponsor_name": "BAMF", "brand_names": [ "SODIUM FLUORIDE F-18" ], "active_ingredients": [ "SODIUM FLUORIDE F-18" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-12-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216404", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214172", "application_type": "ANDA", "sponsor_name": "HQ SPCLT PHARMA", "brand_names": [ "ESMOLOL HYDROCHLORIDE" ], "active_ingredients": [ "ESMOLOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206720", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "OLMESARTAN MEDOXOMIL" ], "active_ingredients": [ "OLMESARTAN MEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215814", "application_type": "NDA", "sponsor_name": "RIGEL PHARMS", "brand_names": [ "REZLIDHIA" ], "active_ingredients": [ "OLUTASIDENIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-12-01", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA206241", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-12-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215332", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207355", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212479", "application_type": "NDA", "sponsor_name": "SHORLA", "brand_names": [ "JYLAMVO" ], "active_ingredients": [ "METHOTREXATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-29", "review_priority": "STANDARD", "submission_class": "Efficacy" }, { "application_number": "ANDA212506", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216815", "application_type": "ANDA", "sponsor_name": "WILSHIRE PHARMS INC", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216760", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216537", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216044", "application_type": "ANDA", "sponsor_name": "UNIQUE", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214849", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "URSODIOL" ], "active_ingredients": [ "URSODIOL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214192", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212871", "application_type": "ANDA", "sponsor_name": "OMNIVIUM PHARMS", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208949", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216486", "application_type": "ANDA", "sponsor_name": "RITEDOSE CORP", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216209", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "RAMELTEON" ], "active_ingredients": [ "RAMELTEON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208230", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216436", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215886", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-11-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215813", "application_type": "NDA", "sponsor_name": "AVYXA HOLDINGS", "brand_names": [ "DOCETAXEL", "DOCIVYX" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE", "SOLUTION" ], "routes": [ "INJECTION", "INTRAVENOUS" ], "approval_date": "2022-11-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA210850", "application_type": "NDA", "sponsor_name": "MAIA PHARMS INC", "brand_names": [ "SINCALIDE" ], "active_ingredients": [ "SINCALIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-22", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216648", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215828", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213630", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216212", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "ERYTHROMYCIN ETHYLSUCCINATE" ], "active_ingredients": [ "ERYTHROMYCIN ETHYLSUCCINATE" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216896", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NIFEDIPINE" ], "active_ingredients": [ "NIFEDIPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216019", "application_type": "ANDA", "sponsor_name": "PHARMADAX", "brand_names": [ "NIFEDIPINE" ], "active_ingredients": [ "NIFEDIPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216004", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215910", "application_type": "NDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "SEZABY" ], "active_ingredients": [ "PHENOBARBITAL SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-17", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761183", "application_type": "BLA", "sponsor_name": "PROVENTION BIO INC", "brand_names": [ "TZIELD" ], "active_ingredients": [ "TEPLIZUMAB-MZWV" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215124", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215061", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "GADOBUTROL" ], "active_ingredients": [ "GADOBUTROL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214010", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "AMPHOTERICIN B" ], "active_ingredients": [ "AMPHOTERICIN B" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211665", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216922", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DESMOPRESSIN ACETATE" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214894", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216953", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216891", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216128", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215980", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215107", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214811", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MUPIROCIN" ], "active_ingredients": [ "MUPIROCIN CALCIUM" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761310", "application_type": "BLA", "sponsor_name": "IMMUNOGEN INC", "brand_names": [ "ELAHERE" ], "active_ingredients": [ "MIRVETUXIMAB SORAVTANSINE-GYNX" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216172", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214913", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761270", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "IMJUDO" ], "active_ingredients": [ "TREMELIMUMAB-ACTL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-10", "review_priority": "STANDARD", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA215892", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214745", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "DIAZEPAM" ], "active_ingredients": [ "DIAZEPAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216463", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216448", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212710", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "PENCICLOVIR" ], "active_ingredients": [ "PENCICLOVIR" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209050", "application_type": "ANDA", "sponsor_name": "YABAO PHARM", "brand_names": [ "SORAFENIB TOSYLATE" ], "active_ingredients": [ "SORAFENIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216890", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "TRIAZOLAM" ], "active_ingredients": [ "TRIAZOLAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208923", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "SODIUM NITROPRUSSIDE" ], "active_ingredients": [ "SODIUM NITROPRUSSIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216557", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ISOSORBIDE MONONITRATE" ], "active_ingredients": [ "ISOSORBIDE MONONITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214792", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214009", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216464", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215666", "application_type": "ANDA", "sponsor_name": "CADILA", "brand_names": [ "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214970", "application_type": "ANDA", "sponsor_name": "MEDEFIL INC", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209652", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216848", "application_type": "ANDA", "sponsor_name": "LEPU PHARM", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215219", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212627", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211698", "application_type": "ANDA", "sponsor_name": "UNIV ALAHAMA BIRM", "brand_names": [ "AMMONIA N 13" ], "active_ingredients": [ "AMMONIA N-13" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216446", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "PROMETHAZINE HYDROCHLORIDE" ], "active_ingredients": [ "PROMETHAZINE HYDROCHLORIDE" ], "dosage_forms": [ "SUPPOSITORY" ], "routes": [ "RECTAL" ], "approval_date": "2022-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214456", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212567", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216462", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "SODIUM PHENYLBUTYRATE" ], "active_ingredients": [ "SODIUM PHENYLBUTYRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212071", "application_type": "ANDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "CUPRIC CHLORIDE" ], "active_ingredients": [ "CUPRIC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211813", "application_type": "ANDA", "sponsor_name": "HETERO LABS", "brand_names": [ "LINEZOLID" ], "active_ingredients": [ "LINEZOLID" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205160", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-10-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091086", "application_type": "ANDA", "sponsor_name": "SENTISS", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-10-31", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216967", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216393", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "TRIMETHOPRIM" ], "active_ingredients": [ "TRIMETHOPRIM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215336", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211065", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "NAPROXEN SODIUM" ], "active_ingredients": [ "NAPROXEN SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216351", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216013", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "FLUDROCORTISONE ACETATE" ], "active_ingredients": [ "FLUDROCORTISONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216624", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216549", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216437", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214635", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207693", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761291", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "TECVAYLI" ], "active_ingredients": [ "TECLISTAMAB-CQYV" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216983", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PYRIMETHAMINE" ], "active_ingredients": [ "PYRIMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216715", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PREDNISOLONE SODIUM PHOSPHATE" ], "active_ingredients": [ "PREDNISOLONE SODIUM PHOSPHATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216467", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216216", "application_type": "ANDA", "sponsor_name": "NE RX PHARMA", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215595", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216599", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215616", "application_type": "ANDA", "sponsor_name": "RENATA", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215241", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213784", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761289", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "IMJUDO" ], "active_ingredients": [ "TREMELIMUMAB-ACTL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-21", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA217038", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216407", "application_type": "ANDA", "sponsor_name": "ATNAHS PHARMA US", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215333", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213406", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216874", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214941", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214775", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212219", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)" ], "active_ingredients": [ "DOXORUBICIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215637", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215615", "application_type": "ANDA", "sponsor_name": "TAGI", "brand_names": [ "METHAZOLAMIDE" ], "active_ingredients": [ "METHAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211757", "application_type": "ANDA", "sponsor_name": "XGEN PHARMS", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210414", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216872", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "MISOPROSTOL" ], "active_ingredients": [ "MISOPROSTOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216629", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213071", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "CALCIUM GLUCONATE" ], "active_ingredients": [ "CALCIUM GLUCONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213834", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "EXTENDED PHENYTOIN SODIUM" ], "active_ingredients": [ "PHENYTOIN SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216961", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216932", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "ALYQ" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215742", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "ZILEUTON" ], "active_ingredients": [ "ZILEUTON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213985", "application_type": "ANDA", "sponsor_name": "H2-PHARMA", "brand_names": [ "MEMANTINE HYDROCHLORIDE" ], "active_ingredients": [ "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211898", "application_type": "ANDA", "sponsor_name": "RELIANCE LIFE SCI", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210849", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207585", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "RHUZDAH" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL-28" ], "approval_date": "2022-10-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216109", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "CEFAZOLIN SODIUM" ], "active_ingredients": [ "CEFAZOLIN SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA209988", "application_type": "NDA", "sponsor_name": "SCPHARMACEUTICALS", "brand_names": [ "FUROSCIX", "FUROSCIX READYFLOW (AUTOINJECTOR)" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-10-07", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA214815", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212385", "application_type": "ANDA", "sponsor_name": "P AND L DEVELOPMENT", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214628", "application_type": "NDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-06", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214277", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213699", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "NAPROXEN AND ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM", "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205537", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BIMATOPROST" ], "active_ingredients": [ "BIMATOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213366", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211475", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-10-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201949", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-10-04", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA214501", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212457", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "CLOFARABINE" ], "active_ingredients": [ "CLOFARABINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-10-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214801", "application_type": "NDA", "sponsor_name": "TAIHO ONCOLOGY", "brand_names": [ "LYTGOBI" ], "active_ingredients": [ "FUTIBATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-30", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213932", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "CARIPRAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CARIPRAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216660", "application_type": "NDA", "sponsor_name": "AMYLYX", "brand_names": [ "RELYVRIO" ], "active_ingredients": [ "SODIUM PHENYLBUTYRATE", "TAURURSODIOL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216859", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215708", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209488", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208098", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202073", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "DARUNAVIR" ], "active_ingredients": [ "DARUNAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-29", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA215381", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209485", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "MIRABEGRON" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216227", "application_type": "NDA", "sponsor_name": "HARROW EYE", "brand_names": [ "IHEEZO" ], "active_ingredients": [ "CHLOROPROCAINE HYDROCHLORIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-27", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761268", "application_type": "BLA", "sponsor_name": "CELLTRION", "brand_names": [ "VEGZELMA" ], "active_ingredients": [ "BEVACIZUMAB-ADCD" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216798", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216804", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215657", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LINCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "LINCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214004", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213570", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206355", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204389", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "MEMANTINE HYDROCHLORIDE" ], "active_ingredients": [ "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203125", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "METHYLPREDNISOLONE SODIUM SUCCINATE" ], "active_ingredients": [ "METHYLPREDNISOLONE SODIUM SUCCINATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216845", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "DICLOXACILLIN SODIUM" ], "active_ingredients": [ "DICLOXACILLIN SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216521", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216413", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216275", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214567", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209532", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "GEFITINIB" ], "active_ingredients": [ "GEFITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207124", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215092", "application_type": "NDA", "sponsor_name": "OCUVEX THERAP", "brand_names": [ "OMLONTI" ], "active_ingredients": [ "OMIDENEPAG ISOPROPYL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216725", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216229", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215733", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION, GEL FORMING/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216986", "application_type": "NDA", "sponsor_name": "GUERBET", "brand_names": [ "ELUCIREM" ], "active_ingredients": [ "GADOPICLENOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-21", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA216505", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212674", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208021", "application_type": "ANDA", "sponsor_name": "LUPIN PHARMS", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212937", "application_type": "NDA", "sponsor_name": "FENNEC PHARMS INC", "brand_names": [ "PEDMARK" ], "active_ingredients": [ "SODIUM THIOSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-20", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215542", "application_type": "ANDA", "sponsor_name": "PENN LIFE", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215628", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215520", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214267", "application_type": "ANDA", "sponsor_name": "YILING", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210596", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "VYDUO" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE", "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216457", "application_type": "NDA", "sponsor_name": "HERON THERAPS INC", "brand_names": [ "APONVIE" ], "active_ingredients": [ "APREPITANT" ], "dosage_forms": [ "EMULSION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-16", "review_priority": "STANDARD", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA216090", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ISOSULFAN BLUE" ], "active_ingredients": [ "ISOSULFAN BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-09-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202666", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "DEXLANSOPRAZOLE" ], "active_ingredients": [ "DEXLANSOPRAZOLE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-16", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215700", "application_type": "NDA", "sponsor_name": "INFORLIFE", "brand_names": [ "NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216091", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ZIPRASIDONE MESYLATE" ], "active_ingredients": [ "ZIPRASIDONE MESYLATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2022-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215195", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA022231", "application_type": "NDA", "sponsor_name": "MALLINCKRODT IRELAND", "brand_names": [ "TERLIVAZ" ], "active_ingredients": [ "TERLIPRESSIN ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216335", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215675", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213944", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216533", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215693", "application_type": "ANDA", "sponsor_name": "ORIENT PHARMA", "brand_names": [ "EZETIMIBE" ], "active_ingredients": [ "EZETIMIBE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215433", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214136", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "TAZAROTENE" ], "active_ingredients": [ "TAZAROTENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211444", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212913", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210154", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214958", "application_type": "NDA", "sponsor_name": "BRISTOL", "brand_names": [ "SOTYKTU" ], "active_ingredients": [ "DEUCRAVACITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-09", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761148", "application_type": "BLA", "sponsor_name": "SPECTRUM PHARMS", "brand_names": [ "ROLVEDON" ], "active_ingredients": [ "EFLAPEGRASTIM-XNST" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-09-09", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213984", "application_type": "ANDA", "sponsor_name": "ZYDUS", "brand_names": [ "CARIPRAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CARIPRAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208037", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216295", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215599", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "FLECAINIDE ACETATE" ], "active_ingredients": [ "FLECAINIDE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214505", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211869", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ISOSULFAN BLUE" ], "active_ingredients": [ "ISOSULFAN BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761127", "application_type": "BLA", "sponsor_name": "REVANCE THERAPEUTICS, INC.", "brand_names": [ "DAXXIFY" ], "active_ingredients": [ "DAXIBOTULINUMTOXINA-LANM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2022-09-07", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216596", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215363", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208256", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ROFLUMILAST" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208003", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216008", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CLOBAZAM" ], "active_ingredients": [ "CLOBAZAM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214504", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212573", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210435", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090541", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "TRI-LO-LINYAH" ], "active_ingredients": [ "NORGESTIMATE", "ETHINYL ESTRADIOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL", "ORAL-28" ], "approval_date": "2022-09-02", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761244", "application_type": "BLA", "sponsor_name": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC", "brand_names": [ "SPEVIGO" ], "active_ingredients": [ "SPESOLIMAB-SBZO" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-09-01", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761173", "application_type": "BLA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "STIMUFEND" ], "active_ingredients": [ "PEGFILGRASTIM-FPGK" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2022-09-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211135", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "RIOCIGUAT" ], "active_ingredients": [ "RIOCIGUAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-09-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207883", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-09-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761261", "application_type": "BLA", "sponsor_name": "GENZYME CORP", "brand_names": [ "XENPOZYME" ], "active_ingredients": [ "OLIPUDASE ALFA-RPCP" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-31", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214349", "application_type": "ANDA", "sponsor_name": "HOSPIRA", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212844", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "MEDROXYPROGESTERONE ACETATE" ], "active_ingredients": [ "MEDROXYPROGESTERONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210480", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213593", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "KONVOMEP" ], "active_ingredients": [ "OMEPRAZOLE", "SODIUM BICARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA217069", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215726", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215622", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213912", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211022", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210470", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "CIPROFLOXACIN AND DEXAMETHASONE" ], "active_ingredients": [ "CIPROFLOXACIN", "DEXAMETHASONE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2022-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215981", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE", "SIMETHICONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215860", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213104", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216262", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216151", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215846", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "SODIUM NITROPRUSSIDE" ], "active_ingredients": [ "SODIUM NITROPRUSSIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215577", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215315", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216651", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204928", "application_type": "ANDA", "sponsor_name": "RISING PHARMS", "brand_names": [ "ZAFIRLUKAST" ], "active_ingredients": [ "ZAFIRLUKAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217003", "application_type": "NDA", "sponsor_name": "PHARMACYCLICS LLC", "brand_names": [ "IMBRUVICA" ], "active_ingredients": [ "IBRUTINIB" ], "dosage_forms": [ "SUSPENSION", "TABLET", "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-24", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215435", "application_type": "ANDA", "sponsor_name": "ANDAS 5 HOLDING", "brand_names": [ "RAMELTEON" ], "active_ingredients": [ "RAMELTEON" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206954", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204470", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "NAPROXEN AND ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM", "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215534", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216082", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "GUAIFENESIN", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215053", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213284", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212824", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "MEDROXYPROGESTERONE ACETATE" ], "active_ingredients": [ "MEDROXYPROGESTERONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206454", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "LINEZOLID" ], "active_ingredients": [ "LINEZOLID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206329", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "FENTANYL CITRATE" ], "active_ingredients": [ "FENTANYL CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "BUCCAL, SUBLINGUAL" ], "approval_date": "2022-08-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215961", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "DESMOPRESSIN ACETATE" ], "active_ingredients": [ "DESMOPRESSIN ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212677", "application_type": "ANDA", "sponsor_name": "VISTAPHARM LLC", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215430", "application_type": "NDA", "sponsor_name": "AXSOME", "brand_names": [ "AUVELITY" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE", "DEXTROMETHORPHAN HYDROBROMIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "ANDA216594", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216154", "application_type": "ANDA", "sponsor_name": "BROOKS STERISCIENCE", "brand_names": [ "MEROPENEM" ], "active_ingredients": [ "MEROPENEM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215890", "application_type": "ANDA", "sponsor_name": "HAINAN POLY PHARM", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215724", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215420", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214436", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211897", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210102", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ROPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "ROPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208198", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206095", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "DEXTROAMPHETAMINE SULFATE" ], "active_ingredients": [ "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215472", "application_type": "ANDA", "sponsor_name": "ONESOURCE", "brand_names": [ "NAPROXEN SODIUM" ], "active_ingredients": [ "NAPROXEN SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212449", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204964", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215105", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215104", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "IPRATROPIUM BROMIDE" ], "active_ingredients": [ "IPRATROPIUM BROMIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214955", "application_type": "ANDA", "sponsor_name": "NE RX PHARMA", "brand_names": [ "BUTALBITAL AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211363", "application_type": "NDA", "sponsor_name": "INTL MEDICATION SYS", "brand_names": [ "EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-15", "review_priority": "STANDARD", "submission_class": "Type 7 - Drug Already Marketed without Approved NDA" }, { "application_number": "ANDA215478", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214314", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215737", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS INC", "brand_names": [ "CETRORELIX ACETATE" ], "active_ingredients": [ "CETRORELIX ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213692", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "BREXPIPRAZOLE" ], "active_ingredients": [ "BREXPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210609", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210608", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203003", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "MECLIZINE HYDROCHLORIDE" ], "active_ingredients": [ "MECLIZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-11", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA211783", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "GEL" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214499", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216359", "application_type": "NDA", "sponsor_name": "RAFA LABS LTD", "brand_names": [ "MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)" ], "active_ingredients": [ "MIDAZOLAM HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2022-08-08", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216495", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216304", "application_type": "ANDA", "sponsor_name": "UTOPIC PHARMS", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215604", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212719", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "LABETALOL HYDROCHLORIDE" ], "active_ingredients": [ "LABETALOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214668", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212944", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211328", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "HALOETTE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "ETONOGESTREL" ], "dosage_forms": [ "RING" ], "routes": [ "VAGINAL" ], "approval_date": "2022-08-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216427", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215587", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215364", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214185", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ADAPALENE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210047", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216387", "application_type": "NDA", "sponsor_name": "ASTRAZENECA", "brand_names": [ "CALQUENCE" ], "active_ingredients": [ "ACALABRUTINIB MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-03", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA212465", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "MUPIROCIN" ], "active_ingredients": [ "MUPIROCIN CALCIUM" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212138", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "EMPAGLIFLOZIN" ], "active_ingredients": [ "EMPAGLIFLOZIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761165", "application_type": "BLA", "sponsor_name": "SANDOZ INC", "brand_names": [ "CIMERLI" ], "active_ingredients": [ "RANIBIZUMAB-EQRN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216046", "application_type": "ANDA", "sponsor_name": "ONESOURCE", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215210", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212078", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212077", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-08-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215985", "application_type": "NDA", "sponsor_name": "ARCUTIS", "brand_names": [ "ZORYVE" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-07-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215964", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215453", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215197", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215331", "application_type": "NDA", "sponsor_name": "MAIA PHARMS INC", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA213953", "application_type": "NDA", "sponsor_name": "MARIUS", "brand_names": [ "KYZATREX" ], "active_ingredients": [ "TESTOSTERONE UNDECANOATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA211875", "application_type": "NDA", "sponsor_name": "AM REGENT", "brand_names": [ "PACLITAXEL" ], "active_ingredients": [ "PACLITAXEL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216617", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215196", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213418", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212351", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215441", "application_type": "NDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215880", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215011", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212958", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211317", "application_type": "ANDA", "sponsor_name": "CARLSBAD", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210859", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "EZETIMIBE" ], "active_ingredients": [ "EZETIMIBE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209622", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208460", "application_type": "ANDA", "sponsor_name": "HOSPIRA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204405", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA203654", "application_type": "ANDA", "sponsor_name": "CAPLIN ONE LABS", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202963", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-07-26", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216332", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "ABACAVIR SULFATE AND LAMIVUDINE" ], "active_ingredients": [ "ABACAVIR SULFATE", "LAMIVUDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215725", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215680", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214726", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216531", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "AMBRISENTAN" ], "active_ingredients": [ "AMBRISENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212747", "application_type": "ANDA", "sponsor_name": "AIZANT", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215868", "application_type": "NDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "MIDAZOLAM IN 0.8% SODIUM CHLORIDE" ], "active_ingredients": [ "MIDAZOLAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-20", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216635", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215002", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214489", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "AZILSARTAN MEDOXOMIL" ], "active_ingredients": [ "AZILSARTAN KAMEDOXOMIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214408", "application_type": "NDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216341", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215835", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215042", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENOXYBENZAMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212724", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212722", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216197", "application_type": "ANDA", "sponsor_name": "MARKSANS PHARMA", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214475", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "FENOPROFEN CALCIUM" ], "active_ingredients": [ "FENOPROFEN CALCIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212789", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID" ], "active_ingredients": [ "CITRIC ACID", "MAGNESIUM OXIDE", "SODIUM PICOSULFATE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211857", "application_type": "ANDA", "sponsor_name": "AMPHASTAR PHARMS INC", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214273", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "ZONISADE" ], "active_ingredients": [ "ZONISAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216649", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215772", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214757", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212178", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "EFINACONAZOLE" ], "active_ingredients": [ "EFINACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216130", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2022-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215065", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "METHOCARBAMOL" ], "active_ingredients": [ "METHOCARBAMOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "IM-IV" ], "approval_date": "2022-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214752", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213873", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213550", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "OXYBUTYNIN CHLORIDE" ], "active_ingredients": [ "OXYBUTYNIN CHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216206", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216066", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215467", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "ELETRIPTAN HYDROBROMIDE" ], "active_ingredients": [ "ELETRIPTAN HYDROBROMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214181", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NYSTATIN AND TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "NYSTATIN", "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215773", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207320", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205011", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216264", "application_type": "NDA", "sponsor_name": "PROVEPHARM SAS", "brand_names": [ "BLUDIGO" ], "active_ingredients": [ "INDIGOTINDISULFONATE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-08", "review_priority": "STANDARD", "submission_class": "Type 7 - Drug Already Marketed without Approved NDA" }, { "application_number": "ANDA215723", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "ISOSORBIDE DINITRATE" ], "active_ingredients": [ "ISOSORBIDE DINITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215565", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213273", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212198", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216591", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216291", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214768", "application_type": "ANDA", "sponsor_name": "BIOCON GENERICS", "brand_names": [ "TRIAMTERENE" ], "active_ingredients": [ "TRIAMTERENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213698", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212467", "application_type": "ANDA", "sponsor_name": "COHANCE LIFESCIENCES", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212400", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210754", "application_type": "ANDA", "sponsor_name": "CEDIPROF INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215669", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA200854", "application_type": "ANDA", "sponsor_name": "ACTAVIS GROUP", "brand_names": [ "HALOPERIDOL" ], "active_ingredients": [ "HALOPERIDOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-07-01", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA216285", "application_type": "NDA", "sponsor_name": "EXELTIS USA INC", "brand_names": [ "DROSPIRENONE" ], "active_ingredients": [ "DROSPIRENONE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215429", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "VENLAFAXINE BESYLATE" ], "active_ingredients": [ "VENLAFAXINE BESYLATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form" }, { "application_number": "ANDA215370", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5" ], "active_ingredients": [ "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM ACETATE", "SODIUM CHLORIDE", "SODIUM GLUCONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212894", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209465", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208643", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "PALIPERIDONE" ], "active_ingredients": [ "PALIPERIDONE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214896", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "PRIMIDONE" ], "active_ingredients": [ "PRIMIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203078", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-28", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214201", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM" ], "active_ingredients": [ "DIATRIZOATE MEGLUMINE", "DIATRIZOATE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL, RECTAL" ], "approval_date": "2022-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213503", "application_type": "ANDA", "sponsor_name": "CROSSMEDIKA SA", "brand_names": [ "TRANYLCYPROMINE SULFATE" ], "active_ingredients": [ "TRANYLCYPROMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201442", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-27", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216349", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215113", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214961", "application_type": "ANDA", "sponsor_name": "PYROS PHARMS", "brand_names": [ "VIGPODER" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214645", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION, GEL FORMING/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212206", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ABIRATERONE ACETATE" ], "active_ingredients": [ "ABIRATERONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207471", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "AMOXICILLIN" ], "active_ingredients": [ "AMOXICILLIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216117", "application_type": "NDA", "sponsor_name": "OSMOTICA PHARM US", "brand_names": [ "RELEXXII" ], "active_ingredients": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-23", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216356", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "TRIENTINE HYDROCHLORIDE" ], "active_ingredients": [ "TRIENTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207619", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214218", "application_type": "NDA", "sponsor_name": "HOSPIRA", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216342", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ERLOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "ERLOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213395", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "CARGLUMIC ACID" ], "active_ingredients": [ "CARGLUMIC ACID" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210042", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209641", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS UT INC", "brand_names": [ "ADAPALENE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212135", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "IMATINIB MESYLATE" ], "active_ingredients": [ "IMATINIB MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211951", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211011", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216513", "application_type": "NDA", "sponsor_name": "MEDUNIK", "brand_names": [ "PHEBURANE" ], "active_ingredients": [ "SODIUM PHENYLBUTYRATE" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2022-06-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA214522", "application_type": "NDA", "sponsor_name": "CMP DEV LLC", "brand_names": [ "TADLIQ" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761262", "application_type": "BLA", "sponsor_name": "ABBVIE INC", "brand_names": [ "SKYRIZI" ], "active_ingredients": [ "RISANKIZUMAB-RZAA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-16", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213730", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "CLORAZEPATE DIPOTASSIUM" ], "active_ingredients": [ "CLORAZEPATE DIPOTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207802", "application_type": "ANDA", "sponsor_name": "RICONPHARMA LLC", "brand_names": [ "FLUNISOLIDE" ], "active_ingredients": [ "FLUNISOLIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204316", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-16", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215761", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214653", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215566", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "CLORAZEPATE DIPOTASSIUM" ], "active_ingredients": [ "CLORAZEPATE DIPOTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214856", "application_type": "ANDA", "sponsor_name": "EMERGE BIOSCIENCE", "brand_names": [ "ENOXAPARIN SODIUM" ], "active_ingredients": [ "ENOXAPARIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215515", "application_type": "NDA", "sponsor_name": "ALNYLAM PHARMS INC", "brand_names": [ "AMVUTTRA" ], "active_ingredients": [ "VUTRISIRAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-06-13", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216202", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PROCHLORPERAZINE MALEATE" ], "active_ingredients": [ "PROCHLORPERAZINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212600", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217500", "application_type": "NDA", "sponsor_name": "ABSOLUTE AIR, LLC", "brand_names": [ "OXYGEN, USP" ], "active_ingredients": [ "OXYGEN" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2022-06-10", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA217499", "application_type": "NDA", "sponsor_name": "ABSOLUTE AIR, LLC", "brand_names": [ "Nitrogen, NF" ], "active_ingredients": [ "Nitrogen" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2022-06-10", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA208746", "application_type": "NDA", "sponsor_name": "HOSPIRA", "brand_names": [ "PEMETREXED DITROMETHAMINE" ], "active_ingredients": [ "PEMETREXED DITROMETHAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-10", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA212300", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215132", "application_type": "ANDA", "sponsor_name": "AFAXYS", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214748", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "BRIVARACETAM" ], "active_ingredients": [ "BRIVARACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214071", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "ORAL" ], "approval_date": "2022-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213843", "application_type": "ANDA", "sponsor_name": "MYLAN LABS LTD", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212681", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216399", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215371", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4" ], "active_ingredients": [ "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM ACETATE", "SODIUM CHLORIDE", "SODIUM GLUCONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216073", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SORAFENIB TOSYLATE" ], "active_ingredients": [ "SORAFENIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215776", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "NAPROXEN" ], "active_ingredients": [ "NAPROXEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216243", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214996", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213062", "application_type": "ANDA", "sponsor_name": "WES PHARMA INC", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212963", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-06-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA206968", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-06-03", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216441", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214553", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ADAPALENE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216318", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "AZMIRO" ], "active_ingredients": [ "TESTOSTERONE CYPIONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2022-06-02", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216198", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "TIOPRONIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212756", "application_type": "ANDA", "sponsor_name": "DIFGEN PHARMS", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "FILM" ], "routes": [ "BUCCAL, SUBLINGUAL" ], "approval_date": "2022-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211360", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "NAPROXEN SODIUM", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216204", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "IBUPROFEN AND DIPHENHYDRAMINE CITRATE" ], "active_ingredients": [ "DIPHENHYDRAMINE CITRATE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215434", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215279", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FLUDROCORTISONE ACETATE" ], "active_ingredients": [ "FLUDROCORTISONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214111", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212464", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "ADAPALENE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "ADAPALENE", "BENZOYL PEROXIDE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209301", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216375", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215466", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "MINOCYCLINE HYDROCHLORIDE" ], "active_ingredients": [ "MINOCYCLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215311", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212407", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214657", "application_type": "NDA", "sponsor_name": "SANDOZ", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761084", "application_type": "BLA", "sponsor_name": "KASHIV BIOSCIENCES LLC", "brand_names": [ "FYLNETRA" ], "active_ingredients": [ "PEGFILGRASTIM-PBBK" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA216434", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "BUMETANIDE" ], "active_ingredients": [ "BUMETANIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216120", "application_type": "ANDA", "sponsor_name": "AM REGENT", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215385", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212668", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ROCURONIUM BROMIDE" ], "active_ingredients": [ "ROCURONIUM BROMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212390", "application_type": "ANDA", "sponsor_name": "MEDUNIK", "brand_names": [ "NITISINONE" ], "active_ingredients": [ "NITISINONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214632", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214073", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211899", "application_type": "ANDA", "sponsor_name": "RELIANCE LIFE", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211090", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209851", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209085", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208768", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208696", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207352", "application_type": "ANDA", "sponsor_name": "NANG KUANG PHARM CO", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204890", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA203774", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA203485", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202596", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA202111", "application_type": "ANDA", "sponsor_name": "HOSPIRA", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA090384", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "PEMETREXED DISODIUM" ], "active_ingredients": [ "PEMETREXED DISODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-25", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA216096", "application_type": "ANDA", "sponsor_name": "DEXCEL", "brand_names": [ "OMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "OMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215516", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212772", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215272", "application_type": "NDA", "sponsor_name": "ORGANON LLC", "brand_names": [ "VTAMA" ], "active_ingredients": [ "TAPINAROF" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-05-23", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214324", "application_type": "NDA", "sponsor_name": "UNITED THERAP", "brand_names": [ "TYVASO DPI" ], "active_ingredients": [ "TREPROSTINIL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2022-05-23", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214252", "application_type": "ANDA", "sponsor_name": "IMS LTD", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216454", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "EXEMESTANE" ], "active_ingredients": [ "EXEMESTANE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212708", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214680", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214672", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214271", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "IODIXANOL" ], "active_ingredients": [ "IODIXANOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210701", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "AMBRISENTAN" ], "active_ingredients": [ "AMBRISENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214518", "application_type": "NDA", "sponsor_name": "SIGA TECHNOLOGIES", "brand_names": [ "TPOXX" ], "active_ingredients": [ "TECOVIRIMAT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA216171", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213778", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212680", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210568", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEFPODOXIME PROXETIL" ], "active_ingredients": [ "CEFPODOXIME PROXETIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210163", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "PERPHENAZINE" ], "active_ingredients": [ "PERPHENAZINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204400", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-18", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA207490", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA INTL", "brand_names": [ "BUPRENORPHINE" ], "active_ingredients": [ "BUPRENORPHINE" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215000", "application_type": "NDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-16", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA214293", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "ESTRADIOL AND PROGESTERONE" ], "active_ingredients": [ "ESTRADIOL", "PROGESTERONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215866", "application_type": "NDA", "sponsor_name": "ELI LILLY AND CO", "brand_names": [ "MOUNJARO", "MOUNJARO KWIKPEN", "MOUNJARO (AUTOINJECTOR)" ], "active_ingredients": [ "TIRZEPATIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-05-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215798", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215357", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "NICOTINE POLACRILEX" ], "active_ingredients": [ "NICOTINE POLACRILEX" ], "dosage_forms": [ "TROCHE/LOZENGE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215446", "application_type": "NDA", "sponsor_name": "SHIONOGI", "brand_names": [ "RADICAVA ORS" ], "active_ingredients": [ "EDARAVONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-12", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215750", "application_type": "ANDA", "sponsor_name": "UMEDICA", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214585", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204413", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ROPINIROLE HYDROCHLORIDE" ], "active_ingredients": [ "ROPINIROLE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-11", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215601", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214779", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212226", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208299", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ROFLUMILAST" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207588", "application_type": "ANDA", "sponsor_name": "WATSON LABS TEVA", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203759", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "RITONAVIR" ], "active_ingredients": [ "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-10", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214516", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "VORICONAZOLE" ], "active_ingredients": [ "VORICONAZOLE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209970", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207714", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215775", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214269", "application_type": "ANDA", "sponsor_name": "YILING", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214217", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212788", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206890", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "ILOPERIDONE" ], "active_ingredients": [ "ILOPERIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214730", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "TAMSULOSIN HYDROCHLORIDE" ], "active_ingredients": [ "TAMSULOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209956", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215153", "application_type": "NDA", "sponsor_name": "PHATHOM", "brand_names": [ "VOQUEZNA DUAL PAK" ], "active_ingredients": [ "AMOXICILLIN", "VONOPRAZAN FUMARATE" ], "dosage_forms": [ "CAPSULE, TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-03", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA215152", "application_type": "NDA", "sponsor_name": "PHATHOM", "brand_names": [ "VOQUEZNA TRIPLE PAK" ], "active_ingredients": [ "AMOXICILLIN", "CLARITHROMYCIN", "VONOPRAZAN FUMARATE" ], "dosage_forms": [ "CAPSULE, TABLET, TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-05-03", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA216249", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ZINC SULFATE" ], "active_ingredients": [ "ZINC SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215839", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOCOSANOL" ], "active_ingredients": [ "DOCOSANOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214677", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211043", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ZILEUTON" ], "active_ingredients": [ "ZILEUTON" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091040", "application_type": "ANDA", "sponsor_name": "LUPIN LTD", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-05-03", "review_priority": "", "submission_class": "" }, { "application_number": "NDA209191", "application_type": "NDA", "sponsor_name": "HOSPIRA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215313", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213823", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212825", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210824", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210204", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209659", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208392", "application_type": "ANDA", "sponsor_name": "PHARMASCIENCE INC", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205857", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205533", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BORTEZOMIB" ], "active_ingredients": [ "BORTEZOMIB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-05-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215809", "application_type": "NDA", "sponsor_name": "MYLAN", "brand_names": [ "ERMEZA" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-04-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214115", "application_type": "ANDA", "sponsor_name": "SHANDONG", "brand_names": [ "ISOSORBIDE MONONITRATE" ], "active_ingredients": [ "ISOSORBIDE MONONITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213658", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "CROMOLYN SODIUM" ], "active_ingredients": [ "CROMOLYN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215760", "application_type": "NDA", "sponsor_name": "ORPHALAN", "brand_names": [ "CUVRIOR" ], "active_ingredients": [ "TRIENTINE TETRAHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-28", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "NDA214998", "application_type": "NDA", "sponsor_name": "BRISTOL", "brand_names": [ "CAMZYOS" ], "active_ingredients": [ "MAVACAMTEN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213901", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212560", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215398", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "BEXAROTENE" ], "active_ingredients": [ "BEXAROTENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213517", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217332", "application_type": "NDA", "sponsor_name": "LINDE GAS EQUIP", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2022-04-26", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA215888", "application_type": "NDA", "sponsor_name": "MYCOVIA PHARMS", "brand_names": [ "VIVJOA" ], "active_ingredients": [ "OTESECONAZOLE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA208781", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214510", "application_type": "NDA", "sponsor_name": "MAYNE PHARMA", "brand_names": [ "EPSOLAY" ], "active_ingredients": [ "BENZOYL PEROXIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214596", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212424", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "PHYTONADIONE" ], "active_ingredients": [ "PHYTONADIONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209645", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ENZALUTAMIDE" ], "active_ingredients": [ "ENZALUTAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214919", "application_type": "NDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2022-04-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215838", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215825", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208703", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "THIAMINE HYDROCHLORIDE" ], "active_ingredients": [ "THIAMINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091442", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-04-20", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA213796", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212405", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "PYRIDOSTIGMINE BROMIDE" ], "active_ingredients": [ "PYRIDOSTIGMINE BROMIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2022-04-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215576", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215417", "application_type": "ANDA", "sponsor_name": "SOLA PHARMS", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214655", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213472", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210018", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DOFETILIDE" ], "active_ingredients": [ "DOFETILIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216129", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215674", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215323", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DOFETILIDE" ], "active_ingredients": [ "DOFETILIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761231", "application_type": "BLA", "sponsor_name": "AMNEAL PHARMS LLC", "brand_names": [ "ALYMSYS" ], "active_ingredients": [ "BEVACIZUMAB-MALY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-13", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215402", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "ETRAVIRINE" ], "active_ingredients": [ "ETRAVIRINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215847", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "BETAMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BETAMETHASONE DIPROPIONATE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2022-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215843", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215304", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "GADOTERATE MEGLUMINE" ], "active_ingredients": [ "GADOTERATE MEGLUMINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213236", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213210", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212806", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207604", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "REGADENOSON" ], "active_ingredients": [ "REGADENOSON" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213923", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LIDOCAINE AND PRILOCAINE" ], "active_ingredients": [ "LIDOCAINE", "PRILOCAINE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2022-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214301", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214088", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "BUTALBITAL AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212682", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212613", "application_type": "ANDA", "sponsor_name": "AMPHASTAR PHARMS INC", "brand_names": [ "GANIRELIX ACETATE" ], "active_ingredients": [ "GANIRELIX ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212500", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215586", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE" ], "active_ingredients": [ "HYDRALAZINE HYDROCHLORIDE", "ISOSORBIDE DINITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213891", "application_type": "ANDA", "sponsor_name": "RENATA", "brand_names": [ "FROVATRIPTAN SUCCINATE" ], "active_ingredients": [ "FROVATRIPTAN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215390", "application_type": "NDA", "sponsor_name": "BIOXCEL", "brand_names": [ "IGALMI" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "FILM" ], "routes": [ "BUCCAL, SUBLINGUAL" ], "approval_date": "2022-04-05", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215039", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "VIJOICE" ], "active_ingredients": [ "ALPELISIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-05", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA213126", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091087", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "BRIMONIDINE TARTRATE AND TIMOLOL MALEATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-04-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215848", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-04-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216331", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215591", "application_type": "ANDA", "sponsor_name": "ZHEJIANG JIUZHOU", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214695", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213349", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210178", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215413", "application_type": "NDA", "sponsor_name": "VIIV HLTHCARE", "brand_names": [ "TRIUMEQ PD" ], "active_ingredients": [ "ABACAVIR SULFATE", "DOLUTEGRAVIR SODIUM", "LAMIVUDINE" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-30", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215318", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213792", "application_type": "ANDA", "sponsor_name": "CURIUM", "brand_names": [ "IOFLUPANE I-123" ], "active_ingredients": [ "IOFLUPANE I-123" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213714", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212487", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209997", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM PHOSPHATES" ], "active_ingredients": [ "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE", "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216232", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "FLUOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216067", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "NIFEDIPINE" ], "active_ingredients": [ "NIFEDIPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA208088", "application_type": "NDA", "sponsor_name": "VERITY", "brand_names": [ "TLANDO" ], "active_ingredients": [ "TESTOSTERONE UNDECANOATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215672", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210332", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "DEXTROSE 5% AND LACTATED RINGER'S" ], "active_ingredients": [ "CALCIUM CHLORIDE", "DEXTROSE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209590", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209474", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206266", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215135", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212570", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214404", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "CLOBAZAM" ], "active_ingredients": [ "CLOBAZAM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214108", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215841", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "LOCAMETZ" ], "active_ingredients": [ "GALLIUM GA-68 GOZETOTIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "NDA215833", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "PLUVICTO" ], "active_ingredients": [ "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA216250", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215788", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "KETOROLAC TROMETHAMINE" ], "active_ingredients": [ "KETOROLAC TROMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215510", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214663", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "EPLERENONE" ], "active_ingredients": [ "EPLERENONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211638", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215401", "application_type": "NDA", "sponsor_name": "NOVEN PHARMS INC", "brand_names": [ "XELSTRYM" ], "active_ingredients": [ "DEXTROAMPHETAMINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-03-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA213478", "application_type": "NDA", "sponsor_name": "NOBELPHARMA", "brand_names": [ "HYFTOR" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-22", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215249", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216244", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ESMOLOL HYDROCHLORIDE" ], "active_ingredients": [ "ESMOLOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213857", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "LOPINAVIR AND RITONAVIR" ], "active_ingredients": [ "LOPINAVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212485", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "IVERMECTIN" ], "active_ingredients": [ "IVERMECTIN" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215904", "application_type": "NDA", "sponsor_name": "IMMEDICA PHARMA", "brand_names": [ "ZTALMY" ], "active_ingredients": [ "GANAXOLONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-18", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761234", "application_type": "BLA", "sponsor_name": "BRISTOL MYERS SQUIBB", "brand_names": [ "OPDUALAG" ], "active_ingredients": [ "NIVOLUMAB", "RELATLIMAB-RMBW" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-03-18", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA204813", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "BROMFENAC SODIUM" ], "active_ingredients": [ "BROMFENAC SODIUM" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-03-18", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215712", "application_type": "NDA", "sponsor_name": "PERRIGO PHARMA INTL", "brand_names": [ "NASONEX 24HR ALLERGY" ], "active_ingredients": [ "MOMETASONE FUROATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "Type 8 - Partial Rx to OTC Switch" }, { "application_number": "ANDA215829", "application_type": "ANDA", "sponsor_name": "HERITAGE", "brand_names": [ "VERAPAMIL HYDROCHLORIDE" ], "active_ingredients": [ "VERAPAMIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208308", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206982", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PENTAMIDINE ISETHIONATE" ], "active_ingredients": [ "PENTAMIDINE ISETHIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205237", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205031", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205006", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204974", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204921", "application_type": "ANDA", "sponsor_name": "MSN LABS PVT LTD", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204857", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204787", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "LACOSAMIDE" ], "active_ingredients": [ "LACOSAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213581", "application_type": "NDA", "sponsor_name": "BAUSCH AND LOMB INC", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215932", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "GUAIFENESIN" ], "active_ingredients": [ "GUAIFENESIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213830", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212727", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "DOXAZOSIN MESYLATE" ], "active_ingredients": [ "DOXAZOSIN MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211884", "application_type": "ANDA", "sponsor_name": "VISTAPHARM LLC", "brand_names": [ "SUCRALFATE" ], "active_ingredients": [ "SUCRALFATE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211699", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "BREYNA" ], "active_ingredients": [ "BUDESONIDE", "FORMOTEROL FUMARATE DIHYDRATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2022-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215483", "application_type": "ANDA", "sponsor_name": "JUBILANT CADISTA", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206497", "application_type": "ANDA", "sponsor_name": "MYLAN TECH VIATRIS", "brand_names": [ "METHYLPHENIDATE" ], "active_ingredients": [ "METHYLPHENIDATE" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-03-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212304", "application_type": "NDA", "sponsor_name": "CORIUM", "brand_names": [ "ADLARITY" ], "active_ingredients": [ "DONEPEZIL HYDROCHLORIDE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-03-11", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215209", "application_type": "ANDA", "sponsor_name": "AMICI PHARMA", "brand_names": [ "DIGOXIN" ], "active_ingredients": [ "DIGOXIN" ], "dosage_forms": [ "ELIXIR" ], "routes": [ "ORAL" ], "approval_date": "2022-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212432", "application_type": "ANDA", "sponsor_name": "PIRAMAL", "brand_names": [ "CISATRACURIUM BESYLATE" ], "active_ingredients": [ "CISATRACURIUM BESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215223", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "COLESTIPOL HYDROCHLORIDE" ], "active_ingredients": [ "COLESTIPOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214346", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "NYSTATIN" ], "active_ingredients": [ "NYSTATIN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211790", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209173", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212988", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210153", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2022-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214443", "application_type": "ANDA", "sponsor_name": "HARMAN FINOCHEM", "brand_names": [ "ALLOPURINOL" ], "active_ingredients": [ "ALLOPURINOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-03-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215375", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214186", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NYSTATIN AND TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "NYSTATIN", "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204934", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NIACIN" ], "active_ingredients": [ "NIACIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-03", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214736", "application_type": "ANDA", "sponsor_name": "RITEDOSE CORP", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212169", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "EFINACONAZOLE" ], "active_ingredients": [ "EFINACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-03-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212472", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE" ], "active_ingredients": [ "DOXYLAMINE SUCCINATE", "PYRIDOXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216018", "application_type": "NDA", "sponsor_name": "SPIL", "brand_names": [ "ASPRUZYO SPRINKLE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "GRANULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-28", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215457", "application_type": "NDA", "sponsor_name": "KALEO INC", "brand_names": [ "NALOXONE HYDROCHLORIDE (AUTOINJECTOR)" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2022-02-28", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA208712", "application_type": "NDA", "sponsor_name": "SOBI", "brand_names": [ "VONJO" ], "active_ingredients": [ "PACRITINIB CITRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215456", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "THIOTHIXENE" ], "active_ingredients": [ "THIOTHIXENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214949", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208485", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "CYTARABINE" ], "active_ingredients": [ "CYTARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-02-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA217082", "application_type": "NDA", "sponsor_name": "CONTINENTAL CARBONIC PRODUCTS, INC.", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2022-02-25", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "NDA022388", "application_type": "NDA", "sponsor_name": "JOHNSON JOHNSON VISN", "brand_names": [ "ACUVUE THERAVISION WITH KETOTIFEN" ], "active_ingredients": [ "KETOTIFEN FUMARATE" ], "dosage_forms": [ "DRUG-ELUTING CONTACT LENS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-02-25", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "BLA761082", "application_type": "BLA", "sponsor_name": "KASHIV BIOSCIENCES LLC", "brand_names": [ "RELEUKO" ], "active_ingredients": [ "FILGRASTIM-AYOW" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS", "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-02-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA216146", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214643", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "DIVALPROEX SODIUM" ], "active_ingredients": [ "DIVALPROEX SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214439", "application_type": "NDA", "sponsor_name": "CMP DEV LLC", "brand_names": [ "NORLIQVA" ], "active_ingredients": [ "AMLODIPINE BESYLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-24", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214467", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212878", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212875", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216211", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "TRIAMTERENE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "HYDROCHLOROTHIAZIDE", "TRIAMTERENE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215620", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215026", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212025", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "APOMORPHINE HYDROCHLORIDE" ], "active_ingredients": [ "APOMORPHINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2022-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214629", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214993", "application_type": "NDA", "sponsor_name": "THERAGNOSTICS", "brand_names": [ "NEPHROSCAN" ], "active_ingredients": [ "TECHNETIUM TC-99M SUCCIMER" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-02-18", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215270", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "METHYLTESTOSTERONE" ], "active_ingredients": [ "METHYLTESTOSTERONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215186", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "BETAMETHASONE DIPROPIONATE" ], "active_ingredients": [ "BETAMETHASONE DIPROPIONATE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214623", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "CARDIOPLEGIC IN PLASTIC CONTAINER" ], "active_ingredients": [ "CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "PERFUSION, CARDIAC" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212604", "application_type": "ANDA", "sponsor_name": "ANDA REPOSITORY", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211354", "application_type": "ANDA", "sponsor_name": "ONESOURCE", "brand_names": [ "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211013", "application_type": "ANDA", "sponsor_name": "INVENTIA", "brand_names": [ "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)" ], "active_ingredients": [ "NITROFURANTOIN", "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216196", "application_type": "NDA", "sponsor_name": "AGIOS PHARMS INC", "brand_names": [ "PYRUKYND", "AQVESME" ], "active_ingredients": [ "MITAPIVAT SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA211240", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210169", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA200791", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "MECLIZINE HYDROCHLORIDE" ], "active_ingredients": [ "MECLIZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-17", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA200432", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "MECLIZINE HYDROCHLORIDE" ], "active_ingredients": [ "MECLIZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-17", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA215781", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "TROSPIUM CHLORIDE" ], "active_ingredients": [ "TROSPIUM CHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213059", "application_type": "ANDA", "sponsor_name": "KNACK", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-02-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206119", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215290", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "ERYTHROMYCIN LACTOBIONATE" ], "active_ingredients": [ "ERYTHROMYCIN LACTOBIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-02-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212715", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "TOBRAMYCIN AND DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE", "TOBRAMYCIN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215732", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "ESOMEPRAZOLE SODIUM" ], "active_ingredients": [ "ESOMEPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214722", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214682", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2022-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212845", "application_type": "ANDA", "sponsor_name": "SOLARIS PHARMA CORP", "brand_names": [ "CLINDAMYCIN PHOSPHATE AND TRETINOIN" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE", "TRETINOIN" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208303", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "ROFLUMILAST" ], "active_ingredients": [ "ROFLUMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215710", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211320", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214982", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DIGOXIN" ], "active_ingredients": [ "DIGOXIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214641", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214330", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "SULFAMETHOXAZOLE AND TRIMETHOPRIM" ], "active_ingredients": [ "SULFAMETHOXAZOLE", "TRIMETHOPRIM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212955", "application_type": "ANDA", "sponsor_name": "KNOA PHARMA", "brand_names": [ "NALMEFENE HYDROCHLORIDE" ], "active_ingredients": [ "NALMEFENE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206994", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216003", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215584", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS NJ", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215537", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213068", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2022-02-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203347", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "MARAVIROC" ], "active_ingredients": [ "MARAVIROC" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-07", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215602", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "FLEQSUVY" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-02-04", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761164", "application_type": "BLA", "sponsor_name": "RECORDATI RARE DISEASES, INC.", "brand_names": [ "ENJAYMO" ], "active_ingredients": [ "SUTIMLIMAB-JOME" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-02-04", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214476", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213847", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "DAPSONE" ], "active_ingredients": [ "DAPSONE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-02-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214124", "application_type": "ANDA", "sponsor_name": "J MOLNER", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2022-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213693", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213444", "application_type": "ANDA", "sponsor_name": "NOVAST LABS", "brand_names": [ "PRAMIPEXOLE DIHYDROCHLORIDE" ], "active_ingredients": [ "PRAMIPEXOLE DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211549", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "AZACITIDINE" ], "active_ingredients": [ "AZACITIDINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2022-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209325", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "MIGLUSTAT" ], "active_ingredients": [ "MIGLUSTAT" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215568", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "BUPROPION HYDROCHLORIDE" ], "active_ingredients": [ "BUPROPION HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212278", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "ATAZANAVIR SULFATE" ], "active_ingredients": [ "ATAZANAVIR SULFATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211925", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE", "CHLORDIAZEPOXIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211695", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "ACETAMINOPHEN, ASPIRIN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "ASPIRIN", "CAFFEINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205894", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "CYCLOSPORINE" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214407", "application_type": "ANDA", "sponsor_name": "L PERRIGO CO", "brand_names": [ "GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE" ], "active_ingredients": [ "GUAIFENESIN", "PSEUDOEPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215428", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "CITALOPRAM HYDROBROMIDE" ], "active_ingredients": [ "CITALOPRAM HYDROBROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-31", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form" }, { "application_number": "ANDA210876", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210459", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CLARITHROMYCIN" ], "active_ingredients": [ "CLARITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA078479", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-01-31", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761235", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "VABYSMO" ], "active_ingredients": [ "FARICIMAB-SVOA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVITREAL" ], "approval_date": "2022-01-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215822", "application_type": "ANDA", "sponsor_name": "VKT PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210508", "application_type": "ANDA", "sponsor_name": "ETON", "brand_names": [ "BETAINE" ], "active_ingredients": [ "BETAINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209040", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "TAFLUPROST" ], "active_ingredients": [ "TAFLUPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215794", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215660", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215337", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214827", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213467", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212803", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211353", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "SOFOSBUVIR" ], "active_ingredients": [ "SOFOSBUVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090977", "application_type": "ANDA", "sponsor_name": "BARR", "brand_names": [ "LANTHANUM CARBONATE" ], "active_ingredients": [ "LANTHANUM CARBONATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-27", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215995", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215342", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215138", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE", "CODEINE PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214076", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212363", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ALLOPURINOL SODIUM" ], "active_ingredients": [ "ALLOPURINOL SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211881", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210275", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "POMALIDOMIDE" ], "active_ingredients": [ "POMALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213645", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "DAPTOMYCIN IN 0.9% SODIUM CHLORIDE", "DAPZURA RT" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "SOLUTION", "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761228", "application_type": "BLA", "sponsor_name": "IMMUNOCORE LTD", "brand_names": [ "KIMMTRAK" ], "active_ingredients": [ "TEBENTAFUSP-TEBN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215936", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215885", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213212", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "CARBIDOPA, LEVODOPA AND ENTACAPONE" ], "active_ingredients": [ "CARBIDOPA", "ENTACAPONE", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212759", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212730", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211272", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209068", "application_type": "ANDA", "sponsor_name": "SUNNY", "brand_names": [ "CHLORTHALIDONE" ], "active_ingredients": [ "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213717", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DOXERCALCIFEROL" ], "active_ingredients": [ "DOXERCALCIFEROL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206868", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "LANTHANUM CARBONATE" ], "active_ingredients": [ "LANTHANUM CARBONATE" ], "dosage_forms": [ "TABLET, CHEWABLE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203053", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EFAVIRENZ", "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-24", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214877", "application_type": "ANDA", "sponsor_name": "AIPING PHARM INC", "brand_names": [ "CHOLESTYRAMINE" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2022-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214297", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "METHYLPREDNISOLONE ACETATE" ], "active_ingredients": [ "METHYLPREDNISOLONE ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213456", "application_type": "ANDA", "sponsor_name": "UNITED RES LABS", "brand_names": [ "COLESEVELAM HYDROCHLORIDE" ], "active_ingredients": [ "COLESEVELAM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212731", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215707", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215038", "application_type": "ANDA", "sponsor_name": "FDC LTD", "brand_names": [ "OFLOXACIN" ], "active_ingredients": [ "OFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2022-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214035", "application_type": "ANDA", "sponsor_name": "VKT PHARMA", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213543", "application_type": "ANDA", "sponsor_name": "LONG GROVE PHARMS", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215607", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2022-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209920", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214581", "application_type": "NDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "SOVUNA" ], "active_ingredients": [ "HYDROXYCHLOROQUINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA213871", "application_type": "NDA", "sponsor_name": "PFIZER", "brand_names": [ "CIBINQO" ], "active_ingredients": [ "ABROCITINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215940", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "ADAPALENE" ], "active_ingredients": [ "ADAPALENE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2022-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211746", "application_type": "NDA", "sponsor_name": "GLENMARK SPECLT", "brand_names": [ "RYALTRIS" ], "active_ingredients": [ "MOMETASONE FUROATE", "OLOPATADINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-01-13", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA214656", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211894", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207270", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215939", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208769", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS UT INC", "brand_names": [ "SCOPOLAMINE" ], "active_ingredients": [ "SCOPOLAMINE" ], "dosage_forms": [ "SYSTEM" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2022-01-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214985", "application_type": "NDA", "sponsor_name": "IDORSIA", "brand_names": [ "QUVIVIQ" ], "active_ingredients": [ "DARIDOREXANT HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-07", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215630", "application_type": "ANDA", "sponsor_name": "VKT PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215444", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215947", "application_type": "ANDA", "sponsor_name": "NOVUGEN", "brand_names": [ "ABIRATERONE ACETATE" ], "active_ingredients": [ "ABIRATERONE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215634", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "PROGESTERONE" ], "active_ingredients": [ "PROGESTERONE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2022-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213594", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2022-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214423", "application_type": "ANDA", "sponsor_name": "PHARMADAX", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214105", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DIHYDROERGOTAMINE MESYLATE" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212601", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ENTACAPONE" ], "active_ingredients": [ "ENTACAPONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210597", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209029", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "SILODOSIN" ], "active_ingredients": [ "SILODOSIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207477", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "SOLIFENACIN SUCCINATE" ], "active_ingredients": [ "SOLIFENACIN SUCCINATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2022-01-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213230", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "SILODOSIN" ], "active_ingredients": [ "SILODOSIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213075", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212569", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "PIRFENIDONE" ], "active_ingredients": [ "PIRFENIDONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2022-01-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214133", "application_type": "NDA", "sponsor_name": "STRONGBRIDGE", "brand_names": [ "RECORLEV" ], "active_ingredients": [ "LEVOKETOCONAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-30", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA214928", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "HYDROCODONE BITARTRATE AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "HYDROCODONE BITARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214051", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "IVABRADINE HYDROCHLORIDE" ], "active_ingredients": [ "IVABRADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201295", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "HYDROCODONE BITARTRATE AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "HYDROCODONE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-12-30", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA207949", "application_type": "NDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "CABAZITAXEL" ], "active_ingredients": [ "CABAZITAXEL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-12-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215771", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214531", "application_type": "ANDA", "sponsor_name": "RITEDOSE CORP", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-12-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761180", "application_type": "BLA", "sponsor_name": "LEO PHARMA AS", "brand_names": [ "ADBRY" ], "active_ingredients": [ "TRALOKINUMAB" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-27", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215016", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "SIROLIMUS" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212474", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214962", "application_type": "NDA", "sponsor_name": "CYCLE", "brand_names": [ "TASCENSO ODT" ], "active_ingredients": [ "FINGOLIMOD LAURYL SULFATE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2021-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214608", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "PRAZOSIN HYDROCHLORIDE" ], "active_ingredients": [ "PRAZOSIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201513", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-12-23", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA214012", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "LEQVIO" ], "active_ingredients": [ "INCLISIRAN SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-12-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213541", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EFAVIRENZ", "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208120", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "VALPROATE SODIUM" ], "active_ingredients": [ "VALPROATE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210285", "application_type": "ANDA", "sponsor_name": "SAWAI USA", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205431", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "CYPROHEPTADINE HYDROCHLORIDE" ], "active_ingredients": [ "CYPROHEPTADINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2021-12-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215859", "application_type": "NDA", "sponsor_name": "JANSSEN PHARMS", "brand_names": [ "XARELTO" ], "active_ingredients": [ "RIVAROXABAN" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-12-20", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215499", "application_type": "NDA", "sponsor_name": "VIIV HLTHCARE", "brand_names": [ "APRETUDE" ], "active_ingredients": [ "CABOTEGRAVIR" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-12-20", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA216157", "application_type": "NDA", "sponsor_name": "GLOBAL BLOOD THERAPS", "brand_names": [ "OXBRYTA" ], "active_ingredients": [ "VOXELOTOR" ], "dosage_forms": [ "TABLET, FOR SUSPENSION", "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-17", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215395", "application_type": "NDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "LANREOTIDE ACETATE" ], "active_ingredients": [ "LANREOTIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA214032", "application_type": "NDA", "sponsor_name": "TELIX", "brand_names": [ "ILLUCCIX" ], "active_ingredients": [ "GALLIUM GA-68 GOZETOTIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form and Type 4 - New Combination" }, { "application_number": "BLA761224", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "TEZSPIRE" ], "active_ingredients": [ "TEZEPELUMAB-EKKO" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-12-17", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "BLA761216", "application_type": "BLA", "sponsor_name": "EMERGE BIOSCIENCE PTE LTD", "brand_names": [ "YUSIMRY" ], "active_ingredients": [ "ADALIMUMAB-AQVH" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "BLA761215", "application_type": "BLA", "sponsor_name": "ELI LILLY CO", "brand_names": [ "REZVOGLAR" ], "active_ingredients": [ "INSULIN GLARGINE-AGLR" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "BLA761195", "application_type": "BLA", "sponsor_name": "ARGENX BV", "brand_names": [ "VYVGART" ], "active_ingredients": [ "EFGARTIGIMOD ALFA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215041", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "RIFABUTIN" ], "active_ingredients": [ "RIFABUTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212917", "application_type": "ANDA", "sponsor_name": "REYOUNG", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211053", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208717", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "NEBIVOLOL HYDROCHLORIDE" ], "active_ingredients": [ "NEBIVOLOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215019", "application_type": "NDA", "sponsor_name": "EDENBRIDGE PHARMS", "brand_names": [ "DARTISLA ODT" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2021-12-16", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215935", "application_type": "NDA", "sponsor_name": "CALLIDITAS", "brand_names": [ "TARPEYO" ], "active_ingredients": [ "BUDESONIDE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-15", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA211538", "application_type": "ANDA", "sponsor_name": "EAGLE PHARMS", "brand_names": [ "VASOPRESSIN" ], "active_ingredients": [ "VASOPRESSIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-12-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212514", "application_type": "ANDA", "sponsor_name": "SPIL", "brand_names": [ "AMPHOTERICIN B" ], "active_ingredients": [ "AMPHOTERICIN B" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213948", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE" ], "active_ingredients": [ "FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INHALATION" ], "approval_date": "2021-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213356", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212592", "application_type": "ANDA", "sponsor_name": "J MOLNER", "brand_names": [ "TIMOLOL MALEATE" ], "active_ingredients": [ "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-12-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215423", "application_type": "NDA", "sponsor_name": "BLUE WATER BIOTECH", "brand_names": [ "ENTADFI" ], "active_ingredients": [ "FINASTERIDE", "TADALAFIL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-09", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA207577", "application_type": "ANDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "VERARING" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "ETONOGESTREL" ], "dosage_forms": [ "RING" ], "routes": [ "VAGINAL" ], "approval_date": "2021-12-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215523", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "DEXMETHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMETHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213949", "application_type": "ANDA", "sponsor_name": "YILING", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211831", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "THIOTEPA" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215650", "application_type": "NDA", "sponsor_name": "ORGANON LLC", "brand_names": [ "XACIATO" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2021-12-07", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212924", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "FEBUXOSTAT" ], "active_ingredients": [ "FEBUXOSTAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201275", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-12-06", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA213320", "application_type": "ANDA", "sponsor_name": "HARMAN FINOCHEM", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215359", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "ARSENIC TRIOXIDE" ], "active_ingredients": [ "ARSENIC TRIOXIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205742", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "GLYCEROL PHENYLBUTYRATE" ], "active_ingredients": [ "GLYCEROL PHENYLBUTYRATE" ], "dosage_forms": [ "LIQUID" ], "routes": [ "ORAL" ], "approval_date": "2021-12-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204364", "application_type": "ANDA", "sponsor_name": "STEVENS J", "brand_names": [ "CINACALCET HYDROCHLORIDE" ], "active_ingredients": [ "CINACALCET HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-02", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213561", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL" ], "approval_date": "2021-12-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203025", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "ARIPIPRAZOLE" ], "active_ingredients": [ "ARIPIPRAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-12-01", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213803", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209450", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "LUBIPROSTONE" ], "active_ingredients": [ "LUBIPROSTONE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214907", "application_type": "NDA", "sponsor_name": "ON TARGET LABS", "brand_names": [ "CYTALUX" ], "active_ingredients": [ "PAFOLACIANINE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214630", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212630", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215624", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215215", "application_type": "ANDA", "sponsor_name": "HANGZHOU ZHONGMEI", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214403", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214138", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215596", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "LIVTENCITY" ], "active_ingredients": [ "MARIBAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214864", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "BETAINE" ], "active_ingredients": [ "BETAINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213328", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "TEMOZOLOMIDE" ], "active_ingredients": [ "TEMOZOLOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211290", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "ISOSORBIDE DINITRATE" ], "active_ingredients": [ "ISOSORBIDE DINITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203180", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "DASATINIB" ], "active_ingredients": [ "DASATINIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-23", "review_priority": "", "submission_class": "" }, { "application_number": "NDA215422", "application_type": "NDA", "sponsor_name": "STRIDES PHARMA INTL", "brand_names": [ "LYVISPAH" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA213312", "application_type": "NDA", "sponsor_name": "AADI", "brand_names": [ "FYARRO" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-22", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215307", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "DIGOXIN" ], "active_ingredients": [ "DIGOXIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215078", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214428", "application_type": "ANDA", "sponsor_name": "BEIJING", "brand_names": [ "NIACIN" ], "active_ingredients": [ "NIACIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214347", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208263", "application_type": "ANDA", "sponsor_name": "NESHER PHARMS", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214938", "application_type": "NDA", "sponsor_name": "BIOMARIN PHARM", "brand_names": [ "VOXZOGO" ], "active_ingredients": [ "VOSORITIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-11-19", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214486", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214180", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212189", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215821", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "VANCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "VANCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201942", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "RASAGILINE MESYLATE" ], "active_ingredients": [ "RASAGILINE MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-18", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA215185", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215047", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215037", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "NELARABINE" ], "active_ingredients": [ "NELARABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212312", "application_type": "ANDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211526", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-11-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215671", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215522", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214816", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "TIAGABINE HYDROCHLORIDE" ], "active_ingredients": [ "TIAGABINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213053", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "MUPIROCIN" ], "active_ingredients": [ "MUPIROCIN CALCIUM" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-11-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215458", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "OMEGA-3-ACID ETHYL ESTERS" ], "active_ingredients": [ "OMEGA-3-ACID ETHYL ESTERS" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212202", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-11-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214869", "application_type": "NDA", "sponsor_name": "AVION PHARMS", "brand_names": [ "DHIVY" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-12", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761166", "application_type": "BLA", "sponsor_name": "PHARMAESSENTIA CORP", "brand_names": [ "BESREMI" ], "active_ingredients": [ "ROPEGINTERFERON ALFA-2B-NJFT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-11-12", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212152", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206916", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "PALONOSETRON HYDROCHLORIDE" ], "active_ingredients": [ "PALONOSETRON HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212533", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "LEVOCARNITINE" ], "active_ingredients": [ "LEVOCARNITINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209358", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208195", "application_type": "ANDA", "sponsor_name": "YUNG SHIN PHARM", "brand_names": [ "ENTECAVIR" ], "active_ingredients": [ "ENTECAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207939", "application_type": "ANDA", "sponsor_name": "HEC PHARM CO LTD", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214213", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212984", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TESTOSTERONE" ], "active_ingredients": [ "TESTOSTERONE" ], "dosage_forms": [ "GEL", "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211428", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER" ], "active_ingredients": [ "CALCIUM CHLORIDE", "DEXTROSE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA200293", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-11-09", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA215766", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215082", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "LINCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "LINCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214339", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214336", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "LIDOCAINE HYDROCHLORIDE" ], "active_ingredients": [ "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209642", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "MAGNESIUM SULFATE IN PLASTIC CONTAINER" ], "active_ingredients": [ "MAGNESIUM SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206517", "application_type": "ANDA", "sponsor_name": "HOSPIRA", "brand_names": [ "AZTREONAM" ], "active_ingredients": [ "AZTREONAM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-11-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214679", "application_type": "NDA", "sponsor_name": "AZURITY", "brand_names": [ "EPRONTIA" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-05", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA206734", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "DEXMETHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMETHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA210526", "application_type": "NDA", "sponsor_name": "TRIS PHARMA INC", "brand_names": [ "DYANAVEL XR 20", "DYANAVEL XR 10", "DYANAVEL XR 15", "DYANAVEL XR 5" ], "active_ingredients": [ "AMPHETAMINE", "AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215767", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215562", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE" ], "active_ingredients": [ "BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215556", "application_type": "ANDA", "sponsor_name": "VKT PHARMA", "brand_names": [ "TADALAFIL" ], "active_ingredients": [ "TADALAFIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211967", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211047", "application_type": "ANDA", "sponsor_name": "ENCUBE ETHICALS", "brand_names": [ "HYDROCORTISONE VALERATE" ], "active_ingredients": [ "HYDROCORTISONE VALERATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-11-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA216030", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214289", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213542", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "GATIFLOXACIN" ], "active_ingredients": [ "GATIFLOXACIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213130", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "ISOSULFAN BLUE" ], "active_ingredients": [ "ISOSULFAN BLUE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-11-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214871", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214102", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213797", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "LEVOLEUCOVORIN CALCIUM" ], "active_ingredients": [ "LEVOLEUCOVORIN CALCIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211476", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211248", "application_type": "ANDA", "sponsor_name": "YILING", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-11-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215265", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-11-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215358", "application_type": "NDA", "sponsor_name": "NOVARTIS", "brand_names": [ "SCEMBLIX" ], "active_ingredients": [ "ASCIMINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215563", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "BISOPROLOL FUMARATE" ], "active_ingredients": [ "BISOPROLOL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211278", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215252", "application_type": "NDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA214028", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "VUITY" ], "active_ingredients": [ "PILOCARPINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-10-28", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA204038", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-27", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA215659", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215560", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "ATENOLOL AND CHLORTHALIDONE" ], "active_ingredients": [ "ATENOLOL", "CHLORTHALIDONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215555", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214272", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "ATOVAQUONE" ], "active_ingredients": [ "ATOVAQUONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207842", "application_type": "ANDA", "sponsor_name": "WESTMINSTER PHARMS", "brand_names": [ "EPLERENONE" ], "active_ingredients": [ "EPLERENONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211950", "application_type": "NDA", "sponsor_name": "BAUSCH AND LOMB INC", "brand_names": [ "XIPERE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-22", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "BLA761197", "application_type": "BLA", "sponsor_name": "GENENTECH INC", "brand_names": [ "SUSVIMO" ], "active_ingredients": [ "RANIBIZUMAB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-22", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA215579", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214554", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "FOSFOMYCIN TROMETHAMINE" ], "active_ingredients": [ "FOSFOMYCIN TROMETHAMINE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-10-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215687", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "MITOMYCIN" ], "active_ingredients": [ "MITOMYCIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215141", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212692", "application_type": "ANDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "POTASSIUM ACETATE" ], "active_ingredients": [ "POTASSIUM ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211789", "application_type": "ANDA", "sponsor_name": "POINTVIEW HLDINGS", "brand_names": [ "CARISOPRODOL" ], "active_ingredients": [ "CARISOPRODOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214514", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213875", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211856", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CHOLESTYRAMINE" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2021-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211799", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CHOLESTYRAMINE LIGHT" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2021-10-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216614", "application_type": "NDA", "sponsor_name": "MIDDLESEX GASES TECHNOLOGIES, INC.", "brand_names": [ "CARBON DIOXIDE, USP" ], "active_ingredients": [ "CARBON DIOXIDE" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2021-10-18", "review_priority": "UNKNOWN", "submission_class": "" }, { "application_number": "ANDA205775", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205230", "application_type": "ANDA", "sponsor_name": "LGM PHARMA", "brand_names": [ "BUTALBITAL, ASPIRIN AND CAFFEINE" ], "active_ingredients": [ "ASPIRIN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213978", "application_type": "NDA", "sponsor_name": "OYSTER POINT PHARMA", "brand_names": [ "TYRVAYA" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2021-10-15", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA213426", "application_type": "NDA", "sponsor_name": "KOWA PHARMS", "brand_names": [ "SEGLENTIS" ], "active_ingredients": [ "CELECOXIB", "TRAMADOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-15", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA212854", "application_type": "NDA", "sponsor_name": "ZMI PHARMA", "brand_names": [ "ZIMHI" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, SUBCUTANEOUS" ], "approval_date": "2021-10-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215689", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214011", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ARSENIC TRIOXIDE" ], "active_ingredients": [ "ARSENIC TRIOXIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215106", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213648", "application_type": "ANDA", "sponsor_name": "AMVIKA", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "VAGINAL" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212750", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "DOFETILIDE" ], "active_ingredients": [ "DOFETILIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209442", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "BENZTROPINE MESYLATE" ], "active_ingredients": [ "BENZTROPINE MESYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209348", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206036", "application_type": "ANDA", "sponsor_name": "BEIJING TIDE PHARM", "brand_names": [ "COLESEVELAM HYDROCHLORIDE" ], "active_ingredients": [ "COLESEVELAM HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213729", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "CARGLUMIC ACID" ], "active_ingredients": [ "CARGLUMIC ACID" ], "dosage_forms": [ "TABLET, FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-10-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212591", "application_type": "ANDA", "sponsor_name": "NIVAGEN", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209708", "application_type": "ANDA", "sponsor_name": "WOODWARD", "brand_names": [ "MIVACURIUM CHLORIDE" ], "active_ingredients": [ "MIVACURIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207228", "application_type": "ANDA", "sponsor_name": "AYANA PHARMA LTD", "brand_names": [ "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)" ], "active_ingredients": [ "DOXORUBICIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE, LIPOSOMAL" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206408", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "PROPOFOL" ], "active_ingredients": [ "PROPOFOL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206254", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "ROMIDEPSIN" ], "active_ingredients": [ "ROMIDEPSIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215585", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "DICLOFENAC POTASSIUM" ], "active_ingredients": [ "DICLOFENAC POTASSIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214363", "application_type": "ANDA", "sponsor_name": "NAVINTA LLC", "brand_names": [ "PENICILLAMINE" ], "active_ingredients": [ "PENICILLAMINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214487", "application_type": "NDA", "sponsor_name": "CHEMOCENTRYX", "brand_names": [ "TAVNEOS" ], "active_ingredients": [ "AVACOPAN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-07", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215059", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ARSENIC TRIOXIDE" ], "active_ingredients": [ "ARSENIC TRIOXIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214845", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "FLUOROURACIL" ], "active_ingredients": [ "FLUOROURACIL" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-10-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201806", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE", "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-07", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA215001", "application_type": "ANDA", "sponsor_name": "EDENBRIDGE PHARMS", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214091", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201618", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "VALSARTAN" ], "active_ingredients": [ "VALSARTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-05", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA215133", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-04", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213584", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "OXYMETAZOLINE HYDROCHLORIDE" ], "active_ingredients": [ "OXYMETAZOLINE HYDROCHLORIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-10-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213199", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "FOSAPREPITANT DIMEGLUMINE" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215208", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214957", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214089", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211263", "application_type": "ANDA", "sponsor_name": "AREVA PHARMS", "brand_names": [ "CASPOFUNGIN ACETATE" ], "active_ingredients": [ "CASPOFUNGIN ACETATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210652", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-10-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212948", "application_type": "ANDA", "sponsor_name": "ANBISON LAB", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212469", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "ZOLMITRIPTAN" ], "active_ingredients": [ "ZOLMITRIPTAN" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2021-09-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214662", "application_type": "NDA", "sponsor_name": "MIRUM", "brand_names": [ "LIVMARLI" ], "active_ingredients": [ "MARALIXIBAT CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-09-29", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214959", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213899", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213247", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215206", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "QULIPTA" ], "active_ingredients": [ "ATOGEPANT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213626", "application_type": "ANDA", "sponsor_name": "VIWIT PHARM", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209583", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "TERIFLUNOMIDE" ], "active_ingredients": [ "TERIFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215109", "application_type": "ANDA", "sponsor_name": "DEXCEL", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210272", "application_type": "ANDA", "sponsor_name": "DIFGEN PHARMS", "brand_names": [ "BUPRENORPHINE" ], "active_ingredients": [ "BUPRENORPHINE" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209158", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "BRIMONIDINE TARTRATE" ], "active_ingredients": [ "BRIMONIDINE TARTRATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208315", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214107", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215309", "application_type": "NDA", "sponsor_name": "INCYTE CORP", "brand_names": [ "OPZELURA" ], "active_ingredients": [ "RUXOLITINIB PHOSPHATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-09-21", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "ANDA212333", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211761", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208075", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "CEFTAROLINE FOSAMIL" ], "active_ingredients": [ "CEFTAROLINE FOSAMIL" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207481", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "METHYLPREDNISOLONE" ], "active_ingredients": [ "METHYLPREDNISOLONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761208", "application_type": "BLA", "sponsor_name": "SEAGEN", "brand_names": [ "TIVDAK" ], "active_ingredients": [ "TISOTUMAB VEDOTIN-TFTV" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214569", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212232", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "FENOFIBRATE (MICRONIZED)" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210778", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-09-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761202", "application_type": "BLA", "sponsor_name": "SAMSUNG BIOEPIS CO LTD", "brand_names": [ "BYOOVIZ" ], "active_ingredients": [ "RANIBIZUMAB-NUNA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214331", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212589", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "QUINIDINE GLUCONATE" ], "active_ingredients": [ "QUINIDINE GLUCONATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215310", "application_type": "NDA", "sponsor_name": "TAKEDA PHARMS USA", "brand_names": [ "EXKIVITY" ], "active_ingredients": [ "MOBOCERTINIB SUCCINATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-15", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214699", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204287", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EFAVIRENZ", "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-13", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213484", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE", "SIMETHICONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214723", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "HALCINONIDE" ], "active_ingredients": [ "HALCINONIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212463", "application_type": "ANDA", "sponsor_name": "AIZANT", "brand_names": [ "ELIGLUSTAT TARTRATE" ], "active_ingredients": [ "ELIGLUSTAT TARTRATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208475", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE" ], "active_ingredients": [ "EPINEPHRINE", "LIDOCAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214533", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "LABETALOL HYDROCHLORIDE" ], "active_ingredients": [ "LABETALOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213852", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "AMPHETAMINE SULFATE" ], "active_ingredients": [ "AMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213081", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "EPTIFIBATIDE" ], "active_ingredients": [ "EPTIFIBATIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215003", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214794", "application_type": "ANDA", "sponsor_name": "PIRAMAL CRITICAL", "brand_names": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "active_ingredients": [ "DEXMEDETOMIDINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214756", "application_type": "ANDA", "sponsor_name": "COHANCE LIFESCIENCES", "brand_names": [ "CHLOROQUINE PHOSPHATE" ], "active_ingredients": [ "CHLOROQUINE PHOSPHATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212646", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "METRONIDAZOLE" ], "active_ingredients": [ "METRONIDAZOLE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209836", "application_type": "ANDA", "sponsor_name": "TWI PHARMS", "brand_names": [ "TESTOSTERONE" ], "active_ingredients": [ "TESTOSTERONE" ], "dosage_forms": [ "SOLUTION, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-09-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213436", "application_type": "NDA", "sponsor_name": "IMPEL PHARMS", "brand_names": [ "TRUDHESA" ], "active_ingredients": [ "DIHYDROERGOTAMINE MESYLATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2021-09-02", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214969", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213171", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-09-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213076", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "MUPIROCIN" ], "active_ingredients": [ "MUPIROCIN CALCIUM" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208335", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "LINAGLIPTIN" ], "active_ingredients": [ "LINAGLIPTIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212929", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "TRIENTINE HYDROCHLORIDE" ], "active_ingredients": [ "TRIENTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212858", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209524", "application_type": "ANDA", "sponsor_name": "HANGZHOU ZHONGMEI", "brand_names": [ "PANTOPRAZOLE SODIUM" ], "active_ingredients": [ "PANTOPRAZOLE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208336", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "LINAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "LINAGLIPTIN", "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214826", "application_type": "NDA", "sponsor_name": "ALMATICA", "brand_names": [ "LOREEV XR" ], "active_ingredients": [ "LORAZEPAM" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-27", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA212645", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213895", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "VANCOMYCIN" ], "active_ingredients": [ "VANCOMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, ORAL" ], "approval_date": "2021-08-26", "review_priority": "PRIORITY", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215414", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201448", "application_type": "ANDA", "sponsor_name": "SANKALP LIFECARE", "brand_names": [ "OXYCODONE AND ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN", "OXYCODONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-08-26", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "NDA210735", "application_type": "NDA", "sponsor_name": "EUGIA PHARMA SPECLTS", "brand_names": [ "CYCLOPHOSPHAMIDE" ], "active_ingredients": [ "CYCLOPHOSPHAMIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-08-25", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761177", "application_type": "BLA", "sponsor_name": "ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S", "brand_names": [ "SKYTROFA" ], "active_ingredients": [ "LONAPEGSOMATROPIN-TCGD" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-25", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215486", "application_type": "ANDA", "sponsor_name": "MARKSANS PHARMA", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213977", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "ONSURA" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORELGESTROMIN" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-08-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215316", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211304", "application_type": "ANDA", "sponsor_name": "AZURITY", "brand_names": [ "METARAMINOL BITARTRATE" ], "active_ingredients": [ "METARAMINOL BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208047", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214916", "application_type": "NDA", "sponsor_name": "VIFOR INTL", "brand_names": [ "KORSUVA" ], "active_ingredients": [ "DIFELIKEFALIN ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-08-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215409", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "PENICILLAMINE" ], "active_ingredients": [ "PENICILLAMINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215143", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2021-08-20", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA215184", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215046", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214178", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "AMANTADINE HYDROCHLORIDE" ], "active_ingredients": [ "AMANTADINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2021-08-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215101", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214264", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213293", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "PENICILLAMINE" ], "active_ingredients": [ "PENICILLAMINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211953", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "LABETALOL HYDROCHLORIDE" ], "active_ingredients": [ "LABETALOL HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204884", "application_type": "ANDA", "sponsor_name": "BAUSCH AND LOMB", "brand_names": [ "BRINZOLAMIDE" ], "active_ingredients": [ "BRINZOLAMIDE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-08-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761223", "application_type": "BLA", "sponsor_name": "GLAXOSMITHKLINE LLC", "brand_names": [ "JEMPERLI" ], "active_ingredients": [ "DOSTARLIMAB-GXLY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-17", "review_priority": "PRIORITY", "submission_class": "Type 9 - New indication submitted as distinct BLA, consolidated" }, { "application_number": "ANDA214751", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NYSTATIN AND TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "NYSTATIN", "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-08-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214328", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213914", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "SUNITINIB MALATE" ], "active_ingredients": [ "SUNITINIB MALATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215383", "application_type": "NDA", "sponsor_name": "MERCK SHARP DOHME", "brand_names": [ "WELIREG" ], "active_ingredients": [ "BELZUTIFAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-13", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215506", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS", "brand_names": [ "PYRIMETHAMINE" ], "active_ingredients": [ "PYRIMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214087", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "BUTALBITAL, ACETAMINOPHEN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "BUTALBITAL", "CAFFEINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213829", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "LEUPROLIDE ACETATE" ], "active_ingredients": [ "LEUPROLIDE ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213553", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212842", "application_type": "ANDA", "sponsor_name": "SOLARIS PHARMA CORP", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209945", "application_type": "ANDA", "sponsor_name": "ECI PHARMS LLC", "brand_names": [ "TRIENTINE HYDROCHLORIDE" ], "active_ingredients": [ "TRIENTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208993", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208954", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203976", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "COLCHICINE" ], "active_ingredients": [ "COLCHICINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-12", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213612", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213359", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213070", "application_type": "ANDA", "sponsor_name": "ONESOURCE", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209929", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "ASPIRIN AND DIPYRIDAMOLE" ], "active_ingredients": [ "ASPIRIN", "DIPYRIDAMOLE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201785", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "VARENICLINE TARTRATE" ], "active_ingredients": [ "VARENICLINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-11", "review_priority": "", "submission_class": "Not Applicable" }, { "application_number": "ANDA213566", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NYSTATIN" ], "active_ingredients": [ "NYSTATIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212408", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "ENALAPRIL MALEATE" ], "active_ingredients": [ "ENALAPRIL MALEATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-08-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214651", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "MEMANTINE HYDROCHLORIDE" ], "active_ingredients": [ "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211776", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "DIFLUPREDNATE" ], "active_ingredients": [ "DIFLUPREDNATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-08-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204438", "application_type": "ANDA", "sponsor_name": "PH HEALTH", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-08-09", "review_priority": "", "submission_class": "" }, { "application_number": "BLA761194", "application_type": "BLA", "sponsor_name": "GENZYME CORP", "brand_names": [ "NEXVIAZYME" ], "active_ingredients": [ "AVALGLUCOSIDASE ALFA-NGPT" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-06", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214654", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215654", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "active_ingredients": [ "DEXAMETHASONE SODIUM PHOSPHATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211822", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "CLOMIPRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "CLOMIPRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203158", "application_type": "ANDA", "sponsor_name": "ANDA REPOSITORY", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213394", "application_type": "ANDA", "sponsor_name": "UTOPIC PHARMS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213266", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NICOTINE POLACRILEX" ], "active_ingredients": [ "NICOTINE POLACRILEX" ], "dosage_forms": [ "TROCHE/LOZENGE" ], "routes": [ "ORAL" ], "approval_date": "2021-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211890", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "IBUPROFEN AND FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE", "IBUPROFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213460", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-08-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204397", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "TOLTERODINE TARTRATE" ], "active_ingredients": [ "TOLTERODINE TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-08-02", "review_priority": "", "submission_class": "" }, { "application_number": "NDA212125", "application_type": "NDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "MICAFUNGIN" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-30", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761123", "application_type": "BLA", "sponsor_name": "ASTRAZENECA AB", "brand_names": [ "SAPHNELO" ], "active_ingredients": [ "ANIFROLUMAB-FNIA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-30", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212348", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER", "POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER" ], "active_ingredients": [ "DEXTROSE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214275", "application_type": "NDA", "sponsor_name": "ACTELION", "brand_names": [ "UPTRAVI" ], "active_ingredients": [ "SELEXIPAG" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA215234", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215158", "application_type": "ANDA", "sponsor_name": "SENORES PHARMS", "brand_names": [ "CHLORZOXAZONE" ], "active_ingredients": [ "CHLORZOXAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214616", "application_type": "ANDA", "sponsor_name": "ASPIRO", "brand_names": [ "FOSAPREPITANT DIMEGLUMINE" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214525", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "MYCOPHENOLATE MOFETIL" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213390", "application_type": "ANDA", "sponsor_name": "PROPEL PHARMA", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-07-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761201", "application_type": "BLA", "sponsor_name": "MYLAN PHARMS INC", "brand_names": [ "SEMGLEE" ], "active_ingredients": [ "INSULIN GLARGINE-YFGN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-28", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA214329", "application_type": "ANDA", "sponsor_name": "PHARMAZONE", "brand_names": [ "URSODIOL" ], "active_ingredients": [ "URSODIOL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212626", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-07-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212482", "application_type": "ANDA", "sponsor_name": "PADAGIS US", "brand_names": [ "LIDOCAINE AND PRILOCAINE" ], "active_ingredients": [ "LIDOCAINE", "PRILOCAINE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211271", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "PYRIMETHAMINE" ], "active_ingredients": [ "PYRIMETHAMINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA216307", "application_type": "NDA", "sponsor_name": "GENERAL AIR SERVICE & SUPPLY COMPANY", "brand_names": [ "HELIUM, USP" ], "active_ingredients": [ "HELIUM" ], "dosage_forms": [ "GAS" ], "routes": [ "INHALATION" ], "approval_date": "2021-07-26", "review_priority": "UNKNOWN", "submission_class": "Medical Gas" }, { "application_number": "NDA214902", "application_type": "NDA", "sponsor_name": "MAYNE PHARMA", "brand_names": [ "TWYNEO" ], "active_ingredients": [ "BENZOYL PEROXIDE", "TRETINOIN" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-07-26", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA214507", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "HALOPERIDOL DECANOATE" ], "active_ingredients": [ "HALOPERIDOL DECANOATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212868", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211975", "application_type": "ANDA", "sponsor_name": "TORRENT", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209845", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "APIXABAN" ], "active_ingredients": [ "APIXABAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215498", "application_type": "NDA", "sponsor_name": "IPSEN", "brand_names": [ "BYLVAY" ], "active_ingredients": [ "ODEVIXIBAT" ], "dosage_forms": [ "CAPSULE", "CAPSULE, PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-07-20", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214292", "application_type": "ANDA", "sponsor_name": "AMNEAL PHARMS", "brand_names": [ "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204920", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "NAPROXEN AND ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM", "NAPROXEN" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-20", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213361", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "NIFEDIPINE" ], "active_ingredients": [ "NIFEDIPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214783", "application_type": "NDA", "sponsor_name": "KADMON PHARMS LLC", "brand_names": [ "REZUROCK" ], "active_ingredients": [ "BELUMOSUDIL MESYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214429", "application_type": "NDA", "sponsor_name": "SANOFI", "brand_names": [ "FEXINIDAZOLE" ], "active_ingredients": [ "FEXINIDAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-16", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214114", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205646", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "TOLVAPTAN" ], "active_ingredients": [ "TOLVAPTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214322", "application_type": "ANDA", "sponsor_name": "CHANGZHOU PHARM", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214242", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "MESALAMINE" ], "active_ingredients": [ "MESALAMINE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212991", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "TOBRAMYCIN AND DEXAMETHASONE" ], "active_ingredients": [ "DEXAMETHASONE", "TOBRAMYCIN" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212313", "application_type": "ANDA", "sponsor_name": "PRASCO", "brand_names": [ "ESTRADIOL" ], "active_ingredients": [ "ESTRADIOL" ], "dosage_forms": [ "CREAM" ], "routes": [ "VAGINAL" ], "approval_date": "2021-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204355", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "DICLOFENAC SODIUM AND MISOPROSTOL" ], "active_ingredients": [ "DICLOFENAC SODIUM", "MISOPROSTOL" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214659", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ATORVASTATIN CALCIUM" ], "active_ingredients": [ "ATORVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214099", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213998", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "SUMATRIPTAN SUCCINATE" ], "active_ingredients": [ "SUMATRIPTAN SUCCINATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-07-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214971", "application_type": "ANDA", "sponsor_name": "BE PHARMS", "brand_names": [ "SODIUM NITROPRUSSIDE" ], "active_ingredients": [ "SODIUM NITROPRUSSIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213890", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "PROMETHAZINE HYDROCHLORIDE" ], "active_ingredients": [ "PROMETHAZINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2021-07-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215341", "application_type": "NDA", "sponsor_name": "BAYER HLTHCARE", "brand_names": [ "KERENDIA" ], "active_ingredients": [ "FINERENONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-09", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA215083", "application_type": "ANDA", "sponsor_name": "METHODIST", "brand_names": [ "AMMONIA N 13" ], "active_ingredients": [ "AMMONIA N-13" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213363", "application_type": "ANDA", "sponsor_name": "JIANGSU HANSOH PHARM", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213261", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211420", "application_type": "ANDA", "sponsor_name": "PAI HOLDINGS", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208597", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "TICAGRELOR" ], "active_ingredients": [ "TICAGRELOR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214719", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "ERLOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "ERLOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211685", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209785", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DESIPRAMINE HYDROCHLORIDE" ], "active_ingredients": [ "DESIPRAMINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215246", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212802", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211687", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212959", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211431", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214781", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE" ], "active_ingredients": [ "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213510", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-07-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761179", "application_type": "BLA", "sponsor_name": "JAZZ PHARMS", "brand_names": [ "RYLAZE" ], "active_ingredients": [ "ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-06-30", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214609", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211782", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209437", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "ICOSAPENT ETHYL" ], "active_ingredients": [ "ICOSAPENT ETHYL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213786", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213623", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211238", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ESLICARBAZEPINE ACETATE" ], "active_ingredients": [ "ESLICARBAZEPINE ACETATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202951", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "PALONOSETRON HYDROCHLORIDE" ], "active_ingredients": [ "PALONOSETRON HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-29", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214526", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213628", "application_type": "ANDA", "sponsor_name": "CADILA PHARMS LTD", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214575", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211935", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NITROFURANTOIN" ], "active_ingredients": [ "NITROFURANTOIN, MACROCRYSTALLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206617", "application_type": "ANDA", "sponsor_name": "HIKMA INTL PHARMS", "brand_names": [ "GEMCITABINE HYDROCHLORIDE" ], "active_ingredients": [ "GEMCITABINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-06-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214965", "application_type": "NDA", "sponsor_name": "HARROW EYE", "brand_names": [ "VERKAZIA" ], "active_ingredients": [ "CYCLOSPORINE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-06-23", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA213762", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213132", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207306", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "ARFORMOTEROL TARTRATE" ], "active_ingredients": [ "ARFORMOTEROL TARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-06-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091141", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "FORMOTEROL FUMARATE" ], "active_ingredients": [ "FORMOTEROL FUMARATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-06-22", "review_priority": "", "submission_class": "" }, { "application_number": "NDA214358", "application_type": "NDA", "sponsor_name": "BOEHRINGER INGELHEIM", "brand_names": [ "PRADAXA" ], "active_ingredients": [ "DABIGATRAN ETEXILATE MESYLATE" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-06-21", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA210282", "application_type": "NDA", "sponsor_name": "HOSPIRA", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-21", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212428", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "OXCARBAZEPINE" ], "active_ingredients": [ "OXCARBAZEPINE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211969", "application_type": "ANDA", "sponsor_name": "NIVAGEN PHARMS INC", "brand_names": [ "EFINACONAZOLE" ], "active_ingredients": [ "EFINACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-06-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213872", "application_type": "NDA", "sponsor_name": "BAYER HLTHCARE", "brand_names": [ "ASTEPRO ALLERGY", "CHILDREN'S ASTEPRO ALLERGY" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2021-06-17", "review_priority": "STANDARD", "submission_class": "Type 8 - Partial Rx to OTC Switch" }, { "application_number": "ANDA213906", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "LEVORPHANOL TARTRATE" ], "active_ingredients": [ "LEVORPHANOL TARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211438", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE", "SIMETHICONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212156", "application_type": "NDA", "sponsor_name": "PH HEALTH", "brand_names": [ "MICAFUNGIN" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-16", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA213145", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SEVELAMER HYDROCHLORIDE" ], "active_ingredients": [ "SEVELAMER HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208740", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204329", "application_type": "ANDA", "sponsor_name": "NANG KUANG PHARM CO", "brand_names": [ "IBANDRONATE SODIUM" ], "active_ingredients": [ "IBANDRONATE SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-16", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA078509", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "EFAVIRENZ" ], "active_ingredients": [ "EFAVIRENZ" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-16", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214930", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "BUPRENORPHINE HYDROCHLORIDE", "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2021-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207685", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213536", "application_type": "NDA", "sponsor_name": "DR REDDYS LABS SA", "brand_names": [ "REZIPRES" ], "active_ingredients": [ "EPHEDRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA213218", "application_type": "NDA", "sponsor_name": "SARFE PHARMS", "brand_names": [ "SOAANZ" ], "active_ingredients": [ "TORSEMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214895", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SHAMPOO" ], "routes": [ "TOPICAL" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214579", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "EPHEDRINE SULFATE" ], "active_ingredients": [ "EPHEDRINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214196", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ETRAVIRINE" ], "active_ingredients": [ "ETRAVIRINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212882", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TESTOSTERONE" ], "active_ingredients": [ "TESTOSTERONE" ], "dosage_forms": [ "SOLUTION, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212110", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215069", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "LEVETIRACETAM" ], "active_ingredients": [ "LEVETIRACETAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212797", "application_type": "ANDA", "sponsor_name": "XIAMEN LP PHARM CO", "brand_names": [ "PRAMIPEXOLE DIHYDROCHLORIDE" ], "active_ingredients": [ "PRAMIPEXOLE DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211730", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "FULVESTRANT" ], "active_ingredients": [ "FULVESTRANT" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209330", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "CARFILZOMIB" ], "active_ingredients": [ "CARFILZOMIB" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215110", "application_type": "NDA", "sponsor_name": "ABBVIE", "brand_names": [ "MAVYRET" ], "active_ingredients": [ "GLECAPREVIR", "PIBRENTASVIR" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-06-10", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "NDA215025", "application_type": "NDA", "sponsor_name": "MAIA PHARMS INC", "brand_names": [ "SODIUM PHENYLACETATE AND SODIUM BENZOATE" ], "active_ingredients": [ "SODIUM BENZOATE", "SODIUM PHENYLACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-10", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA214187", "application_type": "NDA", "sponsor_name": "GILEAD SCIENCES INC", "brand_names": [ "EPCLUSA" ], "active_ingredients": [ "SOFOSBUVIR", "VELPATASVIR" ], "dosage_forms": [ "PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-06-10", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA214127", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212035", "application_type": "NDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "ARGATROBAN IN SODIUM CHLORIDE" ], "active_ingredients": [ "ARGATROBAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-07", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "BLA761178", "application_type": "BLA", "sponsor_name": "BIOGEN INC", "brand_names": [ "ADUHELM" ], "active_ingredients": [ "ADUCANUMAB-AVWA" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-06-07", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212160", "application_type": "ANDA", "sponsor_name": "WINDER LABS LLC", "brand_names": [ "DEXTROAMPHETAMINE SULFATE" ], "active_ingredients": [ "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215256", "application_type": "NDA", "sponsor_name": "NOVO", "brand_names": [ "WEGOVY", "WEGOVY HD", "WEGOVY FLEXTOUCH" ], "active_ingredients": [ "SEMAGLUTIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-06-04", "review_priority": "PRIORITY", "submission_class": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated" }, { "application_number": "NDA214461", "application_type": "NDA", "sponsor_name": "EMERGENT BIODEFENSE", "brand_names": [ "TEMBEXA" ], "active_ingredients": [ "BRINCIDOFOVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-04", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "NDA214460", "application_type": "NDA", "sponsor_name": "EMERGENT BIODEFENSE", "brand_names": [ "TEMBEXA" ], "active_ingredients": [ "BRINCIDOFOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-06-04", "review_priority": "PRIORITY", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "ANDA204131", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA091677", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "LOPINAVIR AND RITONAVIR" ], "active_ingredients": [ "LOPINAVIR", "RITONAVIR" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-04", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA212184", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "THEOPHYLLINE" ], "active_ingredients": [ "THEOPHYLLINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214542", "application_type": "ANDA", "sponsor_name": "GENUS", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CONCENTRATE" ], "routes": [ "ORAL" ], "approval_date": "2021-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213761", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "OXYCODONE HYDROCHLORIDE" ], "active_ingredients": [ "OXYCODONE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211713", "application_type": "ANDA", "sponsor_name": "XELLIA PHARMS APS", "brand_names": [ "MICAFUNGIN SODIUM" ], "active_ingredients": [ "MICAFUNGIN SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-06-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214900", "application_type": "NDA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "BREXAFEMME" ], "active_ingredients": [ "IBREXAFUNGERP CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-01", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212943", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "TOFACITINIB CITRATE" ], "active_ingredients": [ "TOFACITINIB CITRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207085", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "ALBUTEROL SULFATE" ], "active_ingredients": [ "ALBUTEROL SULFATE" ], "dosage_forms": [ "AEROSOL, METERED" ], "routes": [ "INHALATION" ], "approval_date": "2021-06-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214770", "application_type": "NDA", "sponsor_name": "MSD MERCK CO", "brand_names": [ "NOXAFIL POWDERMIX KIT" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "FOR SUSPENSION, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-31", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA214665", "application_type": "NDA", "sponsor_name": "AMGEN INC", "brand_names": [ "LUMAKRAS" ], "active_ingredients": [ "SOTORASIB" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA214622", "application_type": "NDA", "sponsor_name": "HELSINN HLTHCARE", "brand_names": [ "TRUSELTIQ" ], "active_ingredients": [ "INFIGRATINIB PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-28", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA213378", "application_type": "NDA", "sponsor_name": "ALKERMES INC", "brand_names": [ "LYBALVI" ], "active_ingredients": [ "OLANZAPINE", "SAMIDORPHAN L-MALATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-28", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA213078", "application_type": "ANDA", "sponsor_name": "HAINAN POLY", "brand_names": [ "BIVALIRUDIN" ], "active_ingredients": [ "BIVALIRUDIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212960", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "MELPHALAN HYDROCHLORIDE" ], "active_ingredients": [ "MELPHALAN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205479", "application_type": "ANDA", "sponsor_name": "LGM PHARMA", "brand_names": [ "HYDROCODONE BITARTRATE AND ASPIRIN" ], "active_ingredients": [ "ASPIRIN", "HYDROCODONE BITARTRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214552", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214541", "application_type": "ANDA", "sponsor_name": "GUARDIAN DRUG", "brand_names": [ "LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE" ], "active_ingredients": [ "LOPERAMIDE HYDROCHLORIDE", "SIMETHICONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212669", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214846", "application_type": "NDA", "sponsor_name": "SUMITOMO PHARMA AM", "brand_names": [ "MYFEMBREE" ], "active_ingredients": [ "ESTRADIOL", "NORETHINDRONE ACETATE", "RELUGOLIX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-26", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "NDA214793", "application_type": "NDA", "sponsor_name": "PROGENICS PHARMS INC", "brand_names": [ "PYLARIFY" ], "active_ingredients": [ "PIFLUFOLASTAT F-18" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-05-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA211488", "application_type": "NDA", "sponsor_name": "ACCORD", "brand_names": [ "CAMCEVI KIT" ], "active_ingredients": [ "LEUPROLIDE MESYLATE" ], "dosage_forms": [ "EMULSION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-05-25", "review_priority": "STANDARD", "submission_class": "Type 2 - New Active Ingredient" }, { "application_number": "BLA761210", "application_type": "BLA", "sponsor_name": "JANSSEN BIOTECH", "brand_names": [ "RYBREVANT" ], "active_ingredients": [ "AMIVANTAMAB-VMJW" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-21", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213601", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "AEROSOL, FOAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213222", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "ICATIBANT ACETATE" ], "active_ingredients": [ "ICATIBANT ACETATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212007", "application_type": "ANDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "ZINC CHLORIDE" ], "active_ingredients": [ "ZINC CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211648", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205187", "application_type": "ANDA", "sponsor_name": "MICRO LABS LTD INDIA", "brand_names": [ "AMOXICILLIN AND CLAVULANATE POTASSIUM" ], "active_ingredients": [ "AMOXICILLIN", "CLAVULANATE POTASSIUM" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA201452", "application_type": "ANDA", "sponsor_name": "ARROW INTL", "brand_names": [ "LENALIDOMIDE" ], "active_ingredients": [ "LENALIDOMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-21", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA212443", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "KETOCONAZOLE" ], "active_ingredients": [ "KETOCONAZOLE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205432", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214548", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212444", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211237", "application_type": "ANDA", "sponsor_name": "J MOLNER", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212930", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211189", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TOBRAMYCIN SULFATE" ], "active_ingredients": [ "TOBRAMYCIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214253", "application_type": "NDA", "sponsor_name": "HIKMA", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-05-17", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA209374", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA215014", "application_type": "NDA", "sponsor_name": "APELLIS PHARMS", "brand_names": [ "EMPAVELI" ], "active_ingredients": [ "PEGCETACOPLAN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-05-14", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214341", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212416", "application_type": "ANDA", "sponsor_name": "CUSTOPHARM INC", "brand_names": [ "CALCITONIN-SALMON" ], "active_ingredients": [ "CALCITONIN SALMON" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209614", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL INC", "brand_names": [ "ENZALUTAMIDE" ], "active_ingredients": [ "ENZALUTAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207629", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-05-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214992", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214020", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "TIGECYCLINE" ], "active_ingredients": [ "TIGECYCLINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213248", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211988", "application_type": "NDA", "sponsor_name": "HERON THERAPS INC", "brand_names": [ "ZYNRELEF KIT" ], "active_ingredients": [ "BUPIVACAINE", "MELOXICAM" ], "dosage_forms": [ "SOLUTION, EXTENDED RELEASE" ], "routes": [ "PERIARTICULAR" ], "approval_date": "2021-05-12", "review_priority": "PRIORITY", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA213404", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "CLOBAZAM" ], "active_ingredients": [ "CLOBAZAM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213014", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204993", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214956", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "GABAPENTIN" ], "active_ingredients": [ "GABAPENTIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214698", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214366", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ERLOTINIB HYDROCHLORIDE" ], "active_ingredients": [ "ERLOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213497", "application_type": "ANDA", "sponsor_name": "AET PHARMA", "brand_names": [ "LEFLUNOMIDE" ], "active_ingredients": [ "LEFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214092", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "CARBIDOPA AND LEVODOPA" ], "active_ingredients": [ "CARBIDOPA", "LEVODOPA" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212215", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "TAVABOROLE" ], "active_ingredients": [ "TAVABOROLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210409", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD III", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2021-05-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214323", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213039", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CLOBAZAM" ], "active_ingredients": [ "CLOBAZAM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-05-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214543", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-05-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214805", "application_type": "ANDA", "sponsor_name": "MILLA PHARMS", "brand_names": [ "SODIUM ACETATE" ], "active_ingredients": [ "SODIUM ACETATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213099", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE" ], "active_ingredients": [ "DORZOLAMIDE HYDROCHLORIDE", "TIMOLOL MALEATE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-05-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214790", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "SERTRALINE HYDROCHLORIDE" ], "active_ingredients": [ "SERTRALINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210162", "application_type": "ANDA", "sponsor_name": "MYLAN TECH VIATRIS", "brand_names": [ "BUPRENORPHINE" ], "active_ingredients": [ "BUPRENORPHINE" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209779", "application_type": "ANDA", "sponsor_name": "RUBICON RESEARCH", "brand_names": [ "NITROGLYCERIN" ], "active_ingredients": [ "NITROGLYCERIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "SUBLINGUAL" ], "approval_date": "2021-05-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214760", "application_type": "ANDA", "sponsor_name": "UTOPIC PHARMS", "brand_names": [ "TROSPIUM CHLORIDE" ], "active_ingredients": [ "TROSPIUM CHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212623", "application_type": "ANDA", "sponsor_name": "POINTVIEW HLDINGS", "brand_names": [ "METHOCARBAMOL" ], "active_ingredients": [ "METHOCARBAMOL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212579", "application_type": "ANDA", "sponsor_name": "LAURUS", "brand_names": [ "ATAZANAVIR SULFATE" ], "active_ingredients": [ "ATAZANAVIR SULFATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212045", "application_type": "NDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "KLOXXADO" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2021-04-29", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA213814", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "SILDENAFIL CITRATE" ], "active_ingredients": [ "SILDENAFIL CITRATE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205882", "application_type": "ANDA", "sponsor_name": "NAL PHARM", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "PATCH" ], "routes": [ "TOPICAL" ], "approval_date": "2021-04-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202861", "application_type": "ANDA", "sponsor_name": "INTL MEDICATION SYS", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-29", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213033", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212433", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE" ], "active_ingredients": [ "BENZOYL PEROXIDE", "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212248", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM CHLORIDE 23.4%" ], "active_ingredients": [ "SODIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212070", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "SODIUM CHLORIDE 23.4%", "SODIUM CHLORIDE 14.6%" ], "active_ingredients": [ "SODIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208209", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "VILAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "VILAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214326", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "TIOPRONIN" ], "active_ingredients": [ "TIOPRONIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214065", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE" ], "active_ingredients": [ "CHLORDIAZEPOXIDE HYDROCHLORIDE", "CLIDINIUM BROMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209397", "application_type": "ANDA", "sponsor_name": "BEIJING", "brand_names": [ "FLUVASTATIN SODIUM" ], "active_ingredients": [ "FLUVASTATIN SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207967", "application_type": "ANDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "MAGNESIUM SULFATE" ], "active_ingredients": [ "MAGNESIUM SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761196", "application_type": "BLA", "sponsor_name": "ADC Therapeutics SA", "brand_names": [ "ZYNLONTA" ], "active_ingredients": [ "LONCASTUXIMAB TESIRINE-LPYL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-23", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214721", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "DICYCLOMINE HYDROCHLORIDE" ], "active_ingredients": [ "DICYCLOMINE HYDROCHLORIDE" ], "dosage_forms": [ "SYRUP" ], "routes": [ "ORAL" ], "approval_date": "2021-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209787", "application_type": "ANDA", "sponsor_name": "LOTUS PHARM CO LTD", "brand_names": [ "METHOTREXATE SODIUM" ], "active_ingredients": [ "METHOTREXATE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761174", "application_type": "BLA", "sponsor_name": "GLAXOSMITHKLINE", "brand_names": [ "JEMPERLI" ], "active_ingredients": [ "DOSTARLIMAB-GXLY" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214379", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "PROCHLORPERAZINE EDISYLATE" ], "active_ingredients": [ "PROCHLORPERAZINE EDISYLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213709", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215076", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214184", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "PROPAFENONE HYDROCHLORIDE" ], "active_ingredients": [ "PROPAFENONE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213001", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212250", "application_type": "ANDA", "sponsor_name": "HISUN PHARM HANGZHOU", "brand_names": [ "DAPTOMYCIN" ], "active_ingredients": [ "DAPTOMYCIN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211443", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "LEVOCETIRIZINE DIHYDROCHLORIDE" ], "active_ingredients": [ "LEVOCETIRIZINE DIHYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215043", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FAMOTIDINE" ], "active_ingredients": [ "FAMOTIDINE" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213074", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212695", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212396", "application_type": "ANDA", "sponsor_name": "TIANJIN KINGYORK", "brand_names": [ "METHYLPREDNISOLONE SODIUM SUCCINATE" ], "active_ingredients": [ "METHYLPREDNISOLONE SODIUM SUCCINATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-20", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214380", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "MILRINONE LACTATE" ], "active_ingredients": [ "MILRINONE LACTATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213334", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214154", "application_type": "NDA", "sponsor_name": "MAYNE PHARMA", "brand_names": [ "NEXTSTELLIS" ], "active_ingredients": [ "DROSPIRENONE", "ESTETROL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-15", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA204797", "application_type": "ANDA", "sponsor_name": "EXELA PHARMA", "brand_names": [ "ACETYLCYSTEINE" ], "active_ingredients": [ "ACETYLCYSTEINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214990", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "POLYETHYLENE GLYCOL 3350" ], "active_ingredients": [ "POLYETHYLENE GLYCOL 3350" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211922", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "BUDESONIDE" ], "active_ingredients": [ "BUDESONIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "INHALATION" ], "approval_date": "2021-04-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213313", "application_type": "ANDA", "sponsor_name": "APOTEX", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213311", "application_type": "ANDA", "sponsor_name": "CSPC OUYI", "brand_names": [ "CARBAMAZEPINE" ], "active_ingredients": [ "CARBAMAZEPINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213226", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211948", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211889", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211593", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "PREGABALIN" ], "active_ingredients": [ "PREGABALIN" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213571", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212826", "application_type": "ANDA", "sponsor_name": "QILU PHARM HAINAN", "brand_names": [ "DECITABINE" ], "active_ingredients": [ "DECITABINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213825", "application_type": "ANDA", "sponsor_name": "AJENAT PHARMS", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211121", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "NICARDIPINE HYDROCHLORIDE" ], "active_ingredients": [ "NICARDIPINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206888", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TIROFIBAN HYDROCHLORIDE" ], "active_ingredients": [ "TIROFIBAN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208200", "application_type": "ANDA", "sponsor_name": "INVAGEN PHARMS", "brand_names": [ "VILAZODONE HYDROCHLORIDE" ], "active_ingredients": [ "VILAZODONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211224", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "MACITENTAN" ], "active_ingredients": [ "MACITENTAN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212804", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "NEOSTIGMINE METHYLSULFATE" ], "active_ingredients": [ "NEOSTIGMINE METHYLSULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-04-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA211964", "application_type": "NDA", "sponsor_name": "SUPERNUS PHARMS", "brand_names": [ "QELBREE" ], "active_ingredients": [ "VILOXAZINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212762", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212761", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212760", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212296", "application_type": "ANDA", "sponsor_name": "WILSHIRE PHARMS INC", "brand_names": [ "DEOXYCHOLIC ACID" ], "active_ingredients": [ "DEOXYCHOLIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211100", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "MEMANTINE HYDROCHLORIDE" ], "active_ingredients": [ "MEMANTINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090958", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-04-02", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214908", "application_type": "ANDA", "sponsor_name": "APPCO", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-04-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212848", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-04-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214728", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214090", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "NYSTATIN AND TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "NYSTATIN", "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211344", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "IBRUTINIB" ], "active_ingredients": [ "IBRUTINIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205063", "application_type": "ANDA", "sponsor_name": "ACTAVIS LABS FL", "brand_names": [ "ISOTRETINOIN" ], "active_ingredients": [ "ISOTRETINOIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-31", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA090841", "application_type": "ANDA", "sponsor_name": "ETHYPHARM", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-03-31", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA214799", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213827", "application_type": "ANDA", "sponsor_name": "INNOGENIX", "brand_names": [ "METOLAZONE" ], "active_ingredients": [ "METOLAZONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212918", "application_type": "ANDA", "sponsor_name": "BIONPHARMA", "brand_names": [ "ATOVAQUONE" ], "active_ingredients": [ "ATOVAQUONE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209452", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "active_ingredients": [ "SAPROPTERIN DIHYDROCHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-03-30", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA215022", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "SUCCINYLCHOLINE CHLORIDE" ], "active_ingredients": [ "SUCCINYLCHOLINE CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213652", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA", "brand_names": [ "LEFLUNOMIDE" ], "active_ingredients": [ "LEFLUNOMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213239", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "DEFERIPRONE" ], "active_ingredients": [ "DEFERIPRONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212066", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "EFINACONAZOLE" ], "active_ingredients": [ "EFINACONAZOLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212040", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "ERTAPENEM SODIUM" ], "active_ingredients": [ "ERTAPENEM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAMUSCULAR, INTRAVENOUS" ], "approval_date": "2021-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211207", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210436", "application_type": "ANDA", "sponsor_name": "SOLA PHARMS", "brand_names": [ "DIMETHYL FUMARATE" ], "active_ingredients": [ "DIMETHYL FUMARATE" ], "dosage_forms": [ "CAPSULE, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203451", "application_type": "ANDA", "sponsor_name": "INTL MEDICATION SYS", "brand_names": [ "DEXTROSE 50%" ], "active_ingredients": [ "DEXTROSE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213801", "application_type": "NDA", "sponsor_name": "APGDI", "brand_names": [ "MYRBETRIQ GRANULES" ], "active_ingredients": [ "MIRABEGRON" ], "dosage_forms": [ "FOR SUSPENSION, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-25", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA214867", "application_type": "ANDA", "sponsor_name": "SUN PHARMA CANADA", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SHAMPOO" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213118", "application_type": "ANDA", "sponsor_name": "SUNNY", "brand_names": [ "CARBOPROST TROMETHAMINE" ], "active_ingredients": [ "CARBOPROST TROMETHAMINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213072", "application_type": "NDA", "sponsor_name": "ALTHERA PHARMS", "brand_names": [ "ROSZET" ], "active_ingredients": [ "EZETIMIBE", "ROSUVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-23", "review_priority": "STANDARD", "submission_class": "Type 4 - New Combination" }, { "application_number": "ANDA212144", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214231", "application_type": "NDA", "sponsor_name": "ZEALAND PHARMA", "brand_names": [ "ZEGALOGUE", "ZEGALOGUE (AUTOINJECTOR)" ], "active_ingredients": [ "DASIGLUCAGON HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "SUBCUTANEOUS" ], "approval_date": "2021-03-22", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "NDA211844", "application_type": "NDA", "sponsor_name": "INFORLIFE", "brand_names": [ "MIDAZOLAM IN 0.9% SODIUM CHLORIDE" ], "active_ingredients": [ "MIDAZOLAM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-03-22", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212317", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "DILTIAZEM HYDROCHLORIDE" ], "active_ingredients": [ "DILTIAZEM HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213486", "application_type": "ANDA", "sponsor_name": "GRAVITI PHARMS", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213424", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL" ], "approval_date": "2021-03-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA203767", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "TRAVOPROST" ], "active_ingredients": [ "TRAVOPROST" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-03-19", "review_priority": "", "submission_class": "" }, { "application_number": "NDA213498", "application_type": "NDA", "sponsor_name": "VANDA PHARMS INC", "brand_names": [ "PONVORY" ], "active_ingredients": [ "PONESIMOD" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-18", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214727", "application_type": "ANDA", "sponsor_name": "NEXUS", "brand_names": [ "POTASSIUM CHLORIDE 20MEQ", "POTASSIUM CHLORIDE 10MEQ", "POTASSIUM CHLORIDE 40MEQ" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214650", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211318", "application_type": "ANDA", "sponsor_name": "FOSUN PHARMA", "brand_names": [ "AZITHROMYCIN" ], "active_ingredients": [ "AZITHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214462", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "DIVALPROEX SODIUM" ], "active_ingredients": [ "DIVALPROEX SODIUM" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204615", "application_type": "ANDA", "sponsor_name": "ACCORD HLTHCARE", "brand_names": [ "PALONOSETRON HYDROCHLORIDE" ], "active_ingredients": [ "PALONOSETRON HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-03-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214155", "application_type": "NDA", "sponsor_name": "MELINTA THERAP", "brand_names": [ "KIMYRSA" ], "active_ingredients": [ "ORITAVANCIN DIPHOSPHATE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-03-12", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214753", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "SIROLIMUS" ], "active_ingredients": [ "SIROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212770", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "LINCOMYCIN HYDROCHLORIDE" ], "active_ingredients": [ "LINCOMYCIN HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211202", "application_type": "ANDA", "sponsor_name": "HENGRUI PHARMA", "brand_names": [ "CARMUSTINE" ], "active_ingredients": [ "CARMUSTINE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212438", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211667", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207690", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202682", "application_type": "ANDA", "sponsor_name": "HETERO LABS LTD V", "brand_names": [ "ATOMOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "ATOMOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-11", "review_priority": "", "submission_class": "" }, { "application_number": "NDA212904", "application_type": "NDA", "sponsor_name": "AVEO PHARMS", "brand_names": [ "FOTIVDA" ], "active_ingredients": [ "TIVOZANIB HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-10", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213475", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "DOXYCYCLINE HYCLATE" ], "active_ingredients": [ "DOXYCYCLINE HYCLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211910", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "NAPROXEN" ], "active_ingredients": [ "NAPROXEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-03-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214559", "application_type": "ANDA", "sponsor_name": "AUCTA", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213962", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213523", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%", "POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%", "POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%", "POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%" ], "active_ingredients": [ "DEXTROSE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213445", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%", "POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%" ], "active_ingredients": [ "DEXTROSE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212628", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211619", "application_type": "ANDA", "sponsor_name": "LEADING", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211398", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "MELOXICAM" ], "active_ingredients": [ "MELOXICAM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209597", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "CHOLESTYRAMINE" ], "active_ingredients": [ "CHOLESTYRAMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "ORAL" ], "approval_date": "2021-03-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214604", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "LOTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214222", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "THIOTEPA" ], "active_ingredients": [ "THIOTEPA" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRACAVITARY, INTRAVENOUS, INTRAVESICAL" ], "approval_date": "2021-03-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214374", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "BACLOFEN" ], "active_ingredients": [ "BACLOFEN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211374", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208000", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205426", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212227", "application_type": "ANDA", "sponsor_name": "XIROMED", "brand_names": [ "GLYCOPYRROLATE" ], "active_ingredients": [ "GLYCOPYRROLATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208920", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "LISINOPRIL" ], "active_ingredients": [ "LISINOPRIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-04", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214689", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "GUANFACINE HYDROCHLORIDE" ], "active_ingredients": [ "GUANFACINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213922", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "TESTOSTERONE" ], "active_ingredients": [ "TESTOSTERONE" ], "dosage_forms": [ "GEL, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212143", "application_type": "ANDA", "sponsor_name": "CHIA TAI TIANQING", "brand_names": [ "FOSAPREPITANT DIMEGLUMINE" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212094", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "METHADONE HYDROCHLORIDE" ], "active_ingredients": [ "METHADONE HYDROCHLORIDE" ], "dosage_forms": [ "CONCENTRATE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205151", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "active_ingredients": [ "VALGANCICLOVIR HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212994", "application_type": "NDA", "sponsor_name": "COMMAVE SUB", "brand_names": [ "AZSTARYS" ], "active_ingredients": [ "DEXMETHYLPHENIDATE HYDROCHLORIDE", "SERDEXMETHYLPHENIDATE CHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-02", "review_priority": "STANDARD", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "ANDA214674", "application_type": "ANDA", "sponsor_name": "NOVITIUM PHARMA", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211618", "application_type": "ANDA", "sponsor_name": "VELZEN PHARMA PVT", "brand_names": [ "DOXEPIN HYDROCHLORIDE" ], "active_ingredients": [ "DOXEPIN HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208269", "application_type": "ANDA", "sponsor_name": "ALVOGEN", "brand_names": [ "HYDROCODONE BITARTRATE" ], "active_ingredients": [ "HYDROCODONE BITARTRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-03-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214018", "application_type": "NDA", "sponsor_name": "SENTYNL THERAPS INC", "brand_names": [ "NULIBRY" ], "active_ingredients": [ "FOSDENOPTERIN HYDROBROMIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-02-26", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA212450", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "SUSPENSION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210559", "application_type": "ANDA", "sponsor_name": "INDCHEMIE HEALTH", "brand_names": [ "ESOMEPRAZOLE MAGNESIUM" ], "active_ingredients": [ "ESOMEPRAZOLE MAGNESIUM" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-02-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213026", "application_type": "NDA", "sponsor_name": "SAREPTA THERAPS INC", "brand_names": [ "AMONDYS 45" ], "active_ingredients": [ "CASIMERSEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-02-25", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213950", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ETHINYL ESTRADIOL AND NORELGESTROMIN" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "NORELGESTROMIN" ], "dosage_forms": [ "FILM, EXTENDED RELEASE" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-02-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213441", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "NORTRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "NORTRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212491", "application_type": "ANDA", "sponsor_name": "QUAGEN", "brand_names": [ "CYPROHEPTADINE HYDROCHLORIDE", "CYPROLARA" ], "active_ingredients": [ "CYPROHEPTADINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-24", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214039", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "ACETAMINOPHEN, ASPIRIN AND CAFFEINE" ], "active_ingredients": [ "ACETAMINOPHEN", "ASPIRIN", "CAFFEINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213410", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "RUFINAMIDE" ], "active_ingredients": [ "RUFINAMIDE" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-02-23", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214209", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "SUMATRIPTAN" ], "active_ingredients": [ "SUMATRIPTAN" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2021-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211666", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "IBUPROFEN" ], "active_ingredients": [ "IBUPROFEN" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211372", "application_type": "ANDA", "sponsor_name": "SOMERSET THERAPS LLC", "brand_names": [ "ACETAZOLAMIDE" ], "active_ingredients": [ "ACETAZOLAMIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214426", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "POTASSIUM CITRATE" ], "active_ingredients": [ "POTASSIUM CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213999", "application_type": "ANDA", "sponsor_name": "MANKIND PHARMA", "brand_names": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "active_ingredients": [ "AMITRIPTYLINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211775", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEFIXIME" ], "active_ingredients": [ "CEFIXIME" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210534", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEFDINIR" ], "active_ingredients": [ "CEFDINIR" ], "dosage_forms": [ "FOR SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210220", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "CEFDINIR" ], "active_ingredients": [ "CEFDINIR" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA204957", "application_type": "NDA", "sponsor_name": "B BRAUN MEDICAL", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA214391", "application_type": "ANDA", "sponsor_name": "JUBILANT CADISTA", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214387", "application_type": "ANDA", "sponsor_name": "AUROBINDO PHARMA LTD", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214384", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214017", "application_type": "ANDA", "sponsor_name": "SCIEGEN PHARMS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213911", "application_type": "ANDA", "sponsor_name": "ALKEM LABS LTD", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213661", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213162", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212835", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211818", "application_type": "ANDA", "sponsor_name": "ZYDUS PHARMS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211741", "application_type": "ANDA", "sponsor_name": "MSN PHARMS INC", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211726", "application_type": "ANDA", "sponsor_name": "ANNORA", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211652", "application_type": "ANDA", "sponsor_name": "LUPIN PHARMS", "brand_names": [ "DROXIDOPA" ], "active_ingredients": [ "DROXIDOPA" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208111", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE" ], "active_ingredients": [ "AZELASTINE HYDROCHLORIDE", "FLUTICASONE PROPIONATE" ], "dosage_forms": [ "SPRAY, METERED" ], "routes": [ "NASAL" ], "approval_date": "2021-02-18", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA079021", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "ATOMOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "ATOMOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-18", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA211819", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "APREMILAST" ], "active_ingredients": [ "APREMILAST" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208967", "application_type": "ANDA", "sponsor_name": "REGCON HOLDINGS", "brand_names": [ "SUMATRIPTAN" ], "active_ingredients": [ "SUMATRIPTAN" ], "dosage_forms": [ "SPRAY" ], "routes": [ "NASAL" ], "approval_date": "2021-02-17", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214686", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213485", "application_type": "ANDA", "sponsor_name": "CSPC OUYI", "brand_names": [ "PAROXETINE HYDROCHLORIDE" ], "active_ingredients": [ "PAROXETINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210845", "application_type": "ANDA", "sponsor_name": "MICRO LABS", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208675", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "PIPERACILLIN AND TAZOBACTAM" ], "active_ingredients": [ "PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208674", "application_type": "ANDA", "sponsor_name": "SAGENT PHARMS INC", "brand_names": [ "PIPERACILLIN AND TAZOBACTAM" ], "active_ingredients": [ "PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-16", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214200", "application_type": "NDA", "sponsor_name": "PHARMACOSMOS", "brand_names": [ "COSELA" ], "active_ingredients": [ "TRILACICLIB DIHYDROCHLORIDE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-02-12", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213928", "application_type": "ANDA", "sponsor_name": "PHARMOBEDIENT", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213854", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "METOPROLOL SUCCINATE" ], "active_ingredients": [ "METOPROLOL SUCCINATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211454", "application_type": "ANDA", "sponsor_name": "WINDER LABS LLC", "brand_names": [ "MORPHINE SULFATE" ], "active_ingredients": [ "MORPHINE SULFATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-02-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "BLA761181", "application_type": "BLA", "sponsor_name": "REGENERON PHARMACEUTICALS", "brand_names": [ "EVKEEZA" ], "active_ingredients": [ "EVINACUMAB-DGNB" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-11", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214549", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "ERYTHROMYCIN" ], "active_ingredients": [ "ERYTHROMYCIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214182", "application_type": "ANDA", "sponsor_name": "BIOCON PHARMA", "brand_names": [ "EVEROLIMUS" ], "active_ingredients": [ "EVEROLIMUS" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213724", "application_type": "ANDA", "sponsor_name": "COSETTE PHARMS NC", "brand_names": [ "HYDROCORTISONE VALERATE" ], "active_ingredients": [ "HYDROCORTISONE VALERATE" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212328", "application_type": "ANDA", "sponsor_name": "SUNSHINE", "brand_names": [ "DULOXETINE HYDROCHLORIDE" ], "active_ingredients": [ "DULOXETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE, DELAYED REL PELLETS" ], "routes": [ "ORAL" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211574", "application_type": "ANDA", "sponsor_name": "ALEMBIC GLOBAL", "brand_names": [ "TREPROSTINIL" ], "active_ingredients": [ "TREPROSTINIL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INTRAVENOUS, SUBCUTANEOUS" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209621", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TOBRAMYCIN SULFATE" ], "active_ingredients": [ "TOBRAMYCIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208412", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "PREDNISONE" ], "active_ingredients": [ "PREDNISONE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205141", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204842", "application_type": "ANDA", "sponsor_name": "HIKMA PHARMS", "brand_names": [ "BUPIVACAINE HYDROCHLORIDE" ], "active_ingredients": [ "BUPIVACAINE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214376", "application_type": "ANDA", "sponsor_name": "YICHANG HUMANWELL", "brand_names": [ "MYCOPHENOLATE SODIUM" ], "active_ingredients": [ "MYCOPHENOLATE SODIUM" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214251", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "CLINDAMYCIN PHOSPHATE" ], "active_ingredients": [ "CLINDAMYCIN PHOSPHATE" ], "dosage_forms": [ "GEL" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212616", "application_type": "ANDA", "sponsor_name": "UPSHER SMITH LABS", "brand_names": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "active_ingredients": [ "MOXIFLOXACIN HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION/DROPS" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212080", "application_type": "ANDA", "sponsor_name": "SENTISS", "brand_names": [ "LOTEPREDNOL ETABONATE" ], "active_ingredients": [ "LOTEPREDNOL ETABONATE" ], "dosage_forms": [ "GEL" ], "routes": [ "OPHTHALMIC" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211222", "application_type": "ANDA", "sponsor_name": "NEPHRON", "brand_names": [ "STERILE WATER FOR INJECTION" ], "active_ingredients": [ "STERILE WATER FOR INJECTION" ], "dosage_forms": [ "LIQUID" ], "routes": [ "N/A" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208476", "application_type": "ANDA", "sponsor_name": "BOSTAL", "brand_names": [ "FENOFIBRATE" ], "active_ingredients": [ "FENOFIBRATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-10", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214194", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "DEFERASIROX" ], "active_ingredients": [ "DEFERASIROX" ], "dosage_forms": [ "GRANULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212224", "application_type": "ANDA", "sponsor_name": "CIPLA", "brand_names": [ "TAVABOROLE" ], "active_ingredients": [ "TAVABOROLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211864", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "ISOPROTERENOL HYDROCHLORIDE" ], "active_ingredients": [ "ISOPROTERENOL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209564", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "LINACLOTIDE" ], "active_ingredients": [ "LINACLOTIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209346", "application_type": "ANDA", "sponsor_name": "GLAND", "brand_names": [ "TOBRAMYCIN SULFATE (PHARMACY BULK)" ], "active_ingredients": [ "TOBRAMYCIN SULFATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-02-09", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213139", "application_type": "ANDA", "sponsor_name": "PRINSTON INC", "brand_names": [ "CLOBETASOL PROPIONATE" ], "active_ingredients": [ "CLOBETASOL PROPIONATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212168", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "TAVABOROLE" ], "active_ingredients": [ "TAVABOROLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-08", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213176", "application_type": "NDA", "sponsor_name": "TG THERAPS", "brand_names": [ "UKONIQ" ], "active_ingredients": [ "UMBRALISIB TOSYLATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-05", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214420", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "POTASSIUM CITRATE" ], "active_ingredients": [ "POTASSIUM CITRATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213264", "application_type": "ANDA", "sponsor_name": "TP ANDA HOLDINGS", "brand_names": [ "FLUOCINOLONE ACETONIDE" ], "active_ingredients": [ "FLUOCINOLONE ACETONIDE" ], "dosage_forms": [ "OIL/DROPS" ], "routes": [ "OTIC" ], "approval_date": "2021-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212460", "application_type": "ANDA", "sponsor_name": "PADAGIS ISRAEL", "brand_names": [ "TRIAMCINOLONE ACETONIDE" ], "active_ingredients": [ "TRIAMCINOLONE ACETONIDE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207653", "application_type": "ANDA", "sponsor_name": "INVENTIA", "brand_names": [ "ROSUVASTATIN CALCIUM" ], "active_ingredients": [ "ROSUVASTATIN CALCIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214096", "application_type": "NDA", "sponsor_name": "EMD SERONO INC", "brand_names": [ "TEPMETKO" ], "active_ingredients": [ "TEPOTINIB HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-03", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA211963", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "TAVABOROLE" ], "active_ingredients": [ "TAVABOROLE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-02-03", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213858", "application_type": "ANDA", "sponsor_name": "UTOPIC PHARMS", "brand_names": [ "TOLTERODINE TARTRATE" ], "active_ingredients": [ "TOLTERODINE TARTRATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208016", "application_type": "ANDA", "sponsor_name": "WATSON LABS TEVA", "brand_names": [ "LURASIDONE HYDROCHLORIDE" ], "active_ingredients": [ "LURASIDONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-02-02", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA202228", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "QUETIAPINE FUMARATE" ], "active_ingredients": [ "QUETIAPINE FUMARATE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-02", "review_priority": "", "submission_class": "" }, { "application_number": "NDA204803", "application_type": "NDA", "sponsor_name": "INNOCOLL", "brand_names": [ "POSIMIR" ], "active_ingredients": [ "BUPIVACAINE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INFILTRATION" ], "approval_date": "2021-02-01", "review_priority": "STANDARD", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA213454", "application_type": "ANDA", "sponsor_name": "AET PHARMA", "brand_names": [ "POSACONAZOLE" ], "active_ingredients": [ "POSACONAZOLE" ], "dosage_forms": [ "TABLET, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210465", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "LANSOPRAZOLE" ], "active_ingredients": [ "LANSOPRAZOLE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210278", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "TOPIRAMATE" ], "active_ingredients": [ "TOPIRAMATE" ], "dosage_forms": [ "CAPSULE, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-02-01", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214785", "application_type": "ANDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213392", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212483", "application_type": "ANDA", "sponsor_name": "FRESENIUS KABI USA", "brand_names": [ "FOSCARNET SODIUM" ], "active_ingredients": [ "FOSCARNET SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211980", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211539", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA207417", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "active_ingredients": [ "METHYLPHENIDATE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-29", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214395", "application_type": "ANDA", "sponsor_name": "GUANGZHOU NOVAKEN", "brand_names": [ "POTASSIUM CHLORIDE" ], "active_ingredients": [ "POTASSIUM CHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212889", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "RANOLAZINE" ], "active_ingredients": [ "RANOLAZINE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206655", "application_type": "ANDA", "sponsor_name": "EPIC PHARMA LLC", "brand_names": [ "DICLOFENAC SODIUM" ], "active_ingredients": [ "DICLOFENAC SODIUM" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "TOPICAL" ], "approval_date": "2021-01-28", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214766", "application_type": "ANDA", "sponsor_name": "SAGENT", "brand_names": [ "FUROSEMIDE" ], "active_ingredients": [ "FUROSEMIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214574", "application_type": "ANDA", "sponsor_name": "SUN PHARM INDS INC", "brand_names": [ "AMPHETAMINE SULFATE" ], "active_ingredients": [ "AMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212186", "application_type": "ANDA", "sponsor_name": "GLENMARK PHARMS LTD", "brand_names": [ "AMPHETAMINE SULFATE" ], "active_ingredients": [ "AMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211362", "application_type": "ANDA", "sponsor_name": "WINDER LABS LLC", "brand_names": [ "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE" ], "active_ingredients": [ "ATROPINE SULFATE", "DIPHENOXYLATE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-27", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214492", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "ZONISAMIDE" ], "active_ingredients": [ "ZONISAMIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214140", "application_type": "ANDA", "sponsor_name": "CARNEGIE", "brand_names": [ "AMINOCAPROIC ACID" ], "active_ingredients": [ "AMINOCAPROIC ACID" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213519", "application_type": "ANDA", "sponsor_name": "ANNORA PHARMA", "brand_names": [ "VIGABATRIN" ], "active_ingredients": [ "VIGABATRIN" ], "dosage_forms": [ "FOR SOLUTION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211034", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "ALBENDAZOLE" ], "active_ingredients": [ "ALBENDAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA205971", "application_type": "ANDA", "sponsor_name": "TARO", "brand_names": [ "IMIQUIMOD" ], "active_ingredients": [ "IMIQUIMOD" ], "dosage_forms": [ "CREAM" ], "routes": [ "TOPICAL" ], "approval_date": "2021-01-26", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214352", "application_type": "ANDA", "sponsor_name": "INGENUS PHARMS LLC", "brand_names": [ "MEXILETINE HYDROCHLORIDE" ], "active_ingredients": [ "MEXILETINE HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210739", "application_type": "ANDA", "sponsor_name": "AMNEAL", "brand_names": [ "ARSENIC TRIOXIDE" ], "active_ingredients": [ "ARSENIC TRIOXIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-25", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA213716", "application_type": "NDA", "sponsor_name": "AURINIA", "brand_names": [ "LUPKYNIS" ], "active_ingredients": [ "VOCLOSPORIN" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA214803", "application_type": "ANDA", "sponsor_name": "ZYDUS LIFESCIENCES", "brand_names": [ "LIOTHYRONINE SODIUM" ], "active_ingredients": [ "LIOTHYRONINE SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214455", "application_type": "ANDA", "sponsor_name": "BRECKENRIDGE", "brand_names": [ "NOREPINEPHRINE BITARTRATE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213583", "application_type": "ANDA", "sponsor_name": "SPECGX LLC", "brand_names": [ "AMPHETAMINE SULFATE" ], "active_ingredients": [ "AMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213435", "application_type": "ANDA", "sponsor_name": "MSN", "brand_names": [ "ALBENDAZOLE" ], "active_ingredients": [ "ALBENDAZOLE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212996", "application_type": "ANDA", "sponsor_name": "LANNETT CO INC", "brand_names": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "active_ingredients": [ "CHLORPROMAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210871", "application_type": "ANDA", "sponsor_name": "LUOXIN AUROVITAS", "brand_names": [ "TOBRAMYCIN" ], "active_ingredients": [ "TOBRAMYCIN" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INHALATION" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210344", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "URSODIOL" ], "active_ingredients": [ "URSODIOL" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210165", "application_type": "ANDA", "sponsor_name": "COREPHARMA", "brand_names": [ "PIOGLITAZONE HYDROCHLORIDE" ], "active_ingredients": [ "PIOGLITAZONE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-22", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA212888", "application_type": "NDA", "sponsor_name": "VIIV HLTHCARE", "brand_names": [ "CABENUVA KIT" ], "active_ingredients": [ "CABOTEGRAVIR", "RILPIVIRINE" ], "dosage_forms": [ "SUSPENSION, EXTENDED RELEASE" ], "routes": [ "INTRAMUSCULAR" ], "approval_date": "2021-01-21", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity and Type 4 - New Combination" }, { "application_number": "NDA212887", "application_type": "NDA", "sponsor_name": "VIIV HLTHCARE", "brand_names": [ "VOCABRIA" ], "active_ingredients": [ "CABOTEGRAVIR SODIUM" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-21", "review_priority": "PRIORITY", "submission_class": "Type 3 - New Dosage Form" }, { "application_number": "ANDA214734", "application_type": "ANDA", "sponsor_name": "ALEMBIC", "brand_names": [ "MIDODRINE HYDROCHLORIDE" ], "active_ingredients": [ "MIDODRINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214235", "application_type": "ANDA", "sponsor_name": "CAPLIN", "brand_names": [ "ARGATROBAN" ], "active_ingredients": [ "ARGATROBAN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213927", "application_type": "ANDA", "sponsor_name": "ADAPTIS", "brand_names": [ "VENLAFAXINE HYDROCHLORIDE" ], "active_ingredients": [ "VENLAFAXINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210157", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "OSELTAMIVIR PHOSPHATE" ], "active_ingredients": [ "OSELTAMIVIR PHOSPHATE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208942", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "DOXYCYCLINE" ], "active_ingredients": [ "DOXYCYCLINE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-21", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214377", "application_type": "NDA", "sponsor_name": "MSD", "brand_names": [ "VERQUVO" ], "active_ingredients": [ "VERICIGUAT" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-19", "review_priority": "PRIORITY", "submission_class": "Type 1 - New Molecular Entity" }, { "application_number": "ANDA213271", "application_type": "ANDA", "sponsor_name": "AJANTA PHARMA LTD", "brand_names": [ "LAMOTRIGINE" ], "active_ingredients": [ "LAMOTRIGINE" ], "dosage_forms": [ "TABLET, ORALLY DISINTEGRATING" ], "routes": [ "ORAL" ], "approval_date": "2021-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208005", "application_type": "ANDA", "sponsor_name": "MYLAN", "brand_names": [ "FINGOLIMOD HYDROCHLORIDE" ], "active_ingredients": [ "FINGOLIMOD HYDROCHLORIDE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-19", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "NDA214313", "application_type": "NDA", "sponsor_name": "BAXTER HLTHCARE CORP", "brand_names": [ "NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE", "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE" ], "active_ingredients": [ "NOREPINEPHRINE BITARTRATE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "NDA206610", "application_type": "NDA", "sponsor_name": "RISING", "brand_names": [ "ACETAMINOPHEN" ], "active_ingredients": [ "ACETAMINOPHEN" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "Type 5 - New Formulation or New Manufacturer" }, { "application_number": "ANDA212130", "application_type": "ANDA", "sponsor_name": "MEITHEAL", "brand_names": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "active_ingredients": [ "MYCOPHENOLATE MOFETIL HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA211919", "application_type": "ANDA", "sponsor_name": "RISING", "brand_names": [ "METHYLERGONOVINE MALEATE" ], "active_ingredients": [ "METHYLERGONOVINE MALEATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210473", "application_type": "ANDA", "sponsor_name": "SUN PHARM", "brand_names": [ "EPOPROSTENOL SODIUM" ], "active_ingredients": [ "EPOPROSTENOL SODIUM" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA206604", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "FERUMOXYTOL" ], "active_ingredients": [ "FERUMOXYTOL" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-15", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213826", "application_type": "ANDA", "sponsor_name": "MACLEODS PHARMS", "brand_names": [ "NYSTATIN" ], "active_ingredients": [ "NYSTATIN" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213344", "application_type": "ANDA", "sponsor_name": "GRANULES", "brand_names": [ "METFORMIN HYDROCHLORIDE" ], "active_ingredients": [ "METFORMIN HYDROCHLORIDE" ], "dosage_forms": [ "TABLET, EXTENDED RELEASE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213279", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "NALOXONE HYDROCHLORIDE" ], "active_ingredients": [ "NALOXONE HYDROCHLORIDE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA209931", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA", "brand_names": [ "BEXAROTENE" ], "active_ingredients": [ "BEXAROTENE" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204600", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "SEVELAMER CARBONATE" ], "active_ingredients": [ "SEVELAMER CARBONATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204490", "application_type": "ANDA", "sponsor_name": "HIKMA", "brand_names": [ "DOCETAXEL" ], "active_ingredients": [ "DOCETAXEL" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-14", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214603", "application_type": "ANDA", "sponsor_name": "ASCENT PHARMS INC", "brand_names": [ "GEMFIBROZIL" ], "active_ingredients": [ "GEMFIBROZIL" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213111", "application_type": "ANDA", "sponsor_name": "RHODES PHARMS", "brand_names": [ "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE" ], "active_ingredients": [ "AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA204305", "application_type": "ANDA", "sponsor_name": "TEVA PHARMS USA INC", "brand_names": [ "ETHINYL ESTRADIOL; ETONOGESTREL" ], "active_ingredients": [ "ETHINYL ESTRADIOL", "ETONOGESTREL" ], "dosage_forms": [ "RING" ], "routes": [ "VAGINAL" ], "approval_date": "2021-01-13", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA091055", "application_type": "ANDA", "sponsor_name": "STRIDES PHARMA", "brand_names": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "active_ingredients": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-13", "review_priority": "", "submission_class": "" }, { "application_number": "ANDA213301", "application_type": "ANDA", "sponsor_name": "UNICHEM", "brand_names": [ "CELECOXIB" ], "active_ingredients": [ "CELECOXIB" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210625", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "FOSAPREPITANT DIMEGLUMINE" ], "active_ingredients": [ "FOSAPREPITANT DIMEGLUMINE" ], "dosage_forms": [ "POWDER" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-12", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213951", "application_type": "ANDA", "sponsor_name": "VISTAPHARM LLC", "brand_names": [ "ACYCLOVIR" ], "active_ingredients": [ "ACYCLOVIR" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212301", "application_type": "ANDA", "sponsor_name": "ENCUBE", "brand_names": [ "TESTOSTERONE" ], "active_ingredients": [ "TESTOSTERONE" ], "dosage_forms": [ "SOLUTION, METERED" ], "routes": [ "TRANSDERMAL" ], "approval_date": "2021-01-11", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214684", "application_type": "ANDA", "sponsor_name": "UNIQUE PHARM", "brand_names": [ "LORATADINE" ], "active_ingredients": [ "LORATADINE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA214534", "application_type": "ANDA", "sponsor_name": "DR REDDYS", "brand_names": [ "FLUPHENAZINE HYDROCHLORIDE" ], "active_ingredients": [ "FLUPHENAZINE HYDROCHLORIDE" ], "dosage_forms": [ "TABLET" ], "routes": [ "ORAL" ], "approval_date": "2021-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213806", "application_type": "ANDA", "sponsor_name": "AVET LIFESCIENCES", "brand_names": [ "PENTAMIDINE ISETHIONATE" ], "active_ingredients": [ "PENTAMIDINE ISETHIONATE" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA210696", "application_type": "ANDA", "sponsor_name": "EUGIA PHARMA", "brand_names": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "active_ingredients": [ "PHENYLEPHRINE HYDROCHLORIDE" ], "dosage_forms": [ "SOLUTION" ], "routes": [ "INTRAVENOUS" ], "approval_date": "2021-01-07", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA213256", "application_type": "ANDA", "sponsor_name": "ANI PHARMS", "brand_names": [ "LEVOTHYROXINE SODIUM" ], "active_ingredients": [ "LEVOTHYROXINE SODIUM" ], "dosage_forms": [ "CAPSULE" ], "routes": [ "ORAL" ], "approval_date": "2021-01-06", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212699", "application_type": "ANDA", "sponsor_name": "LUPIN", "brand_names": [ "SULFAMETHOXAZOLE AND TRIMETHOPRIM" ], "active_ingredients": [ "SULFAMETHOXAZOLE", "TRIMETHOPRIM" ], "dosage_forms": [ "SUSPENSION" ], "routes": [ "ORAL" ], "approval_date": "2021-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA208660", "application_type": "ANDA", "sponsor_name": "CHARTWELL RX", "brand_names": [ "LIDOCAINE" ], "active_ingredients": [ "LIDOCAINE" ], "dosage_forms": [ "OINTMENT" ], "routes": [ "TOPICAL" ], "approval_date": "2021-01-05", "review_priority": "STANDARD", "submission_class": "" }, { "application_number": "ANDA212915", "application_type": "ANDA", "sponsor_name": "SANDOZ", "brand_names": [ "CYANOCOBALAMIN" ], "active_ingredients": [ "CYANOCOBALAMIN" ], "dosage_forms": [ "INJECTABLE" ], "routes": [ "INJECTION" ], "approval_date": "2021-01-04", "review_priority": "STANDARD", "submission_class": "" } ] }